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PBST = Phosphate Buffered Saline Tween 20
PC = post challenge
PI = post inoculation
PM. = post mortem
PMSF = Phenylmethylsulphonyl fluoride
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Cowdria ruminatium is the causative agent of heartwater, an important tick-borne disease of ruminants in sub-Saharan Africa.
Animals which recover after natural or experimental infections of heartwater are solidly immune to homologous challenge but, the
immune responses responsible for protection against heartwater are poorly characterised.
This study sought to identify antigens involved in protective immune responses to Cowdria by Western blotting using immune sera
and surface labelling of elementary body (EB) proteins using biotin to identify which of these are outer membrane proteins.
Antigens which could be considered as potential vaccine candidates were identified.
Immunisation of goats with live Cowdria or with inactivated elementary bodies (IEBs) leads to development of antibodies to at
least six antigenic components of the EB of 24kDa, 27kDa, 31kDa, 58kDa and 66kDa. In contrast immunisation of goats with
detergent extracted soluble antigens stimulated production of antibodies to only four antigens of 24kDa, 27kDa, 28kDa and
31kDa. Six surface exposed antigens of the Cowdria elementary body were identified by biotin labelling, with molecular masses
of 21kDa, 28kDa, 31kDa, 62kDa, 74kDa and 115kDa and are therefore considered outer membrane proteins. These proteins
reacted with antibodies in sera raised by immunisation of goats with live or inactivated EBs. The 58kDa heat shock protein
(GroEL) of C. ruminantium is an immunodominant antigen. The immune responses to 58kDa antigen expressed as a recombinant
in E. coli were investigated by immunisation of mice and sheep. The immunised animals stimulated specific antibody which
reacted with the native homologue on the EB 58kDa.
In order to investigate the possibility that immunisation with live or inactivated organisms induces qualitatively different immune
responses , IgG isotyping was undertaken using sera from natural and experimental infections of C. ruminantium or immunisation
with IEBs. Production of IgG, and IgG2 antibodies in animals has been associated with T helperl and T helper 2 (Thl and Th2)
responses respectively. Antigen specific IgG, but not IgG2 was detected in the sera of goats and sheep experimentally infected
with C. ruminantium.. In contrast a low but detectable concentration of IgG2 and a high concentration of IgG, was detectable in
field sera from cattle naturally exposed to heartwater. Specific IgG2 was induced in goats after first priming the immune response
by immunisation with IEBs. IgG, was dominant in sera of goats after immunisation with IEBs however, immunisation of cattle
with killed organisms induced a high level of specific IgG, and IgG2. Live infections of Cowdria in mice induce a dominant IgG2a
antibody response unlike the case in goats and sheep. This indicated that mice respond differently from small ruminants to live C.
ruminantium. The results suggest that live organisms suppress a Thl type antibody profile (IgG2 production) except following
immunisation with killed organisms. The suppression of protective Thl responses of immunised goats aids the transmission of the
parasite. Production of IgG2 after challenge of IEB immunised goats may provide a method for monitoring vaccination trials in the
future.
Immunisation with recombinant 58kDa heat shock protein of C. ruminantium led to development a of specific antibody response
of the IgG, isotype. Challenge of immunised sheep showed a highly significant reduction (p<0.005) in infection rates of brain
capillary endothelial cells in the immunised group compared to control animals. However the incubation period and clinical
outcome were not significantly different in controls and immunised sheep. Mice immunised with recombinant 58kDa were
partially protected against virulent homologous challenge. The lack of protection in sheep was attributed to failure of the antigen
to induce a detectable lymphocyte response.
IFN-y is produced by PBMC from I/T and IEB immunised goats in response to stimulation with Cowdria. In contrast, no IFN-y
response was detected with PBMC from sheep immunised with recombinant 58kDa hsp.
Protection of ruminants against cowdriosis in the future will depend on the development of save and easy to use vaccines. This
study identified at least 6 antigens for further study to which dominant antibody responses were made by animals immunised with
live or inactivated antigens. The use of alternative antigen delivery system for induction of T helper responses to Cowdria antigens
are required for assessment of candidate vaccines for immunisation.




Heartwater (Cowdriosis) is an infectious virulent tick-borne disease of
domestic and wild ruminants caused by the rickettsial organism Cowdria
ruminantium. The disease is characterised by high fever, nervous symptoms,
hydrothorax and hydropericardium. Heartwater is transmitted transtadially by ticks
in the genus Amblyomma (Uilenberg, 1983; Camus and Barre, 1988; Kobold,
Martinez, Camus and Jongejan, 1992).
Heartwater occurs throughout most of sub-Saharan Africa from Cape
Province of South Africa to Kassala in the Sudan, from Senegal in the west to
Somalia in the East (Uilenberg, 1983). It occurs over an estimated area of 13
2
million km (Neitz, 1968). The disease also occurs in the islands near the eastern
coast of Africa such as Madagascar, La Reunion and Mauritius (Perreau et al.,
1980), Zanzibar (Flash et al., 1990), Comoros (Du Plessis, Van Gas, Oliver, and
Bezuidenhout, 1989), Sao Tome in the Atlantic Ocean (Uilenberg, Corten and
Dwinger, 1982) and some Caribbean Islands (Uilenberg, 1983; Kobold, Matrinez,
Camus and Jongejan, 1992). The American continent is now at risk because of the
presence of suitable Amblyomma vectors on the mainland (Camus, Barre, Martinez
and Uilenberg, 1996).
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In East, Central and Southern Africa, heartwater is ranked as the third most
important disease of livestock after east coast fever and the tsetse transmitted
trypanosomiasis (Uilenberg, 1983). In these areas mortalities due to heartwater are
as great as those caused by babesiosis and anaplasmosis combined (Neitz, 1968).
North of the equator, it is ranked as the third most important livestock disease after
rinderpest and schistosomiasis (Camus and Barre, 1988 quoting Provost,
unpublished data). In terms of distribution, however, heartwater is more
widespread than the other tick-borne diseases in that 175 million ruminants in
Africa and 81,000 in the Caribbean are at risk (Norval, 1991).
Animals which recover from natural and experimental heartwater infection
develop solid immunity to homologous challenge and show a variable degree of
resistance to heterologous challenge. Immunity to heartwater in the ruminant is not
clearly understood. Antibodies do not seem to play a significant role in protecting
the animal against challenge. This has led to the belief that cell mediated immunity
may be responsible for protection. In the mouse, protection is by Lyt2+ (CD8+) T
cells (Du Plessis, Berche and Van Gas, 1991; Du Plessis, Gray and Van Strijp,
1992).
Control of heartwater has been achieved in three ways namely:-
1. Tick control by regular application of acaricides to kill the vector i.e. ticks
in the genus Amblyomma.
2. Treatment of infected animals with chemotherapeutic compounds such as
tetracyclines and sulphonamides.
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3. Vaccination by the infection/treatment method. The vaccines used are either
blood stabilates from infected animals or ground-up tick suspensions from
infected tick larvae (Oberem and Bezuidenhout, 1987a). The vaccines are
administered intravenously followed by treatment with antibiotics on the
second day of fever.
These methods have worked well but they have limitations such as
development of resistance to acaricides by the ticks and the high cost of both drugs
and acaricides. Furthermore, the infection and treatment method of vaccination is
severely limited by antigenic diversity among isolates of C. ruminantium, lability of
vaccine therefore requiring cold storage, high cost of production and the fact that
they can only be administered by a qualified person.
1.2. Economic Importance ofHeartwater /Cowdriosis
The economic importance of this disease has been reviewed by Camus and
Barre (1988), Norval (1991) and Camus et al. (1996).
In 1990 FAO/WHO/OIE estimated the population of cattle in Africa and the
Caribbean Islands to be 175 million and 81,000 head respectively. These animals
are either in countries where heartwater has been confirmed (Provost and
Bezuidenhout, 1987) or where vectors occur but the disease has not been confirmed
(Walker and Olwage, 1987).
The economic effects due to heartwater fall into two main categories namely
direct and indirect losses (Camus and Barre, 1988; Norval, 1991).
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Direct losses are those which arise due to mortality which occurs under the
following conditions: when susceptible animals are moved to endemic areas from
heartwater-free areas, when there are epidemics of the disease, when the vectors
spread from endemic areas to previously tick-free areas; when there is failure of tick
control and finally when susceptible animals are raised in endemic areas.
Indirect losses arise from the following: subclinical infections which affect
the productive performance of the animal, the cost of controlling the vectors,
treatment of clinical cases and the inability to upgrade or improve local breeds by
crossbreeding with exotic animals since, pure-bred exotic animals and their crosses
are highly susceptible to this disease and always develop the peracute and the acute
forms of the disease (Uilenberg, 1982b; Camus and Barre, 1988). Finally the
export of animals from heartwater endemic countries is limited by legislation due to
the risk of spreading the disease to free countries. Another danger the disease poses
is that it could spread to areas where there are potential vectors like the North
American continent (Uilenberg, 1983) and the Middle East.
The aim of the work described in this thesis is to study the immune
responses of ruminants and mice to C.ruminantium by: characterisation of antigenic
components of the elementary body of C. ruminantium, Investigation of the
humoral and cellular immune responses of goats inoculated with live or inactivated
immunogens and characterisation of immune responses of mice and sheep
immunised with a recombinant 58kDa heat shock protein of C. ruminantium.
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CHAPTER TWO
REVIEW OF THE LITERATURE
2.1. History.
Heartwater was first recognised in South Africa in sheep and goats. The
earliest record is from 1838 when Louis Trichardt (cited by Neitz, 1947) who
reported a nervous disease in sheep resulting from tick infestation. The tick was
later identified as Amblyomma herbraeum by Lounsbury (1900). Other early
reports of the disease date back to 1858 (Alexander, 1931 quoting the evidence of
Mr. Webb) and 1860 (Hutcheon, 1900). The disease was later reported in Central
Africa (van Saceghem, 1918), Kenya (Daubney, 1930a), Malagasy (Durieux, 1931),
the Sudan (Curasson and Deply, 1928) and the rest of East Africa (Lewis, 1939).
Although the disease was recognised in the mid 1880s it was not until 1925
that Cowdry (1925a, 1925b) demonstrated that the causative agent was a rickettsia-
like organism present in tissues of infected animals and the vector. He gave it the
name Rickettsia ruminantium which was later changed to Cowdria ruminantium by
Moshkovskii (1947).
2.2. Identification and Classification ofCowdria ruminantium.
2.2.1. Classification.
Cowdry (1925a, 1925b) identified the heartwater organism as a rickettsia by
its intracellular location, morphology and gram staining characteristics. Mohan
(1968) and Prozesky, Bezuidenhout and Paterson (1986) examined C. ruminantium
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in endothelial cells and concluded that morphologically were similar to chlamydia
more than rickettsia. Du Plessis (1975), on the other hand observed that Cowdria
were found freely in the cytoplasm of reticuloendothelial cells of ruminants as
rickettsia. Cowdria however are normally found in membrane bound vacuoles in
the cytoplasm of infected endothelial cells (Pienaar, 1970; Du Plessis, 1985b;
Jongejan, et al., 1991c). Although Cowdria and Chlamydia have similar life
cycyles, they do not have close phylogenetic relationship. Scott (1987) gave the





Analysis of the nucleotide sequence of the 16S ribosomal RNA gene of C.
ruminantium shows that it is closely related phylogenetically to some members of
the tribe Ehrlichiae (van Vliet, Jongejan and van der Zeijst, 1992).
2.2.2. Morphology and staining.
Rickettsiae are fastidious obligate intracellular bacteria which are
metabolically independent from their host cells (Bovarnick and Snyder, 1949).
They are pleomorphic coccobacilli which range from 300 nm to 700 nm in size.
They inhabit cytoplasmic vacuoles in the cells they infect. Colonies of organisms
in the Family Ehrlichiae to which C. ruminantium belongs appear as compact
inclusions containing varying number of organisms which occur in clusters referred
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to as initial bodies (reticulate bodies) and elementary bodies (Ewing, 1969). These
organisms are Gram negative, however they stain better with Giemsa (Woldehiwet
and Ristic, 1993).
Organisms in the genus Cowdria range between 300 nm to 500 nm in
diameter and are found in the cytoplasm of endothelial cells of the blood capillaries
in the brain, renal glomeruli, jugular vein and in neutrophils and macrophages of
infected ruminants (Cowdry, 1925a,b; Pienaar, 1970; Du Plessis, 1985a; Logan et
al., 1987b). The colonies of these organisms occur singly or in clumps
morphologically, individual organisms are pleomorphic (Cowdry, 1925a, b;
Jackson and Neitz, 1932; Du Plessis, 1970b). Pienaar (1970) described three forms
of colonies of C. ruminantiun namely: small, medium and giant measuring
0.49 pm, 1.04 pm and 2.7 pm in diameter respectively. Other forms include ring
shapes, bacillary, diploid and horse shoe (Andreasen, 1974; Ilemobade, 1976).
Larger forms of up to 4.0 pm have been reported (Pienaar, 1970). Very small forms
have also been described (Du Plessis, 1975a; Prozesky and Du Plessis, 1987).
Cowdria has a life cycle similar to that of Chlamydia (Jongejan, et al., 1991c). Its
life cycle of infection is composed of elementary (EBs) which change into reticulate
bodies in the host after infection and develop into EBs which mature during
intracellular infection.
2.3. Isolates ofCowdria ruminantium.
Several isolates of C. ruminantium have been described and are reviewed by
(Bezuidenhout, Prozesky, Du Plessis and Van Amstel 1994) (Table 2.1) and
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Camus, Barre, Martinez and Uilenberg, 1996). More stocks are being reported as
research in heartwater continues for instance, the 10 stocks isolated recently from
different parts of Kenya (Ngumi Rumberia, Williamson, Sumption, Lesan, and
Kariuki, 1997).
Table 2.1 Stocks (strains) of C. ruminantium
Country of
Stock Source Reference origin
Ball 3 Cow Haig (1952) S. Africa
Breed Angora goat Du Plessis et.al. (1983)
II
Comoro A. variegatum DuPlessis et.al. (1989) Comoro
Germishuys Sheep Du Plessis et. al. (1984) S. Africa
Kumm Mice Du Plessis & Kumm It
(1971)
Kwanyanga Mice Mackenzie & van
It
Rooyen (1981)
Nonile A. herbraeum Mackenzie & McHardy II
(1984)
Mara A. herbraeum II
Welgevonden Mice Du Plessis (1985a) S. Africa
Mali A. variegatum Logan et.al. (1985) Mali W. Africa
Gardel Goat Uilenberg, et. al. (1985) Guadeloupe
UmBanein Goat Abdel Rahim & Sudan
Shomein (1978)
Kiswani A. variegatum Kocane/.a/. (1987) Kenya
D225 Goat Ilemobade, (1976) Nigeria
Palm River A. herbraeum Byrom&Yunker (1990) Zimbabwe
Highway If II II
Silver Springs It II II
Kenya isolates Ngumi et al. (1997) Kenya
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2.4. Life Cycle of Cowdria ruminantium.
2.4.1. Life cycle in the tick vector.
Cowdria ruminantium parasitises epithelial cells of the midgut (Cowdry,
1925b; Kocan and Bezuidenhout, 1987), malphigian tubules, epithelial cells and
acini of salivary glands (Kocan, Bezuidenhout, and Hart, 1987) and haematocytes
(Du Plessis, 1985a) of its tick host. Colonies have been seen in larval, nymphal and
adult stages of the ticks (Kocan, et ah, 1987; Kocan, Morzaria, Voigt, Kiarie and
Irvin, 1986). These colonies are invariably in membrane-bound intracellular
vacuoles regardless of their location in the host (Bezuidenhout, 1984).
Kocan et al. (1986) described the life cycle of C. ruminantium in A.
variegatum under experimental conditions. Colonies appeared 15 days after the
tick had engorged and dropped off the mammalian host. The size of colonies in the
midgut epithelial cells is variable, the predominant stage of the organism within the
cells being the reticulated form and reproduction was by binary fission. In addition
to the reticulated forms, electron dense forms (possibly elementary bodies) were
present in small colonies seen in some epithelial cells.
Colonies of C. ruminantium in the epithelial cells of salivary gland acini
varied in size from 5 pm to 30 pm in diameter (Kocan et al., 1987). Individual
organisms within the colonies were pleomorphic with small dense staining forms in
some colonies and larger individual organisms present in simple granular cells of
type I and type II acini. Colonies in the salivary gland epithelial cells also contained
the reticulated forms observed in the gut epithelial cells. Multiplication of the
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organisms in these colonies was by binary fission (Kocan et al., 1987). In the insect
vector the life cycle of C. ruminantium is dominated by the reticulate stage
(Reticulate bodies, RBs) but the elementary bodies were not noted.
2.4.2. Life cycle in the mammalian host.
Cowdria ruminantium proliferates in the vascular endothelium, neutrophils,
macrophages and reticulo-endothelial cells of mammals (Cowdry, 1925a; Prozesky
and Du Plessis, 1987; Logan et al., 1987b). Various stages of the life cycle have
been observed by light and electron microscopy in endothelial cells of animals
dying from heartwater (Pienaar, 1970; Du Plessis, 1985a). C. ruminantium was
observed first in endothelial cells of blood capillaries of renal glomeruli and the
superficial layer of the grey matter of the brain (Cowdry, 1925a).
Primary development of C. ruminantium is thought to occur in the reticulum
of lymph nodes draining tick feeding sites. The rickettsiae may be disseminated by
macrophages which phagocytose C. ruminantium at the site and transport them to
the regional lymph node. After multiplication and maturation they are released via
the efferent lymph into the blood stream where they infect endothelial cells of the
blood capillaries in various organs including the brain (Du Plessis, 1970b, 1985b;
Ilemobade, 1976). The life cycle in the mouse is reported to consist of two phases
of rickettsaemia Du Plessis (1982). Ilemobade (1976) was of the opinion that C.
ruminantium is introduced directly into the circulatory system of ruminants
following tick feeding, is taken up by macrophages and transported to the regional
lymph nodes where the first phase of replication occurs. After maturation of EBs,
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infected cells rupture liberating the EBs which enter the blood stream via efferent
lymph and become the first phase of rickettsaemia. The EBs in the blood stream
invade and replicate in endothelial cells. After maturation the EBs are released by
cell lysis into the blood to form the second rickettsaemia.
The life cycle of C. ruminantium in mammals was not clearly understood
until the organism was grown successfully in vitro in cell cultures of endothelial
cells and neutrophils (Bezuidenhout, Camilla and Barnard, 1985; Bezuidenhout,
1987a; Logan et al., 1987b; Jongejan et al., 1991c). Growth of C. ruminantium in
neutrophils is characterised by the appearance of one to several small cocci, large
forms or rods located in membrane bound phagosomes undergoing binary
fission.(Logan et al., 1987a).
The life cycle of C. ruminantium in bovine endothelial cells has been
described in detail by Jongejan et al. (1991c). In these cells it is characterised by
two forms, an extracellular infectious form the elementary body (EB) and an
intracellular vegetative form the reticulate body (RB). The life cycle in the
endothelial cells begins when EBs are internalised by a process similar to
phagocytosis (Prozesky and Du Plessis, 1987; Jongejan et. al., 1991c). The EBs
become surrounded by a double membrane originating from the host cell cytoplasm
and within 2 to 4 days they change to reticulate bodies of 1.2 to 2.0 pm in diameter.
These RBs develop and undergo binary fission, reorganisation and condensation of
DNA material, and subdivide again by binary fission. After 3 to 4 days in cultures
the RBs become smaller in size with an electron dense core to become intermediate
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bodies (IBs). The IBs undergo further DNA condensation without cell division to
become EBs which are released into growth medium by lysis of the host cell. The
complete life cycle in cultured endothelial cells takes 5 to 6 days from infection to
release of EBs
2.5. Transmission ofHeartwater.
2.5.1. Hosts and vectors ofCowdria ruminantium.
Heartwater is a disease of ruminants especially cattle, sheep and goats
(Alexander, 1931; Neitz, 1939; Ilemobade, 1976; Camus and Barre, 1988) and wild
ruminants such as antelopes and blesbucks (Neitz, 1933, 1937). Dardiri, Logan and
Mebus (1987) produced heartwater by experimental infection in white tailed deer
(Odocoileus virginianus) and Okoh, Oyetunde and Ibu (1987) found Cowdria
ruminantium at post mortem in brain smears from a captured Sitatunga
(Tragelaphus spekii) infested with A. variegatum. Several species of wild
ruminants can also be infected (reviewed by Oberem and Bezuidenhut 1987b).
2.5.2. Vectors.
Cowdria ruminantium is transmitted naturally by ticks in the genus
Amblyomma. Transmission occurs transtadially from larvae to nymphs and from
nymphs to adults and to a minor extent transovarially (Uilenberg, 1983;
Bezuidenhout and Jacobz, 1986; Camus and Barre, 1988). Thus any of the 3 stages
can transmit the disease to the mammalian hosts. The most efficient vectors are the
adult females whereas the males appear to be poor vectors (Alexander, 1931;
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Ilemobade, 1976; Ilemobade and Leeflang, 1978). Ticks can remain infected for 15
months to 3 years (Ilemobade, 1976; Neitz, 1968 ).
Two species ofAmblyomma are the main vectors in sub-Saharan Africa and
the Caribbean islands. In Southern Africa A. hebraeum (Lounsbury, 1900) is the
principle vector while in the rest of Africa and the Caribbean it is A. variegatum
(Daubney, 1930b). The other species in this genus are less efficient vectors,
(Walker and Olwage, 1987). Eleven species (9 African and 2 American) of
Amblyomma can transmit heartwater (Uilenberg, 1983) including A. gemma and A.
lepidum (Ngumi et al., 1997). Ticks infected as larvae transmit the disease as
nymphs while those infected as nymphs transmit as adult.
2.5.3. Distribution ofAmblyomma ticks.
The distribution of the tick vectors of C. ruminantium has been reviewed by
Uilenberg (1983) and Camus and Barre (1988). A. variegatum is well adapted to
parasitise domestic livestock and has a wide distribution throughout most parts of
tropical sub-Saharan Africa, the islands around the east and west coast of Africa, to
the south of the Arabian Peninsula and several of the Caribbean Islands. A.
hebraeum is limited to southern and south-eastern Africa (Uilenberg, 1983; Camus
and Barre, 1988). Other species of the tick which can potentially transmit C.
ruminantium include A. gemma and A. lepidum which inhabit the dry areas of
eastern and north-eastern Africa and Kenya (Ngumi et al., 1997), A. pomposum in
Angola and parts of southern and central Africa, and A. cohaerens which infests the
savannah buffalo of central and eastern Africa and cattle in parts of Ethiopia
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(Pegram, Hoogstraal, and Wassef, 1981). The main factors which determine the
distribution of the vectors are height above sea level, temperature, rainfall,
vegetation, seasonality and hosts. Adult A. variegatum are adapted to live on
ruminants. Larvae and nymphs of the tick however are less discriminate and can
feed on any mammal, an adaptation which enables them to survive in situations
where alternative hosts are present. Once the ticks are infected they remain
infective for life and transmit the organism to subsequent instars.
2.5.4. Artificial transmission ofheartwater.
Heartwater was first transmitted artificially to susceptible animals by
inoculation of infectious blood from an infected animal (Edington, 1898; Dixon,
1898 cited by Provost and Bezuidenhout 1987). This was followed by the work of
Spreull (1904) and Theiler (1905). Alexander (1931) showed that administration of
infected blood by the intravenous route (i.v) is more reliable than any other route
and that the size of inoculum was also critical. Alexander (1931) found that i.v
administration of 10 ml or 5 ml infectious cattle or sheep blood respectively was
adequate to cause disease in the two species. Theiler and Du Toit (1928) showed
that C. ruminantium could be transmitted by i.v injection of emulsified infected A.
hebraeum nymphs demonstrating for the first time that nymphs could act as vectors.
Other organs such as mesenteric and popliteal lymph nodes from sheep infected
with heartwater were used to transmit the disease to sheep (Du Plessis, 1970b) and
infected brain suspensions were infective to cattle sheep and goats by i.v
inoculation (Uilenberg, 1971).
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Although 5 ml of infective blood stabilate has been used as the standard
dose for inducing heartwater in small ruminants for many years, lower amounts of
infective blood have been used. Heartwater has been induced in sheep with as little
as 0.02 ml of virulent blood using the i.v route (Camus and Barre, 1988). Other
workers have used 2 mis of virulent infective blood to induce hearwater in goats
(Tafesse, 1992). In the bovine 5 mis of infective blood or 4 mis of infective nymph
suspensions have been used (Oberem and Bezuidenhout, 1987; Lawrence et al.
(1993).
EBs in vitro culture are highly infectious (Jongejan et al., 1991c). The animal
infective dose using EBs and in vitro culture has not been thoroughly investigated
but is of critical importance to these studies.
The other routes of inoculation which have been used to induce heartwater
with varying degrees of success include the subcutaneous (Uilenberg, 1983;
Ilemobade and Blotkamp, 1976, 1978), intracerebral, intrathoracic and
intramuscular routes (Camus and Barre, 1988).
Although the source, dose, concentration and size of the infecting inoculum
is important, the route of administration is critical and i.v. is the most successful,
giving infection rates of 98-100%, depending on the species being inoculated
(Uilenberg, 1983). Susceptibility to infection also varies among domestic
ruminants, cattle are less reactive to i.v inoculation than sheep and goats (Van de
Merwe, 1979; Du Plessis and Bezuidenhout, 1979).
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It is clear from the foregoing review that the amount of inoculum, its origin,
the route of inoculation and the susceptibility of the recipient species determines the
outcome and response to experimental infection. Experimental challenge of goats
and sheep in this study were inoculated by i.v since it is the most reliable and
successful method of infecting ruminants.
2.5.5. Cultivation ofC. ruminantuim.
Cultivation of C. ruminantium in experimental hosts and under in vitro
conditions is reviewed by Camus, et al., (1996).
2.5.5.1. Experimental animals.
Attempts have been made to cultivate C. ruminantium in various
experimental animals with varying degrees of success. Animals that have been used
include rats, guinea pigs (Balozet, 1935, 1936), ferrets (Mason and Alexander,
1940), albino rats deprived of vitamin B2 (Hudson and Henderson, 1941), rabbits
(Mason and Alexander, 1940), hamster (IEMVT, 1968) and vervet monkey
(Pelissier, Troquereau and Triquier, 1950). However, it was not until Haig (1952)
successfully passaged C. ruminantium in mice 9 times without losing infectivity for
sheep that the use of mice for experimental infection became established. Ramisse
and Uilenberg (1971) repeated the work of Haig (1952) successfully. The first
mouse pathogenic C. ruminantium was isolated by Du Plessis and Kumm (1971),
the Kumm stock. Since then other mouse pathogenic stocks have been isolated
(Mackenzie and van Rooyen, 1981; Mackenzie and McHardy, 1984; Du Plessis,
1985a), the Kwanyanga, Nonile and Welgevonden stocks respectively. The clinical
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signs of cowdriosis in the mouse appear 24 hours before death and include,
increased respiratory rate, ruffled hair and difficulty in movement (Mackenzie and
McHardy, 1984). The discovery ofmouse pathogenic stocks of C. ruminantium led
to the development of a mouse model for experimental studies (Du Plessis and
Kumm, 1971). Since then mice have been used in experiments to predict drug
activity against C. ruminantium (McHardy and Mackenzie, 1984, 1987a), for
studies of immunity (Du Plessis et al., 1991) tick infection rates (Du Plessis,
1985a), genetic resistance (Du Plessis et al., 1990a) and pathogenesis (Du Plessis,
1975b).
2.5.5.2. In vitro cultivation.
Research in Cowdria was greatly constrained until its cultivation in vitro
was achieved. C. ruminantium was first cultivated successfully in vitro by
Bezuidenhout et al. (1985) in bovine endothelial cells which had been irradiated to
retard their growth. It has since been cultivated in non-irradiated endothelial cells
in several laboratories (Bezuidenhout, 1987a; Yunker et al., 1988; Jongejan et al.,
1991c; Byrom and Yunker, 1990; Byrom et al., 1991; Pow, Paxton and Sumption,
1993). Growth media such as Leibovits L,5 supplemented with 0.45% glucose and
Glasgow Modified Eagles Essential Medium (GMEM) are used routinely to isolate
and grow C. ruminantium (Camus, et al., 1996). In vitro cultivation of C.
ruminantium has led to a more complete understanding of its life cycle (Jongejan et
al., 1991c). It has enabled production of organisms for infection studies,
identification of antigenic components, preparation of inactivated immunogens, and
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isolation of pure DNA for molecular characterisation and cloning of genes coding
for protective antigens for recombinant vaccine development.
2.6. Pathogenesis ofCowdriosis.
The pathogenesis of cowdriosis is not clearly understood and to date no
satisfactory explanation has been put forward to explain the lesions observed at
postmortem (Camus and Barre, 1988). However a number of hypotheses have been
advanced.
2.6.1. Accumulation offluids in body cavities.
Accumulation of fluid in the thoracic cavity, pericardium, lung and the brain
has been attributed to increased capillary permeability which leads to seepage of
protein resulting in transudation of fluid through serous membranes (Clark, 1962;
Uilenberg and Camus, 1993). Severe lung oedema has been attributed to the
increased permeability of alveolar walls due to direct damage to the endothelial cell
junctions. However, gaps in the endothelium have not been demonstrated in
histological sections (Prozesky and Du Plessis, 1985a). Furthermore, cytopathic
changes in the parasitised cells cannot be observed microscopically indicating that
the organisms may not be responsible for the increased vascular permeability
(Pienaar, 1970; Prozesky and Du Plessis, 1985a). Pulmonary oedema in turn leads
to the concurrent respiratory distress observed in peracute and acute cowdriosis.
Increased capillary permeability and nervous signs which occur in peracute
cowdriosis have been attributed to the activity of a toxin (Jackson and Neitz, 1932;
Bezuidenhout, 1982). Bezuidenhout (1982) suggested that a toxin may be the most
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likely cause of the increased capillary permeability because acute pulmonary
oedema occurs in the absence of large number of organisms. A toxin or immune
complexes were thought to be responsible for severe renal lesions in Angora goats
(Prozesky and Du Plessis and 1985c). "Endotoxin" activity has been demonstrated
in the blood of sheep experimentally infected with heartwater (van Amstel el al.,
1988a; 1994). Two peaks of activity were demonstrated, one occuring shortly after
the febrile reaction and the other at the time when the animal was showing severe
clinical signs such as laboured breathing, cyanosis and recumbency. Van Amstel et
al. (1988a) demonstrated that protein leakage and increased capillary permeability
occurred at the onset of the febrile reaction, they concluded that the endotoxin
activity was responsible for increased capillary permeability. Lipopolysaccharide
has not been demonstrated in Ehrlichia unlike other rickettsiae (Woldehiwet and
Ristic, 1993) therefore LPS may not be responsible for this effect.
Pienaar, Basson and van de Merwe (1966) suggested that brain oedema was
associated with vasculitis caused by the organism in endothelial cells with
subsequent destruction of the endothelium leading to focal haemorrhage and
oedema. The same authors attributed glial lesions to the proximity of the
neurological cells to the infected endothelium. These hypotheses have not been
proved and other factors such as cytokines may be responsible for the lesions.
Involvement of cytokines in the pathogenesis has not been determined but is
strongly implicated.
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The role of cytokines in the pathogenesis of disease in animals and man is
now clearly established. In sheep infected with C. ruminantium, Interleukin-6 (IL-
6) induces secretion of acute phase proteins by hepatocytes and this cytokine is
involved in the inflammatory process of heartwater (Bensaid, Bourdulous, Lerhun
et al., 1993). These authors suggested that prolonged high levels of IL-6 provoke
uncontrolled inflammatory reactions which lead to the lesions observed in
heartwater. IL-6 is produced by macrophages and endothelial cells and acts as a
promoter of immune responses. It upregulates immunoglobulin (Ig) production and
is also involved in T cell activation, growth and differentiation (Shizuo, Tetsuya,
and Tadamitsu, 1993). IL-6 stimulates hepatocytes to produce numerous
antiproteases which negatively regulate the inflammatory response. In humans and
rodents there is a feedback loop in which IL-6 inhibits lipopolysacchide or tumor
necrosis factor (TFN-a) induced IL-1 production (Schindler et al., 1990). Another
pro-inflammatory cytokine produced by macrophages which has synergistic
interactions with TNF-a during the inflammatory process is IL-1 (Cavallion, 1993).
They both activate endothelial cells and induce production of IL-6 and IL-8. IL-1 is
a potent endogenous pyrogen and together with TNF-a and IL-6 stimulates fever.
IL-6 and TNF-a produce fever at higher concentrations than IL-1 and in humans
IL-1 induces fever, slow wave sleep (dullness) hemodynamic shock, leukopenia and
hypotension (Dinarello et al., 1993, cited by Delannoy, Leukeux and Miossec
1993). TNF-a in high doses leads to hemodynamic, pulmonary metabolic and
pathological consequences indistinguishable from endotoxaemia and septic shock.
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It further induces vascular permeability oedema and injury to endothelial cells and
appears to play a key role in systemic hypotension and altered metabolism. TNF-a
has been incriminated in lung injury in sheep (Redl, Schlag and Lamche, 1990),
cattle (Kenison, Elsasser and Fayer, 1991; Gerros, et al., 1993) and goats (van
Miert, van Duin and Wensing, 1992). The role played by cytokines in the
pathogenesis of heartwater is unfolding slowly and will become clearer as research
efforts are now being focused in this area.
Death in heartwater is attributed to extreme pulmonary cardiac distension or
pulmonary oedema (Uilenberg, 1977; Abdul-Rahim and Shomein, 1978), to
suppression of gammaglobulin response (Ilemobade, 1976) or to circulatory
collapse (Clark, 1962; Owen et al., 1973). Circulatory collapse could be attributed
to the effects of IL-1 and TNF-a as both are capable of inducing hemodynamic
shock and hypotension (Delannoy, Lekeux and Miossec, 1993). Extensive nephritis
which leads to irreversible kidney damage has been proposed as another cause of
death in heartwater (Prozesky and Du Plessis, 1985a). Another possibility is
asphyxia caused by extensive pulmonary oedema which is observed consistently in
peracute heartwater. Despite the many proposed causes of death in heartwater, no
firm consensus has been established. Death due to asphyxia resulting from
pulmonary oedema seems to be the most plausible explanation although goats and
sheep do not always show severe pulmonary oedema.
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2.6.2. Clinical signs ofheartwater in ruminants.
The clinical signs of heartwater have been reviewed by Camus and Barre
(1988), Camus et al., (1996), Uilenberg (1983) and van Pypekamp and Prozesky
(1987). The clinical disease occurs in three main forms: peracute, acute and
inapparent (Alexander 1931; Neitz, 1968). The symptoms observed in heartwater
are not characteristic and the form of disease which develops depends on the
species, immune status, age, individual susceptibility, and the stock of C.
ruminantium causing the infection.
The incubation period of the natural disease varies between 7 and 35 days
with an average of 14-18 days (Alexander, 1931; Neitz, 1968; Uilenberg, 1983).
The incubation period of experimental infections on the other hand varies from 5 to
14 days depending on the infecting dose, the type of inoculum and the route of
inoculation. In sheep, it takes 5 to 9 days while in cattle it takes 11 to 12 days
(Alexander, 1931; Neitz, 1968; Uilenberg, 1983) or shorter (van de Merwe, 1979).
Small ruminants are more susceptible to heartwater than cattle. They
develop peracute, acute and mild forms of this infection while cattle are more
resistant.
Peracute heartwater.
The peracute disease is common in exotic breeds and is accompanied by
sudden death with or without clinical symptoms in some animals. Animals which
survive longer develop fever in excess of 41°C followed by prostration, collapse,
convulsions, accelerated respiratory and pulse rates followed by death within 36
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hours (Uilenberg, 1983). A small proportion of sheep and goats show anorexia,
dullness, nystagmus, bleating, forced respiration, frequent urination and
defaecation, chewing movements and lateral recumbency followed by leg-pedalling
(Karrar, 1966; Spruell, 1922).
Acute form.
The acute form of heartwater is frequently seen in sheep and goats. It may
occur with or without pronounced symptoms after development of fever. This form
lasts 2 to 6 days. It is accompanied by a rapid temperature rise to 41 or 42 °C which
persists throughout the infection. The main clinical signs include: progressive
unsteady gait, holding the head down, listlessness, lateral recumbency, increased
respiratory and pulse rates, paddling and continuous galloping, licking of the lips
and nystagmus (Alexander, 1931) and occasionally diarrhoea (Uilenberg, 1981).
The disease can also occur as a subacute form in which less pronounced symptoms
develop over 7 to 10 days or as a chronic or inapparent form which is accompanied
by transient fever (Camus and Barre, 1988).
The disease in cattle is characterised by similar but less severe clinical signs
to those observed in sheep and goats.
The mortality rates of heartwater in ruminants range between 5 and 100%
and are dependent on the same conditions which affect the development of the
clinical disease (Camus and Barre, 1982; Haig, 1955; Uilenberg, 1981).
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2.7 Post Mortem (p.m.) Changes Observed in Cases of Cowdriosis in
Domestic Ruminants.
2.7.1. Macroscopicpathology.
The lesions which occur in heartwater infection of domestic ruminants are
always similar, but variable in extent and not pathognomonic (Uilenberg, 1981;
Prozesky, 1987b). The pathology of heartwater has been reviewed by Uilenberg
(1981) and Prozesky (1987b). In the following review the major and striking
changes which have been reported are given on a system to system basis. The
peracute cases normally show the severest lesions.
2.7 2. Respiratory system.
The most consistent pathological change in the respiratory system observed
in natural and experimental heartwater is marked oedema of the lungs. This
oedema can be diffuse with widened interlobular septae (Prozesky and Du Plessis,
1985c). Hydrothorax is also present with accumulation of a variable amount of
clear yellow fluid ranging from 40 ml in sheep and goats to 60ml or more in cattle.
Lung oedema is severest in animals which die from the peracute form of the disease
(van de PypeKamp and Prozesky, 1987). On cut surfaces, the lungs ooze a serous
and frothy fluid, the trachea and bronchi are filled with froth and the mucosae are
often congested and contain serofibrinous exudate.
2.7.3. Circulatory system.
Pronounced hydropericardium is commonly seen on necropsy examination.
This lesion is usually more severe in small ruminants than in cattle (Henning, 1956;
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Uilenberg, 1981; Prozesky, 1987b). Other changes include haemorrhages on the
heart muscle, and oedema of perirenal and mediastinal tissue (Uilenberg, 1981).
2.7.4. Lymph nodes.
The lymph nodes are usually enlarged and oedematous especially the
mediastinal and bronchial lymph nodes (Uilenberg, 1981; Prozesky and Du Plessis,
1985c; Prozesky, 1987b). On the cut surface, some of these lymph nodes especially
the retropharyngeal, submaxillary, cervical, bronchial and mediastinal have
petechial haemorrhages (Alexander, 1931).
2.7.5. Spleen.
Splenomegaly may or may not be present and is considered an infrequent
lesion in heartwater (Uilenberg, 1981; Andreasen, 1974; Ilemobade, 1976). This
lesion, however, has been observed in many cases examined in South Africa
(Prozesky, 1987b).
2.7.6. Urinogenital system.
In some reported cases of heartwater the kidneys are swollen, slightly pale
in sheep and congested in cattle (Steck, 1928 cited by Prozesky, 1987b). Oedema
of perirenal tissues has been reported in a few cases. The kidneys of experimentally
infected Angora goats were markedly enlarged, pale and with moderate oedema of
perirenal tissues (Prozesky and Du Plessis, 1985c).
2.7.7. Brain.
Oedema of the brain may or may not be present at p.m. (Uilenberg, 1983).
When it is present, the gyri of the cerebellum may be swollen and when the oedema
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is severe partial prolapse of the cerebellum has been observed. Other lesions
include congestion of the meninges, with accumulation of excessive fluid in the
subarachnoid space, thickening of the choroid plexus, petechiae, and ecchymoses in
the mid brain, brain stem and cerebellum (Pienaar, Basson and van de Merwe,
1966).
2.7.8. Other organs.
Congestion and oedema of the mucosa of abomasum, accompanied with
occasional petechial haemorrhages is a regular lesion in cattle but rare in sheep and
goats (Uilenberg, 1981). Petechiae have also been reported in the mucous
membranes of the urinary bladder, vagina and conjunctiva and haemorrhages have
been observed in the rectum accompanied by enterophagia (Prozesky, 1987b).
Hepatic lesions are uncommon in this disease, although slight to mild hepatomegaly
has been reported in some cases. However the gall bladder is normally distended
(Uilenberg, 1981; Prozesky, 1987b).
2.7.9. Microscopic pathology.
The most consistent finding in all animals is the presence of large numbers
of C. ruminantium colonies in endothelial cells of alveolar capillaries and the brain.
The other lesions are not characteristic. The only microscopic changes observed in
parasitised endothelial cells is distension (Cowdry, 1925a), or occasional occlusion
of the capillary lumens ( Prozesky and Du Plessis, 1985c).
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2.8. Immunity to Cowdriosis.
Specific immunity develops in animals which recover from heartwater
infection (Stewart, 1987). Recovered animals have solid immunity to homologous
challenge and show some degree of resistance to heterologous challenge (Neitz,
1939; Neitz and Alexander, 1941; Stewart, 1987; Du Plessis et al., 1989). This
immunity lasts for a variable period of time in different species. In sheep which
recover from experimental infection it lasts for 7 to 34 months extending possibly
to 48 months (Neitz, Alexander and Adelaar 1947) while in cattle it lasts between 4
months and 3.5 years (Neitz and Alexander, 1945; Chabeuf, 1976; Arnold and
Asselberg, 1981). The duration of protective immunity in ruminants seems to be
associated with premmunity since a carrier status has been established in animals
which recover from heartwater. (Ilemobade, 1976; Andrew and Norval, 1989b;
Camus, 1992).
2.8.1. Innate resistance and breed susceptibility.
Young animals are resistant to cowdriosis for the first few weeks of life
(Neitz and Alexander, 1941). Lambs and calves up to 3 weeks old and kids up to 6
weeks of age are relatively resistant to heartwater (Neitz and Alexander, 1941;
Thomas and Mansvelt, 1957). A few young animals, however, succumb to
infection at these ages (Uilenberg, 1971; Du Plessis and Malan, 1988). Creole goat
kids are resistant until they are two weeks old (Camus, unpublished data, cited by
Uilenberg and Camus, 1993) the exception being Angora goats which are highly
susceptible (Du Plessis, Jansen and Prozesky, 1983). Susceptibility in older
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animals, depends on previous exposure to the disease and breed. Uilenberg (1983)
found no differences in susceptibility between Zebu and Taurine breeds in non
endemic areas. In endemic areas local zebu and breeds such as the N'Dama and the
Bauole are very resistant (Camus and Barre, 1990). In contrast, breeds such as the
Sahiwal and the Brahman are as susceptible as Taurine breeds. African Zebu from
cowdriosis free areas are also as susceptible to heartwater as the Taurine breeds
when introduced to Amblyomma-infested areas (Gueye Mbengue, Kebe and Diouf,
1982; Logan, Tembley and Miller, 1988). In terms of species resistance, cattle are
more resistant to cowdriosis than sheep and goats (Du Plessis and van Gas, 1989).
Among the small ruminants Merino sheep were found to be more susceptible than
Persian sheep (Alexander, 1931). Alexander (1931) noted in South Africa that
indigenous sheep were more resistant than Merinos but goats were as susceptible as
the Merinos, he observed that in general animals raised under endemic conditions
were more resistant than those that were not.
2.8.2. Humoral immunity.
Animals which recover from natural and experimental heartwater infections
develop specific antibodies to C. ruminantium (Camus and Barre, 1987; Du Plessis
and Malan, 1987a; Semu, Mahan, Yunker and Burridge, 1992). Three serological
tests are used frequently to monitor antibody responses to C. ruminantium, they are:
Indirect flourescent antibody test (IFAT), Enzyme linked immunosorbent assay
(ELISA), and Western blotting. IFAT using mouse or endothelial cell derived
antigens (Du Plessis, 1982; Brown, Logan, et al., 1989; Du Plessis, et al., 1993;
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Lawrence, et al., 1993), indirect ELISA using soluble antigens (Soldan et al., 1993;
Neitz et al., 1987) and competitive ELISA (Jongejan et al., 1991a; Du Plessis et al.,
1993) have been used. None of these tests however has acceptable specificity
however, ELISA using a recombinant fragment of the Major antigenic protein-1
(MAP-1) (van Vliet et al., 1995) has improved specificity. This recombinant
polypeptide (MAP-lb) does not react with Ehrlichia ovina although it reacts with
E. chaffeensis and E. canis sera. Western blotting has been used to detect
antibodies to immunogenic proteins of the EB (Jongejan and Thielemans, 1989a;
Rossouw, et al., 1990; Mahan et al., 1993).
Circulating specific antibodies to C ruminantium were detected by direct
ELISA in serum samples from goats immunised with inactivated elementary body
antigens on day 10 post inoculation (Tafesse, 1992). After immunisation of mice
with elementary bodies, antibodies were detectable in serum IFAT by day 14 post
inoculation (Byrom, Mahan and Barbet, 1993).
The role of antibodies in immunity to heartwater is not clear, as conflicting
reports are found in the literature. Experimental transfer of serum or gamma
globulin did not confer protection and in vivo neutralisation tests have given
variable results (Du Plessis, 1970a, 1993; Uilenberg, 1983). Du Plessis,
Bezuidenhout and Ludeman (1984) found no correlation between antibody titre and
immunity to heartwater in calves. Sera from 10 calves of 12 whose blood was not
infective to sheep were positive by IFAT 3 months after immunisation, while 17 of
18 calves whose blood was infective were also serologically positive by IFAT. The
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same authors found no correlation between replication of C. ruminantium in calves
with a high degree of natural resistance and their serological responses and eventual
immunity to challenge. Du Plessis, et al., (1989) compared 10 stocks of C.
ruminantium for cross immunity, serological responses and mouse pathogenicity.
They found that the antigenic diversity of the stocks could not be correlated with
antibody levels detected by IFAT since sera raised against all the 10 stocks reacted
positively to Kumm stock antigen which showed no cross-protection. Furthermore
variation in titres could not be related to the stock of C. ruminantium used.
Similarly Martinez et al. (1993) observed that sera from animals which had
survived challenge after immunisation did not neutralise C. ruminantium infection
of endothelial cell cultures in vitro.
In contrast to the above results Du Plessis and van Gas (1989) found
positive correlation between antibody responses of naturally infected sheep and
goats and their susceptibility to experimental challenge. All seronegative animals
developed the disease when challenged while seropositive animals resisted
challenge. In cattle, however, large numbers of seronegative animals have been
found to be partially or totally resistant to natural challenge (Camus and Barre,
1988; Du Plessis and Malan; 1987a). Protection of these animals could be due to
cell mediated immunity which these authors did not determine. Byrom, Mahan and
Barbet (1993) showed that hyperimmune serum from mice inhibited adhesion and
entry of C. ruminantium to and into cultured endothelial cells. They also
demonstrated that two bovine sera one each from experimental and natural
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infection, inhibited C. ruminantium from infecting endothelial cell cultures. Byrom
Mahan and Barbet (1993) however observed that passive transfer of antibodies
given in serum or as gamma globulins given simultaneously with infection, during
incubation or during clinical reaction did not confer protection to susceptible mice.
Furthermore, transfer of immune serum alone or with complement failed to protect
mice against intravenous challenge with C. ruminantium (Byrom, 1993,
unpublished data). In contrast Du Plessis (1993) found that homologous serum in
the presence of complement inhibited the infectivity of C. ruminantium (Kumm
stock) to outbred mice. In three experiments, 2 out of 5, 1 out of 5 and none out of
5 mice died following pre-treatment of C. ruminantium with increasing amounts of
complement while 4 out of 5 mice died in the absence of complement. The
mechanisms by which antibody affects the infectivity of C. ruminantium in the
presence of complement may be by antibody dependent complement mediated lysis
or directly by activation of the alternate complement pathway leading to lysis ( Du
Plessis, 1993).
The role played by antibodies in immunity to other rickettsial species is
better established; antibodies are protective in many cases (Tringali et ah, 1983).
Transfer of immune serum confers protection on challenged animals. Antibodies
enhanced opsonisation and destruction of rickettsiae by neutrophils and
macrophages (Gambril and Wisseman, 1973) in vitro. Experimental studies with
immune sera indicated that macrophages destroy Rickettsia mooseri in the presence
of antibodies but not in their absence (Gambril and Wisseman, 1973; Beaman and
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Wisseman, 1976). Furthermore, there is good correlation between antibody titres,
macrophage activation and levels of immunity (Kekcheeva et al., 1981). The
presence of immune sera enhances the activity of macrophages, indicating the
complementarity of humoral and the cell-mediated immune responses.
It has been shown experimentally that antibodies restrict the infectiveness of
Coxiella burnetii and enhance its uptake by macrophages and granulocytes
(Abinanti and Marmion, 1957; Kazar, Skultetyova and Brezina, 1975). Kishimoto
and Walker (1976) found that immune serum rendered C. burnetii more susceptible
to phagocytosis by guinea pig peritoneal macrophages. Lewis et al. (1978) found
that addition of immune serum greatly reduced the multiplication of Ehrlichia canis
in macrophage cultures. Passive transfer of immune serum from mice which had
recovered from E. risticii infection prevented the disease in 22 out of 24 recipients,
moreover, purified immunoglobulin G (IgG) from immune serum protected mice
from infection with E. risticii while IgG from non immune serum did not provide
protection (Kaylor et al., 1991). Passive transfer of serum enhanced clearance of
rickettsiae in animals experimentally infected with R. mooseri and R. tsutsugamushi
indicating that there was cross protection among closely related organisms (Shirai
et al., 1976).
It is evident from the above review that antibodies can enhance destruction
of rickettsiae by macrophages and that passive transfer of antiserum provides
immunity in some rickettsial species with similar life cycles and Coxiellae. This
role which has not been established in heartwater demands thorough investigation.
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2.8.3. Cellular immunity.
Cowdria ruminantium is an intracellular rickettsia which parasitises the
endothelial cells of blood capillaries of ruminants (Cowdry, 1925a; Prozesky and
Du Plessis, 1987a; Jongejan et al., 1991c), neutrophils, (Logan et al., 1987b);
macrophages and monocytes (Du Plessis, 1970b; Ilemobade, 1976; Pienaar, 1970).
The intracellular location of C. ruminantium during part of its life cycle confers a
degree of protection from antibody responses. However, intracellular parasites are
subject to attack by the parasitised cells and by cell mediated immune responses
with effector mechanisms such as cytotoxic T cells and natural killer (NK) cells.
Cell-mediated immune mechanisms have evolved to control intracellular
infections. These responses are regulated by T lymphocytes which control the
immune response by organizing other effector cells (Kaufmann, 1988). T
lymphocytes represent the major mediators and coordinators of acquired resistance
against intracellular bacteria (Hahn and Kaufmann, 1981). T cells are broadly
+
divided into 3 types based on their antigen receptor type and functionally. CD4 (T
helper/Th) cells, CD8+ (cytotoxic/TC/CTL) cells and CD4"CD8" or y5 T cells
+
(Mombaerts et al., 1993). CD4 T lymphocytes recognise antigen presented in
association with self molecules of class II Major Histocompatibility Complex
(MHC class II) present on antigen presenting cells such as macrophages, dendritic
cells and other cells of the reticuloendothelial system. CD8 T cells recognise
antigen in association with self MHC class I molecules present in all nucleated
cells. Unlike antibodies which recognise antigens directly, T cells recognise non-
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conformational fragments of processed antigens which are usually peptides of 8-20
amino acids. The peptide fragments recognised by T cells are processed in
endosomal or cytoplasmic compartments. They are attached to MHC class II or
+ +
class I molecules, transported to the cell membrane and presented to CD4 or CD 8
+
T cells respectively (Harding and Song, 1994). The antigen receptors on CD4 and
+
CD8 are heterodimeric structures consisting of alpha and beta polypeptide (ap)
chains. The CD4"CD8" T cells have receptors composed of yS polypeptide chains.
+
These receptors are termed T cell receptors (TCRs). In addition to TCRs, CD4 and
+
CD8 T cells also express CD3, a molecule which is intimately associated with
TCR and is involved in initiation of cell activation after antigen stimulation (Fitch,
1986). The y8 cells recognise antigen by a different pathway which is not yet
completely understood.
+
CD4 T cells in mouse and man are composed of two subsets, defined by the
profiles of cytokines they secrete, as Thl and Th2 type (Mossman and Coffman,
1989). The Thl and Th2 T cells control both the humoral and cell-mediated
responses by producing cytokines which cross-regulate each other. Resting T cells
produce only IL-2, but after stimulation they produce other cytokines. The initial
activation step starts after antigen presentation. Thl cells produce interferon
gamma (IFN-y), interleukin-2 (IL-2) and tumour necrosis factor beta (TNF-P) and
their effect is to promote cell mediated immunity and support IgG2 antibody
production. Th2 cells secrete IL-4, IL-5, IL-6 and IL-10 which support IgG,, IgE
and IgA antibody responses and eosinophilia. Cytokines such as IL-3, tumour
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necrosis factor alpha (TNF-a) and granulocyte macrophage colony stimulating
factor (GM-CSF) are secreted by both Thl and Th2 cells (Kemeny, Noble, Homes
and Diaz-Sanchez, 1994).
+
CD8 T cells are also classified into two distinct subsets based on the
+
cytokines they secrete. Type I CD8 T cells secrete the same cytokines as Thl T
+
cells and are restricted by MHC class I. Type II CD8 T cells secrete Th2 type
cytokines and are restricted by MHC class II (Kemeny et al., 1994). These
subdivisions of CD8+ have been observed in vitro and also in vivo as observed in T
cell clones derived from patients with lepromatous leprosy (Kemeny et al., 1994).
The three types of T cells present in peripheral blood mononuclear cells (PBMC) of
humans and mice are found in the peripheral blood of ruminants. In mature
+
ruminants the majority of T cells are CD4 representing 25 to 35% of PBMC while
CD8 constitute 15 to 25%. CD8 T cells mediate MHC class I restricted cytolytic
T cell activity against virus-infected cells and those infected with protozoa and
other intracellular bacteria (Howard and Morrison, 1994). The third T cell type in
ruminants are the gamma delta (y5) T cells. These y8 T cells form a major
proportion of T cells in the peripheral blood of young ruminants. The mean
proportion of y8 T cells in calves 1 to 3 weeks of age ranges between 27% to 60%.
In mature ruminants this cell type constitutes 5 to 10% of PBMC (Hein and
Mackay, 1991). The cytokine profile of the yS T cells is similar to that of Thl cells
and they are cytotoxic against allogeneic cells (Mackay et al., 1988). The role
played by y5 T cells in immunity in the young is thought to be that of providing an
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• + +
early cover of a non-MHC restricted cellular immunity until a mature CD4 , CD8
(aP) T cell system becomes established (Hein and Mackay, 1991).
Cellular immunity in hearwater infections in the mouse is mediated by
CD8 T cytotoxic cells (Du Plessis et al., 1991). Adoptive transfer of CD8
+
(Lyt-2 ) from mice immune to C. ruminantium to non-immune recipients conferred
protection to lethal challenge. In addition, adoptive transfer of immune cells
+ _|_
depleted of Lyt-2 (CD8 ) cells were unable to confer protection against challenge
+ +
whereas depletion of CD4 (L3T4 ) T cells had no effect on protection (Du Plessis,
Berche and Van Gas, 1991). Flow cytometric analysis of purified lymphocytes
obtained from specificied pathogen free BALB/c mice infected with C.
ruminantium and treated to prevent death provided further evidence that CD8+ T
cells are protective (Du Plessis, Gray and Van Strijp, 1992). These authors showed
+
that there was significant increase in the population of Lyt-2 T cells after challenge
+
and that the population of L3T4 dropped below pre-infection levels except on day
+
34 after challenge. The role played by CD8 T cells in protective immunity in
ruminants against Cowdriosis is unknown and this requires to be determined.
2.8.4. The role ofcytokines in cell mediated immunity.
Cytokines play a key role in influencing the type of immunity which develops
in the animal. In addition some cytokines have a direct effect on the invading
organism. Interferon gamma (IFN-y) and alpha (IFN-a) have anti-viral activity in
vitro and in vivo (Tizard, 1994). These cytokines are also known to interfere with
rickettsia (Byrne and Turco, 1988; Manor and Sarov, 1990), to be inhibitory to
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chlamydia (Shemer and Sarov, 1988) and to exhibit anti-Cowdria activity in vitro
(Totte et al., 1993; Mutunga and Sumption, 1995; Mahan et al., 1996). In vitro
experiments have demonstrated that IFN-y and IFN-a have anti-rickettsial effects
that result in clearance of organisms from the cytoplasm of some infected cells
(Turco and Winkler, 1983a, 1993; Wisseman and Waddel, 1983; Jerrels, Turco,
Winkler and Spitalny, 1986; Turco and Winkler, 1983b ; Turco and Winkler, 1988).
Inteferons are important mediators of anti-rickettsial activity. TNF-a is an mediator
in the clearance of R. conorii from murine fibroblasts through induction of nitric
oxide synthesis (Feng and Walker, 1994). Recombinant bovine gamma interferon
(rBOIFN-y) reduces the in vitro growth of the Senegal, Welgevonden and Gardel
stocks of C. ruminantium from bovine endothelial cells. It also inhibits growth of C.
ruminantium in caprine jugular endothelial cells (Totte, Blankaert, Zilimwabagabo
and Werrenne, 1993). The same authors found that cattle which resisted
experimental infection of heartwater produced significantly higher levels of
circulating IFN-a than those which did not resist challenge indicating that IFN-a
may be partly responsible for resistance shown by the cattle which survived
challenge. Flowever multiple effectors are likely to be responsible for protective
immunity to C. ruminantium.
2.9. Control ofCowdriosis.




Vector control of heartwater has been reviewed by Norval, (1991). It is
achieved by using acaricides. This was first reported by Dixon (1899) and
Alexander (1931) and is aimed at interrupting the life cycle of the vector (Camus et
al., 1996) by application of acaricides. Two main methods of application termed as
intensive and strategic or seasonal control are used. Eradication of Amblyomma
ticks is extremely difficult and only limited success has been achieved (Howel, et
al., 1981).
Intensive tick control is aimed at controlling all stages of ticks throughout
the year in order to keep the tick numbers to a minimum. Its advantage is that of
reducing production losses due to tick worry and tick-borne diseases. This method
is recommended for farms with highly susceptible animals such as dairy breeds and
in marginal areas where Amblyomma species are found occasionally or where
ecological conditions are unsuitable for long-term survival of the ticks
(Bezuidenhout et al., 1994). Two disadvantages associated with this method are:
the fact that total tick control is a considerable cost and loss of immunity to tick-
borne diseases owing to lack of tick challenge (Bezuidenhout, 1987b). In addition,
chemical control of heartwater in the absence of other tick-borne diseases is not
justifiable (Pegram and Chizyuka, 1990).
Strategic or seasonal control of adult ticks during the rainy season or when
tick numbers pass a limit is more economical. This type of control is aimed at
reducing the number of vectors in order to promote a stable disease situation and
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limit the adverse effects of tick worry. The advantages of this method are lower
dipping costs and the acquisition of immunity against heartwater by animals,
leading to an epidemiologically stable situation. Despite these advantages,
implementation of this method is complicated by the presence of other tick borne
diseases and this makes it difficult to formulate one policy of strategic control for
all of them (Bezuidenhout and Bigalke, 1987).
Acaricides are applied in two ways, spraying and dipping. Spraying is
achieved by hand pump when few animals are being treated or by spray races for
large numbers of animals. This method has the disadvantage that animals are not
normally covered fully with the acaricide. Plunge dipping is the best method of
applying acaricide since it gives a complete coverage of the body as cattle are fully
immersed (FAO, 1984; Young, Groocock and Kariuki, 1987). Dip concentrations,
however, require to be tested regularly to determine the replenishment rate to
maintain active concentration, or they can become a source of acaricide resistance
when their management is not strict. When dipping is done correctly effective
control of heartwater can be achieved (Currasson, 1932; Norval, 1979). Use of
acaricides to control tick vectors has been practised in eastern and southern Africa
since the turn of this century and has limited the establishment ofAmblyomma ticks
and heartwater in the highveld of Zimbabwe (Norval and Lawrence, 1979). It has
also achieved localised eradication in some parts of South Africa (Stampa, 1969)
and Kenya. Despite this success, use of acaricides to control heartwater faces many
problems and does not give a long-term solution. Major problems associated with
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the vector control method have been reviewed by Norval et al., (1991). The six
most important were considered to be:
1. The cost of acaricides and their application are becoming too high in
relation to income of farmers in many developing countries.
2. Organisational problems of national tick control programmes and
vulnerability to political and economic instability.
3. Development of resistance to acaricides.
4. The results of intensive tick control upon endemic stability for heartwater
and other tick-borne diseases.
5. That tick control has little effect on abundance of Amblyomma where
alternate hosts for the adult stage are present because attached males emit
Aggregation Attachment Pheromone (AAP) that causes unfed nymphs and
adults to attach in preference to untreated hosts (Norval et al., 1989a).
6. Dipping or spraying with acaricides pollutes the environment and may result
in residues in milk and meat.
Alternative ways of controlling vectors of heartwater without dipping and
spraying have been used successfully. Significant control of A. variegatum in
experimental studies has been achieved by use of APP to attract unfed nymphs and
adults to the source of acaricide (Norval et al., 1989a, 1989b, 1991). Synthetic
pheromone incorporated in acaricides can be used as a slow releasing decoys
attached to the host (Norval et al., 1991). The advantages of this method over
traditional dipping or spraying include, the use of less acaricide per head and
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therefore lower costs; it is more environmentally friendly, longer lasting and
reduces the need for frequent mustering of animals for dipping or spraying, control
is specifically toward Amblyomma ticks and does not affect the epidemiology of
other tick-borne diseases. The use of APP to attract unfed ticks leads to effective
control of A. variegatum and A. hebraeum even in the presence of alternate hosts
(Norval et ah, 1991).
2.9.2. Chemotherapy.
Sulfonamides and tetracyclines have been used to treat heartwater
successfully (Camus et al., 1996). Other chemotherapeutic agents have also been
used with variable success (van Amstel and Oberem, 1987).
The first drug used successfully to treat heartwater was Uleron, a short
acting sulfonamide (Neitz, 1940). Treatment during the early stage of the reaction
gave greater success. Later, Alexander, Neitz and Adelaar (1946) successfully used
Uleron and sulphapyridine in treating natural cases of heartwater. Gloxazone has
also been used to treat clinical cases of heartwater (Synge and Scott, 1976; Du
Plessis, 1981). The toxicity of gloxazone however made it unsuitable for treating
heartwater (Camus and Barre, 1982). A range of tetracyclines, chlortetracycline
aureomycin, oxytetracycline, rolitetracycline and doxcycline have been used
extensively to treat heartwater (van Amstel and Oberem, 1987). Successful therapy
depends on the time the treatment is given, the dose of chemotherapeutic agent
used, the formulation and the route of administration (van Amstel and Oberem,
1987). Treatment during the incubation period alters the subsequent course of the
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disease completely, resulting in complete blocking of the clinical response or leads
only to a temporary febrile response without any symptoms developing; The
curative dosage varies from 2 mg/kg to 40 mg/kg body weight (kg/bwt) dose
(Weiss et al., 1952; Haig et al., 1954). It is given as a single dose or two divided
doses over a 24 hour period. A single dose of 20 mg/kg bwt given during the early
febrile stage is curative but in advanced stages larger and multiple doses become
necessary. As to which formulation is the most effective, Uilenberg (1971) did not
find any advantage using different formulations. Various routes of administration
have been used to treat heartwater. Karrar and Elhag-Ali (1965) used the oral route
to treat sheep and cattle with minimum therapeutic doses of 8 mg/kg bwt for sheep
and 500 mg/kg bwt for cattle given daily until recovery. The most common and
most effective routes are the intramuscular and intravenous (Camus and Barre,
1988).
Other antibiotics such as streptomycin have been used with limited success
ranging from no effect (Synge and Scott, 1976) to moderate effects (Du Plessis et
al., 1983). Despite the successes achieved with vector control and chemotherapy,
the limitations which reduce the effectiveness of these two methods demand that
animals be protected against heartwater by immunisation.
2.9.3. Control by vaccination (immunisation)
2.9.3.1. History.
The first reported attempt to protect animals against heartwater was by
Dixon (1898) (cited by Camus and Barre, 1988). Dixon used a mixture of bile and
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infected blood or bile mixed with pericardial fluid to inoculate animals. The trial
produced no conclusive results except that young animals seemed to have been
protected. This was possibly due to innate resistance rather than the vaccination
since young animals are known to be relatively resistant to heartwater in the first
few weeks of life. Theiler (1904) used polyvalent serum, produced by combining
serum from sheep and goats which had been previously infected and presumably
recovered, to protect goats against experimental infection with some limited
success. The first proper vaccine trials against heartwater were attempted by
Hutcheon (1902), Spreull (1904) and Theiler (1905, 1906) (cited by Oberem and
Bezuidenhout, 1987a).
Three findings are considered of historical importance in the development of
a feasible method for vaccination against heartwater. These are: 1. Alexander
(1931) showed that i.v. inoculation of infected blood was the most successful way
of infecting ruminants, 2. Neitz (1940) reported that heartwater could be treated
with the sulphonamide, uleron, and 3. Neitz and Alexander (1941) showed that
young animals were resistant to heartwater. These findings led to the immunisation
of resistant young animals by infection and treatment method (I/T) using live
virulent vaccines. Two other methods of immunisation using attenuated and
inactivated organisms have been used to protect ruminannts against this infection.
The three methods of of immunisation are reviewed.
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2.9.3.2. Live vaccines.
Immunisation for protective immunity against heartwater can be induced in
susceptible ruminants by infection with virulent blood or with supernatant from
ground-up ticks which were previously allowed to feed on infected animals
followed by treatment of the animal with oxytetracycline at the beginning of the
febrile reaction to cowdriosis (Jongejan, et al., (1993). Animals which recover
from heartwater are immune to homologous challenge (Oberem and Bezuidenhout,
1987a). Two live virulent vaccines, the infected blood and infected tick vaccines,
(FAO, 1984; Bezuidenhout, 1981; Oberem and Bezuidnhout, 1987b) have been
tested extensively and found to protect domestic ruminants against heartwater. The
infected blood vaccine commercially produced in South Africa is obtained from
sheep experimentally infected with the Ball 3 reference stock (Bezuidenhout et al
1994). The infected tick vaccine is a supernatant of a ground-up tick suspension
from tick nymphs or larvae infected with the Ball 3 stock (Bezuidenhout, 1981).
Both vaccines are administered intravenously at pre-determined concentrations to
infect animals, the animals are allowed to develop a temperature reaction and
treated once or twice on the second or third day of fever with oxytetracyline at 20
mg/kg bwt. A second treatment is given if the fever continues. Recovered animals
are solidly immune to homologous challenge (Uilenberg, 1983). The effectiveness
of the blood vaccine is greater than 95% (FAO, 1984). Live vaccine have been
used successfully for many years to protect animals against heartwater in South
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Africa where up to 250,000 doses are being used annually (Bezuidenhout et al.,
1994).
Despite the success of the live vaccines they are limited by the following
disadvantages: they are laborious and expensive to produce, they are labile
requiring storage under liquid nitrogen to maintain their efficacy, their
administration through the i.v. route usually requires qualified personnel, there is
also a possibility of transmitting other tick-borne diseases, or the development of
adverse reactions in the young especially following administration of tick
suspensions (Oberem and Bezuidenhout, 1987a), and the danger of virulence of the
vaccine. Another serious limitation with this type of vaccine is the existence of
distinct antigenic differences between C. ruminantium stocks (Du Plessis and Van
Gas, 1989; Du Plessis et al., 1989; Jongejan et al., 1991b) which restricts its use to
certain areas only. Furthermore the live vaccine is not recommended for pregnant
animals (FAO, 1984). However, one major advantage with the live vaccine is that
only one immunisation in the lifetime of the animal appears to be required in the
endemic areas where natural challenge occurs (FAO , 1984).
2.9.3.3. Attenuated live vaccines.
The limitations associated with live virulent vaccines led to the search for
alternative types of vaccines. Live attenuated vaccines against heartwater became
possible following the successful cultivation of C. ruminantium in tissue culture
(Bezuidenhout, et al., 1985). Sequential passage of the Senegalese and the Gardel
isolates in bovine umbilical endothelial cells resulted in attenuation of the organism
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(Jongejan, 1991; Jongejan, et al., 1993b). Vaccination of sheep with the attenuated
organisms protected them against lethal challenge with the virulent homologous
isolate. A solid protective immunity was developed by the immunised animals.
Responses to heterologous challenge were variable depending on the isolate. For
instance immunised animals were not protected against the Welgevonden stock
(Jongejan, 1991). A trial with another cell culture, attenuated Senegalese isolate
vaccine had moderate success under field conditions (Gueye, Jongejan, Mbengue
and Uilenberg, 1994). In this trial 30 sheep were immunised and 30 served as
controls. Upon natural challenge 22 sheep in the control group died from
heartwater while 8 of the vaccinated died from cowdriosis and 5 died from inter¬
current infections. These results indicate that attenuated vaccines may be useful in
controlling heartwater in the future. The fact that only two stocks of C.
ruminantium have been attenuated successfully limits their use due to limited cross-
protection between many stocks of this organism. Attenuated vaccines are
advantageous in that natural infection is simulated to a much higher degree than is
possible with inactivated vaccines and the animal should acquire a long-lasting
cell-mediated and humoral immunity. They are also practical and economical since
they may only be administered once in the life-time of the animal. The major risks
with this type of vaccine are reversion to virulence by the organism if it is not
attenuated sufficiently and possible transmission of the low virulence strains.
Recent studies in Kenya (Ngumi 1997) show that low virulence isolates do not
protect against challenge with highly virulent isolates but highly virulent isolates
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protect against a wide range of stocks. Furthermore animals immunised with low
virulence isolates succumbed more quickly on challenge with virulent stocks. This
suggests that attenuation may increase susceptibility on challenge.
2.9.3.4. Inactivated vaccines.
Inactivated vaccines have gained importance in the 1990s and reports of
their use are increasing. Martinez et al. (1993, 1994) immunised 9 goats with
inactivated elementary bodies of the Gardel stock of C. ruminantium suspended in
Freund's complete adjuvant. Each goat received 2 subcutaneous injections.
Challenge of the vaccinated animals with a lethal dose of homologous isolate
caused temperature reaction in 6 out of 9 animals and 3 died. All unvaccinated
goats died within 7 to 12 days after challenge. Tafesse (1992) immunised 12 goats
and 10 mice with inactivated elementary bodies of the Welgevonden isolate in
Freund's complete adjuvant using two regimens. Six goats received primay
inoculation only and the other 6 received primary and booster inoculations 21 days
apart. Upon challenge with the virulent Welgevonden stock a total of 7 out of 12 (3
given primary immunisation only and 4 given two doses) were protected against
lethal homologous challenge all controls were not. Surprisingly, immunisation of
mice with inactivated elementary bodies did not confer protective immunity upon
challenge with virulent homologous stock but survival rates was increased.
Mahan, Andrew, Tebele, Burridge and Barbet (1995) reported that they had
successfully protected sheep against heartwater after immunisation with inactivated
C. ruminantium from Zimbabwe emulsified in Freund's complete adjuvant. In their
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trial they used three groups of 5 sheep. Two groups were immunised with
inactivated organisms, one group received intact organisms without adjuvant, the
second group received the organism in Freund's complete adjuvant for primary
inoculation the third group was used as control. Subsequent booster inoculations of
immunised groups were delivered in Freund's incomplete advujant. Animals which
received a primary dose of inactivated EBs in FCA and a booster in FIA were
protected against homologous challenge while the others were not, indicating
immunisation induced protective immunity. The future of inactivated vaccines
against heartwater is promising.
Inactivated vaccines have several advantages over virulent and attenuated
live vaccines. These advantages include: No risk of reverting to virulence, the ease
administration therefore no requirement for qualified personnel, thermostability, no
risk of transmitting other diseases to the vaccinated animals and no export of
virulent stocks of C. ruminantium to other countries where they do not exist.
Despite the fact that inactivated EBs induce protective immunity in a high
proportion of immunised animals, they are still limited by the low level of cross-
protection among C. ruminantium stocks. This requires that other types of vaccines
be developed such as subunit, recombinant or nucleic acid vaccines which may




Recombinant DNA technology has led to the isolation of genes encoding important
immunogenic antigens of pathogenic organisms and to the production of
measurable quantities of antigens. Some recombinant antigens have been used
successfully to protect animals against homologous and heterologous challenge.
Genes for the 32kDa Major antigenic protein 1 (MAPI), (van Vliet. et. al., 1994),
21kDa MAP2 protein (Mahan et al., 1994b) and 58kDa heat shock protein (Hsp)
(Lally et al., 1995) of C. ruminantium have been cloned and the antigens expressed
in E. coli. These recombinant antigens are currently being tested for their
immunogenicity. It is anticipated that these antigens may become candidates for
vaccines for controlling heartwater in the future. One advantage of recombinant
DNA technology is that it is possible to identify the gene of a conserved protective
antigen and to clone it.
Recombinant antigens of a number of rickettsial organisms have been used
successfully to protect animals against lethal homologous challenge. Viswanath,
MacDonald and Watkins (1990) cloned and expressed a 5.5 kilobase Hind III
fragment (gene encoding 198kDa protein) from Rickettsia conori Kenya tick typhus
genomic DNA into E. coli JM107. Immunisation of guinea pigs with sonicated
lysates of this recombinant E. coli strain expressing the 198kDa protein led to the
development of antibodies which recognised the native 198kDa protein. The
immunised animals were protected from experimental infection with the
homologous Rickettsia,conorii species and were also partially protected from
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experimental infection with the heterologous species Rickettsia rickettsii.
MacDonald, Maclean, Mann and Milch (1988) cloned and expressed a gene
encoding a 155kDa protein of R. rickettsii in E. coli JM107. Immunisation of
guinea pigs with sonic lysates of the recombinant JM107 [pGAM22] expressing
this protein protected the animals from experimental infection with R. rickettsii. In
other experiments, immunisation with lysates of E. coli containing pUC8 subclones
of a 155kDa recombinant protein protected mice upon lethal challenge with R.
rickettsii (MacDonald Anacker and Garjian, 1987). Recombinant antigens have
also been used experimentally as vaccines to protect animals against ehrlichial
infections. An affinity purified 55kDa recombinant protein was used to protect
mice against lethal challenge of E. risticii (Dutta, Shankarapa and Matingly-Napier,
1991). Shankarapa, Dutta and Martingly-Napier (1991) used a 44kDa recombinant
protein of E. risticii to protect mice against lethal challenge with the homologous
strain. They also demonstrated potentiation of protective immunity by immunising
mice with two recombinant antigens of 44kDa and 70kDa proteins. Recombinant
antigens of other intracellular pathogens such as Mycobacteria have also been used
to immunise and protect experimental animals against lethal homologous challenge.
Silva and Lowrie (1994) successfully vaccinated mice with recombinant heat shock
protein Hsp65 of Mycobacterium leprae to protect them against the homologous
organism and M. bovis (BCG) and M. tuberculosis H37RV. The vaccine used was
composed ofmonocyte-like murine tumour cells transfected with a retroviral shuttle
plasmid [pZIPNeoSV(X)] expressing the gene for the Mycobacteria Hsp. Silva et
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al. (1994) demonstrated that antigen specific T cell clones from the spleens of
immune animals were capable of transferring immunity to non vaccinated
recipients. The cell types responsible for this transfer were CD8 T cells and were
shown to effectively and specifically lyse mycobacteria infected macrophages. The
above method is a form of DNA immunisation using antigen presenting cells to
process genes expressed in APC.
This brief review, indicates that recombinant antigens are becoming
increasingly important as candidate vaccines for controlling infectious diseases. It
is hoped that on going research on recombinant antigens of C. ruminantium will
lead to identification of an antigen to fulfil this role.
The immune mechanisms responsible for protection against heartwater in
the ruminant have not been fully determined. Therefore, in the following work I
sought to attempt to characterise the mechanisms responsible for protective
immunity against the Welgevonden stock of C. ruminantium by:
1. Characterisation of surface exposed antigenic proteins of the elementary
body (infective stage) of C. ruminantium (Chapter 4).
2. Characterisation of Isotype-specific IgG responses of ruminants and mice
immunised with live, inactivated and recombinant antigens of this stock
(Chapter 5).
3. Investigating the cellular immune responses to immunisation with live or
inactivated antigens of C. ruminantium before and after challenge of
immunised and control goats (Chapter 6).
4. Investigating the immune responses and level of protection resulting from
immunisation with a recombinant heat shock protein (GroEL) of C.
ruminantium. This represents the first report of a trial of recombinant
antigens to protect against cowdriosis (Chapter 7).
51
CHAPTER THREE
GENERAL MATERIALS AND METHODS
This section describes materials and methods which are used in at least two
chapters or those which could not be included in specific results chapters of the thesis.
3.1. ExperimentalAnimals.
3.1.1. Mice.
Female outbred 'TO' white mice (Tuck and Sons, England) weighing 20g to
30g were used in immunisation and challenge experiments. They were kept in groups
of five per cage and supplied with feed and water ad libitum. Mouse experiments were
carried out in the small animal unit of the Centre for Tropical Veterinary Medicine
(CTVM), University of Edinburgh.
3.1.2. Goats.
Six mature male and female British cross-breed Saanen goats aged between 18
and 24 months were obtained from Marsh Holdings Damhead, Scotland. They were
housed indoors in groups of two and supplied with water and concentrates ad libitum.
Before being used for immunisation and challenge experiments, they were kept under
quarantine, screened for the exretion of Salmonella spp. (a routine precaution for all
animals brought to CTVM) and dosed with anti-helmintics. Experimental infections
were undertaken in the isolation unit, CTVM.
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3.1.3. Sheep.
Twelve sheep were immunised with recombinant antigens. Six were 6 months
old Merino crosses and the other six were 12 to 18 months old Scottish Blackface
crosses obtained respectively from Blythe Bank and South Bank Farms, Peebleshire,
Scotland. Before and during experiments they were treated in the same way as goats
in Section 3.1.2.
3.2. Preparation of Peripheral Blood Mononuclear Cells (PBMC) from
immunised and control animals.
Blood was obtained from goats and sheep by bleeding from the jugular vein
into 10 ml vacutainer tubes containing the anticoagulant lithium heparin (Becton
Dickinson, UK). Blood was transferred into 25 ml sterile disposable universal tubes
(Sterilin, UK) and centrifuged at 2,880 x g for 20 minutes at 4°C using a Megafuge 3.0
R (Heraeus Sepatech, UK). The buffy coat was taken from the interface between the
red blood cells and plasma using a Pasteur pipette and mixed with 9 ml of phosphate
buffered saline (PBS) containing 10 units of heparin per ml. This cell suspension was
layered carefully onto 8 ml of cold Ficoll-Paque (Pharmacia, Uppsala, Sweden) and
centrifuged at 850 x g for 35 minutes at 15°C. The Peripheral blood mononuclear cells
(PBMC) were obtained from the Ficol-PBS junction using a 5 ml pipette and mixed
with 20 ml of wash buffer (PBS + 10 units/ml heparin) and washed by centrifugation
at 450 x g for 10 minutes at 15°C. The PBMC pellet was re-suspended in fresh 20 ml
wash buffer and washed again. Washed PBMC was re-suspended in 2-3 ml of
complete RPMI 1640 medium containing 8% goat serum (collected from CTVM) or
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foetal bovine serum (Life Technologies, Paisley, Scotland). Viability and cell
concentration was determined by vital staining with 0.45% trypan blue and counting of
unstained cells using a Neubauer chamber. Cell concentration was adjusted to 2 x 106
cells/ml in complete RPMI 1640 medium for cell proliferation assays or flow
cytometric analysis of lymphocyte subsets.
3.2.1. Depletion of adherent cells from PBMC to obtain effectors for cytotoxic
assays.
Peripheral blood was obtained from sheep before and after immunisation and
PBMC was prepared as described earlier (Section 3.2). Then a suspension of PBMC
in RPMI-1640 medium, was added into 25 ml tissue culture flasks (Nunc, Inter Med,
UK) and incubated for 2 hours at 37°C in 5% C02 to remove adherent cells. Non¬
adherent cells were washed out of the flask with warm medium and sedimented at
450xg for 10 minutes at 15°C (Megafuge 3.0, Heraeus Sepatech, UK). The pellet was
suspended in 2 ml RPMI 1640 medium. Viability was determined by vital staining
with 0.45% trypan blue in PBS and the cells counted and their numbers adjusted to
l.OxlO6 cells/ml. The 'pure' lymphocytes were used as effectors in cytotoxic assays
(section 7.2.3.5).
3.3. Preparation ofSerum.
Blood samples were collected into 10 ml vacutainer tubes without
anticoagulant from the jugular veins of goats and sheep. Seven millilitres of blood
from sheep or goats was taken. Blood was obtained from the tail veins ofmice using a
25 gauge needle and at least 0.1 ml was withdrawn after warming the mice for 15
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minutes by placing their cage on top of a radiator until the veins were prominent. The
blood samples were held at 37°C for 1 hour, adherent blood clots were loosened and
the samples stored at 4°C overnight. Serum was aspirated into centrifuge tubes and
centrifuged at 2650 x g for 30 minutes at 4°C and aliquoted into 1 0 ml Eppendorf or
5 ml plastic bijoux bottles and stored at -20°C until use .
3.4. Growth of C. ruminantium in vitro and preparation of Elementary Bodies
(EBs) for experimental use.
Elementary bodies (EBs) of C. ruminantium were the source of antigens for the
cell proliferation assays, Western blotting and enzyme linked immunosorbent assays
(ELISA).
Three stocks of C. ruminantium were propagated in two bovine endothelial
cell lines derived from bovine aortic cells/bovine aortic endothelial cells (BAC/BAE)
or bovine pulmonary cells (BPC). Uninfected cultures were maintained in Glasgow
Minimum Essential Medium (GMEM/BHK21), (Life Technologies, Paisley,
Scotland) supplemented with 20% inactivated, foetal bovine serum, 2mM L-
glutamine, 100 units/ml penicillin, 100 pg/ml streptomycin and 2.5 pg/ml
Amphotericin B (Antibiotic/Antimycotic) in 25, 75 and 175 cm plastic tissue culture
flasks (Nunc). Cells were grown to near confluency (6 to 8 hours) and infected with
C. ruminantium elementary bodies (EBs) from a supernatant of an infected bovine
endothelial cell culture. Briefly: Five millilitres and 7.5 ml of infective culture
medium were used to infect 25 cm2 or 75 cm2 flasks, and 175 cm2 flasks respectively.
The Infected cultures were maintained in GMEM containing 10% foetal bovine
serum, 10% tryptose phosphate broth, 2mM L-glutamine, 20mM Hepes buffer and
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antibiotic/antimycotic. Cultures were incubated at 37°C in 5% CO, for 10 to 14 days
and the EBs harvested. The EBs were harvested by removing half the culture
medium and replacing it with fresh medium. The withdrawn culture medium was
placed in 10 ml centrifuge tubes, centrifuged at 450 x g for 5 minutes to remove cell
debris. The supernatants were centrifuged at 15,000 x g for 20 minutes at 4°C in a
Varifuge 20RS (Heraeus Sepatech UK) to pellet the EBs. The supernatant was
discarded and the pellet of EB's was washed twice by re-suspending them in 20 ml of
sterile PBS followed by centrifugation at 15,000 x g for 15 minutes then the
supernatants were discarded. The washed EBs were stored in 50-100 pi of PBS in 1.5
ml Eppendorf tubes and kept at -20°C.
3.5. Plasmid vectors and bacterial strain usedfor recombinant antigens.
A 7.4kb fragment of C. ruminantium DNA containing the GroEL operon was
identified by immunoscreening a genomic DNA library (Lally et al., 1995). In vivo
excision of the insert in pBluescript II (Strategene) permitted growth in the E. coli
(JM109) host. A 0.7 kb Hindlll fragment from GroEL was subcloned into pTrcHis
(Invitrogen) by Dr. Susan Nicol of the CTVM and grown in XL1 blue cells
(Stratagene) for expression and purification of a 35kDa product (pTrcHis 0.7).
3.6. Growth of E. coli JM109/pBScript, JM109/pBSCr9.4, XLl-blue/pTrcHis,
andXLl-blue/pTrcHisHIIIO. 7 (pTrcHisO. 7).
Cultures of E. coli JM109/pBScript, JM109/pBSCr9.4, XLl-blue/pTrcHis,
XLl-blue/pTrcHisHIII0.7 were grown by plating glycerol stock cultures on LB agar
and incubating overnight at 37°C. Single colonies were picked, inoculated into 10
ml LB broth and grown at 37°C overnight with vigorous shaking. These cultures
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were used to inoculate 500 ml of LB broth medium and cultures were incubated to
log phase where OD600 was between 0.6 and 0.8. Isopropyl-p-D-
thiogalactopyranoside (IPTG) was added to ImM final concentration to cultures of
XLl-blue/pTrcHis and XLl-blue/pTrcHis 0.7 and incubated further at 37°C for
4 hours followed by centrifugation at 4000 x g for 15 minutes using an MSE
centrifuge to collect the cells. Then the pellets were kept at -20°C until needed.
Bacterial antigens were prepared after 100 pi of each bacterial pellet were
dissolved with equal amounts of 2X SDS sample buffer and subjected to SDS-PAGE
using 10% acrylamide as described in Section 3.5. Determination of the presence of
58kDa recombinant antigen was carried out by Western blot analysis as described in
Section 4.2.4. The membranes were screened with a 1/50 dilution in PBST of day 28
serum from an infection and treatment (I/T) goat (G69). After ascertaining the
presence of the recombinant antigens, bacterial pellets were inactivated by
suspending them in 0.15% formalin then incubating for 30 minutes at room
temperature washed twice in sterile PBS and lysed on ice using an a sonicator.
Protein estimation was carried out as described in Section 3.10 then, the
concentration of each antigen was adjusted to 2 mg/ml with PBS. Antigens were
prepared for inoculation by mixing equal volumes of each antigen with either
Complete Freund's adjuvant (FCA, Sigma, UK), Incomplete Freund's adjuvant,
(FIA, Sigma, UK) or Mantonide ISA50 (Seppadec'Quay d'Orsay, Paris, France).
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3.7. Preparation and purification of 35kDa recombinant protein (subclone of
GroEL) ofC. ruminantiumfrom E. coli lysate on nickel columns.
The DNA insert (0.7kbHIII fragment) was positioned downstream and in
frame with the sequence that encodes an N-terminal polyhistidine fusion peptide
(Lally et al., 1995). The polyhistidine residues binding domain of the peptide allows
for a single step purification of recombinant protein. The Histag protein binds to the
column with greater affinity so that any host proteins which bind non-specifically to
the resin could be easily washed away followed by elution of the bound protein. The
nucleotide and amino-acid sequence of GroEL showing the Hind III restriction sites
are given in Figure 3.1. Growth of E. coli (XLl-blue/pTrcHis0.7) was carried out as
described in Section 3.6.
The Xpress ™ Protein Purification system (Invitrogen) for Histag proteins
was carried out following the manufacturer's instructions but without satisfactory
results, and an alternate purification system was optimised for use.
The Qia-express Ni-NTA (Qiagen) protein purification system was modified
and used to purify the protein as follows: the bacterial pellet was removed from
-20°C, thawed for 15 minutes at room temperature, resuspended in 1.0 ml buffer B
(8M Urea, 0.1M Na0H2P04, 0.01M Tris/HCl, pH 8.0), mixed vigorously and
allowed to incubate for 1 hour at room temperature with constant mixing. The
sample was sonicated on ice using a MSE sonicator (MSE, UK). Cellular debris
were removed by centrifuging the lysate at 10,000 x g for 10 minutes at room
temperature and the supernatant was collected.
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Small quantities of the 35kDa subclone (Histag) protein were purified using
Ni-NTA spin columns following the manufacturer's instructions: Six hundred
millilitres of the cleared lysate were loaded onto a pre-equilibrated Ni-NTA spin
column and centrifuged for 2 minutes at 2000 rpm. The flow through was collected
and analysed by SDS-PAGE to check for binding. The spin column was washed
twice with 600 pi of wash buffer (8M Urea, 0.1M Na-phosphate, 0.01M Tris/HCl,
pH 6.5; 32mM imidazole (buffer C) by centrifugation at 2000 rpm for 2 minutes
each. Protein was eluted with 2 x 200 pi buffer of 8M Urea, 0.1M Na-phosphate,
0.01M Tris/HCl, pH 4.5 (Elution buffer/E) by centrifugation at 2000 rpm for
2 minutes each. The eluate was collected into 1.5 ml Eppendorfs and 10 pi aliqouts
were analysed by SDS-PAGE on 10% acrylamide gels, and stained with Coomassie
as described in Section 3.10. A light box was used to locate protein bands and
ascertain the purity of the recombinant protein. The gels were photographed as
described in Section 3.11.
Larger quantities of the 35kDa subclone (Histag) protein were purified using
5 ml columns by gravity. Five millilitres of mixed Ni-NTA resin was allowed to
settle in the column by gravity and the preservative (20% ethanol) was drained out to
the level of the resin. Seven millilitres (three column volumes) of 8M Urea, 0.1M
Na0H2P04, 0.01M Tris/HCl, pH 8.0 (buffer B) was passed through the column to
wash out the ethanol then 10 ml of cleared bacterial lysate was passed through the
column at a flow rate of 10 ml per hour. The column was then treated with 10
column volumes (25 ml) of binding buffer (8M Urea, 0.1M Na0H2P04, 0.01M
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Tris/HCl, pH 8.0, 0.5 %Triton X-100) at a flow rate of 10 ml per hour followed by 6
column volumes of wash buffer (8M Urea, 0.1M Na0H2P04, 0.01M Tris/HCl, pH
6.3, 32mM imidazole, 0.5% Triton X-100).
After washing, the recombinant protein was eluted with 6 column volumes
(15 ml) of elution buffer (8M Urea, 0.1M Na0H2P04, 0.01M Tris/HCl, pH 4.5,
0.5% TritonX-100). One millilitre samples were collected and 10 pi aliqouts were
analysed for protein by SDS-PAGE as described in Section 3.8.
Samples containing only the 35kDa protein were pooled together and
dialysed overnight at 4°C against a buffer containing 1M urea, 0.05M.Tris/HCl,
0.005% Triton X-100, pH 8.0 using a cellulose tubing (Sigma) with a 12kDa cut off
point. Further desalting was performed using Nap 10IM (Sephadex G25 columns,
Pharmacia, Sweden) following the manufacturer's instructions as described in
Section 3.8. The pooled dialysed desalted fractions were concentrated by freeze
drying or by placing them in cellulose tubing and dipping the tube in polyethylene
glycol (PEG) for 3 to 5 minutes and stored at -20°C. Purity of the protein was
ascertained by Western blotting. The purified protein was used for ELISA (Section
7.2.3.5), animal inoculation tests (Section 7.2.1.4) and for cell proliferation assay
(Section 6.2.4).
3.8. Fractionation ofproteins of C. ruminantium and E. coli by Dodecyl Sulfate
Polyacrylamide Gel Electrophoresis (SDS-PAGE).
Electrophoresis was carried out according to the discontinuous bufffer system
of Laemmli (1970). Large and minigels were electrophoresed in XL Protean II and
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Miniprotean II Dual slab Cell apparatus (BioRad) respectively following the
manufacturer's instructions using a power pack model 1000/500, (BioRad).
Stock solutions of acrylamide were mixed to obtain 4%, 10% and 12%
polyacrylamide gels (Appendix A 6). Ten percent gels were used to separate E. coli
proteins, while 12 % gels were used for separating C. ruminantium antigens.
Stacking gels contained 4% acrylamide. Gels were cast with a single tooth
preparative comb or multiple teeth comb depending on the purposes for the
separation. The concentration of EB antigens loaded per gel depended on the
purpose for which the antigen would be used. Samples of EBs for Western blotting
were loaded at 0.272 pg/cm2 or higher. Minigels were run at a constant voltage of
200v for 45 minutes. Prestained molecular weight markers (BioRad) were run
alongside in each gel in 10 pi amounts.
3.9. Electrophoretic Transfer of C. ruminantium and E. coli Proteins onto Nitro¬
cellulose Membranes.
Electroblotting of proteins was carried out as described by Towbin, Staehelin
and Gordon (1979).
Following electrophoresis the gels were soaked in Bjerrum and Schaffer-
Nielsen transfer buffer (48mM Tris, 39mM Glycine, 1.3mM SDS, 20% methanol) for
15 minutes. The proteins were transferred onto nitro-cellulose membranes with pore
size of 0.45 pm (Hybond C fortified nitro-cellulose paper, Amersham International,
UK) using a Transblot SD (Semi-dry) Electrophoretic Cell (BioRad). Electrophoretic
transfer of proteins from the large gels was carried out for 45 minutes at a constant
power of 10v/0.8A per gel while transfer from minigels was carried out for 30 minutes
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at 10v/0.28A. After the transfer, the nitrocellulose membranes were rinsed once and
washed twice (5 minutes/wash) in PBS containing 0.1% Tween 20 (PBST) on a
rocking platform. Non-specific binding was blocked by incubation ofmemmbranes in
5% skimmed milk (Marvel) in PBST overnight or for 1 hour on a rocking platform.
Blots were then washed three times in PBST and dried by placing them between two
sheets of blotting papers. The part of the membrane containing pre-stained standards
was cut off and kept then the remaining part of membrane was cut into vertical strips
5 mm wide with the help of a ruler, strips were numbered sequentially and used for
Western blotting.
3.10. Coomassie Blue Staining ofProtein in SDS-PAGE Gels.
After electrophoresis, gels were placed directly into a clean container with
Coomassie stain (0.1% Brilliant blue, 40% methanol, 10% acetic acid) and left for
1 hour on a rocking platform. The staining solution was poured off and replaced with
a destaining solution (40% methanol, 10% acetic acid 50%). The destaining lasted for
1 hour. Gels were examined over a light box and destained further overnight if
necessary to remove background staining. The stained gels were soaked in distilled
water and photographed.
3.11. Pitotography.
Western blots and Coomassie blue stained gels were photographed with a
Polaroid MP4 Land Camera (Polaroid Corp., USA) using Type 55 Polaroid film and
appropriate filters.
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3.12. Desalting ofProtein Samples.
The samples were desalted using Nap 10 columns (Pharmacia) following the
manufacturer's instructions. Briefly, the top was removed, excess fluid poured off, the
column supported and the gel equilibrated with 1.5 ml of deionised distilled water.
The equilibration buffer was allowed to enter the gel bed and 1.0 ml of the sample was
added and allowed to enter the gel bed. Protein was eluted with 1.5 ml of deionised
distilled water, collected into 1.5 ml Eppendorf tubes and stored at -20°C or freeze
dried overnight. Freeze dried samples were reconstituted in 50-100 pi of double
distilled water before analysis by SDS-PAGE and Western blotting.
3.13. Determination ofprotein concentration ofantigens (Protein Assay).
Assays for protein concentration were carried out using the Bicinchoninic acid
(BCA) Protein Assay Kit (Pierce, Rockford IL., USA) employing the microtitre plate
protocol according to manufacturer's instructions.
Briefly: Protein standards were prepared by diluting bovine serum albumin
(BSA) in distilled water to obtain a range of 200-2000 pg/ml. Ten microlitres of the
standards or samples and 200pl of the BCA reagent were incubated together at 37°C
for 30 minutes using a microtitre plate. The optical density (OD) at 570 nm was read
using a microtitre plate reader (Multiscan Plus, Dynatech) and protein concentration
was determined by reading off the concentration from a standard graph obtained by
plotting the optical density values of the standards on the Y axis and their protein




where P = total protein, A = optical density of the standards with optical density
closest to that of the test sample, B = optical density of the test sample and C = the
protein concentration of the standard in micrograms /ml.
3.14. Preparation of inactivated EBsfor immunisation ofgoats and mice.
The Welgevonden stock of C. ruminantium was propagated in bovine arterial
endothelial cells and the EBs were prepared as described in section 3.4. Washed EBs
were re-suspended in 0.15% formalin in PBS and incubated at room temperature for
30 minutes with constant mixing. Inactivated EBs (IEBs) were pelleted at 13,000 x g
(Micro Centaur, MSE, UK) then re-suspended in PBS and washed twice (5 minutes
each) by centrifugation. Washed IEB's were re-suspended in 1.0 ml PBS and protein
estimation was carried out as described in Section 3.13, the protein concentration
adjusted to 2 mg/ml by addition of PBS. Equal volumes of IEB suspension and
adjuvant were mixed using a double-hubbed method (Hebert, 1979) in which two
syringes are joined by a double hubbed needle. One syringe contained Freund's
complete adjuvant (FCA) and the other an equal volume of the IEB suspension in
PBS. The antigen solution was passed between the syringes until a complete water-in-
oil emulsion was formed. A small volume formed a discrete drop in cold water.
For booster inoculations IEBs were incorporated in Freund's incomplete
adjuvant (FIA).
3.14.1. Immunisation of the goats and mice with inactivated EBs.
Two goats (G107 and G108), were inoculated intramuscularly (I/M) with
150 pg/dose of EB protein as a primary inoculation suspended in FCA. Twenty one
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days later they received a booster inoculaton 75 pg/dose of IEB protein suspended in
Freund's incomplete adjuvant (FIA) subcutaneously in the neck region. These goats
received 5 further booster inoculations of 75 pg/dose at 5, 10, 17, 26 and 31 months
post-inoculation (PI) prepared in FIA. Mice were immunised with 100 pg/dose IEB
protein prepared in FCA and 50 pg/ml prepared in FIA subcutaneously on primary and
booster immunisation respectively. Booster immunisation was given at day 21 PI.
3.14.2. Sample collection.
Serum samples were taken from the goats on day 0, 14, 21 and day 28 post
immunisation as decribed in Section 3.3.
Peripheral blood mononuclear cells were collected on day 28, day 48 and day
143 post immunisation and used for cell proliferation assays with EBs and purified
components of C. ruminantium as stimulants. Serum for serology was collected from
the mice as described earlier on days 0, 14, 21, and day 34 PI.
3.15. Staining of live elementary bodies with 6-Carboxyfluorescein Diacetate
(6-CFDA) and their countingfor use in challenge experiments.
Freshly prepared elementary bodies of the Welgevonden stock of
C. ruminantium were stained with 6-CFDA and counted using a Nebauer chamber and
used for challenge inoculations of experimental animals.
This was achieved as follows:
1. Ninety mililitres of EBs from a highly yielding (10-14 day old) culture of the
Welgevonden stock was harvested and suspended in 90 pi of complete RPMI 1640.
2. Ten microlitres of 1/10 dilution of CFDA (obtained by diluting 10 pi stock 6-
CFDA in 490 pi PBS) was added immediately to the 90 pi of freshly prepared EB
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suspension and the mixture was incubated in the dark at room temperature for 15
minutes.
3. The EB/6-CFDA suspension was centrifuged at 12,000 x g at 4°C, the pellet
resuspended in 500 pi of PBS mixed well using a 26G needle and pelleted by
centrifugation at 12,000 x g for 5 minutes.
4. The clean pellet was re-suspended in 90 pi of PBS, mixed thoroughly by
vortexing. Ten microlitres of the suspension was dropped onto a microscope slide
then a 22x22 mm coverslip was placed over the drop.
5. The slide was examined using a Laborflour fluorescence microscope (Leitz)
fitted with an 12/3 filter block with a blue excitation filter (BP450-490) at X400 total
magnification. Live cells appeared blue. The number of live cells in 10 squares of a
graduated eyepiece were counted then the mean was determined to obtain the grid
counts. The total number of live EBs per ml of culture was calculated by
multiplication of the mean number of EBs (grid count), by the total area of coverslip
(484 mm2), multiplied by the area of the grid (100 mm2), by the dilution factor (XI0')
and the sum was multiplied by 100 or by using the formula:
Total number of EBs/ml = Mean Grid count x Ax. x A2. x Dilution factor
(lO')xlOO.
2 2Where A! = Area of coverslip (mm ), A2 = Area of the slide (mm ).
3.16. Challenge ofanimals with live virulent EB cultures ofthe Welgevonden
stock ofC. ruminantium.
Sheep and goats were challenged in the isolation unit of the CTVM by
intravenous inoculation with 2 ml virulent culture of C. ruminantium containing 3 x
66
105 EBs through the jugular vein. Mice were challenged by intravenous inoculation
... .3
through the tail vein with 0.1 ml virulent culture of C. ruminantium containing 1x10
EBs in the Small animal unit of the CTVM. The EBs used were counted as described
earlier (Section 3.14.).
3.17. Isolation ofEndothelial Cells from Peripheral Blood Mononuclear Cells of
Sheep.
Isolation of endothelial cells from PBMC of sheep by a method described by
Albert Bensaid (Personal Communication, 1995) as follows:
1. An attempt was made to isolate endothelial cell from peripheral blood of six
sheep (S66, S69, S71, S72, 74 and S76). Blood was collected in heparinised
vacutainer tubes as described in Section 3.2 before the sheep were immunised
with recombinant 58kDa Hsp protein of C. ruminantium.
2. PBMC were prepared essentially as described in Section 3.2 except that equal
volumes of blood and sterile heparinised PBS were mixed, layered over
ficol- hypaque and centrifuged at 1000 x g for 30 minutes at 15°C. The PBMC
were removed and transferred into 10 ml RPMI 1640 medium supplemented
with 8% foetal bovine serum (Life Technologies, Paisley, Scotland).
3. Cell concentration was adjusted to 107 cells/ml and the same volume was added
into 25 cm2 or 80 cm2 tissue culture flasks (Nunc, Denmark). The flasks were
incubated at 37°C in a moist atmosphere with 5% C02 for 2 hours. Unattached
cells were removed by washing the flasks twice with warm complete RPMI
1640 medium.
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4. Adherent cells were grown in Glasgow minimum essential medium (GMEM)
supplemented with 20% foetal bovine serum containing 300 pg/ml of
endothelial cell growth supplement (Sigma) for 5 days at 37° in a moist
chamber containing 5%C02 Half the media in the flasks containing
endothelial cells was replaced, and incubation was continued until the cells
were confluent then passaged. Flasks without endothelial cells were treated in
the same way, incubated for 3 weeks then discarded if there was no cell
growth. To passage confluent monolayers of each cell line the cells were
washed once with sterile PBS, incubated in 0.1 solution of trypsin in versene at
37°C for 5 minutes and centrifuged at 1500 rpm for 15 minutes at room
temperature The Cells were re-suspended in fresh medium and passaged. Cell
lines were stored by re-suspending the cells in complete GMEM containing
10% DMSO and freezing at -70°C or in liquid nitrogen as described by Pow et
al. (1993). Endothelial cells were isolated successfully from 3 of 6 sheep (S66,





1612 + + + + + +- 1671
a LKVGGSSEVEVKERKDRVED
GCTCTTCATGCAACTAGAGCTGCTGTTGAAGAAGGTGTTGTGCCAGGTGGTGGTGCTGCA





1792 + + + + + +- 1851
a G INIVKRALQAP IKRI IKNA
GGATCAGAAAATGCACCATGTGTTATTGCTCATTTATTGAAGCAAAATGATAAGGAACTT
1852 + + + + + +- 1911
a GSENAPCVIAHLLKQNDKEL
ATCTTTAATGTGGATGTAACGAATTTTGCTAATGCATTTACTTCTGGAGTAATTGATCCG
1912 + + + + + +- 1971
a IFNVDVTNFANAFTSGVIDP
CTTAAAGTAGTGCGTATAGCATTTGATTTTGCTGTATCTCTTGCTGCAGTATTTATGACA




2032 + + + + + +- 2091
a LNAIVVDIPSKDDNSAAGGA
GGTATGGGAGGCATGGGTGGTATGGGTGGTTTT
2092 + + + 2124
a GMGGMGGMGGF
Figure 3.1 Amino (a) acid and nucleotide sequence of the
C.ruminantium GroEL gene.The Hindlll sites which were used
for cloning the 0.7kb fragment into pTrHisHI110.7 are



























1132 + + + + + +- 1191
a LLTEKKLNIIQPLLPILENI
GCTAGATCAGGTAGACCACTTTTAATTATTGCAGAGGATGTAGAAGGTGAAGCACTTAGT





1312 + + + + + +- 1371
a FGDRRKDMLGD IAILTGAKH
GTAATAAATGATGAGCTTGCTATTAAAATGGAAGATTTGACTCTATGTGATTTAGGAACT
1372 + + + + + +- 1431
a VINDELAIKMEDLTLCDLGT
GCTAAGAATATACGTATTACAAAAGATACTACAACTATTATTGGTAGTGTAGATAATAGT
1432 + + + + + + - 1491
a AKNIRITKDTTTIIGSVDNS
TGTGCTCATGTTCAAAGTAGAATTTGTCAAATTAGAATGCAAATTGATAATTCTACTTCA
1492 + + + + + +- 1551
a CAHVQSRICQIRMQIDNSTS
GATTATGATAAAGAAAAGCTACAAGAGCGTTTAGCAAAGCTTTCTGGTGGTGTTGCTGTA
1552 1 1 H 1 1 f— 1611
CTAATACTATTTCTTTTCGATGTTCTCGCAAATCGTTTCGAAAGACCACCACAACGACAT
CHAPTER FOUR
CHARACTERISATION OF ELEMENTARY BODY ANTIGENS
OF C. RUMINANTIUM.
4.1. Introduction.
Animals which recover from natural infection with C. ruminantium or those
immunised by infection treatment, attenuated organisms or with inactivated
immunogens are immune to homologous challenge (Uilenberg; 1983; Jongejan,
1991; Martinez et al., 1993, 1994; Mahan et al., 1995; Tafesse, 1992). The
development of improved vaccines against heartwater has high priority because
virulent blood stabilates and ground-up tick supernatants are cumbersome to use and
expensive to produce (Oberem and Bezuidenhout, 1987a).
Characterisation of the antigenic components of C. ruminantium would make
it possible to assess antigens that are important in immune response to this organism.
The life cycle of C. ruminantium has two stages, an intracellular developmental
reticulate body (RB) and an extracellular infective elementary body (EB) (Jongejan
et al., 1991c). It is thought that since the EB is the infective stage, its antigenic
components, and in particular those which are on its surface may have functions
associated with infection, may be targets for protective immune responses and could
be used for developing subunit vaccines. Previous workers have identified antigenic
components using antibodies raised in animals that have recovered from natural or
experimental infections and animals that have been immunised with inactivated
antigens. Their results describe antigenic components in general and not those on the
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surface of the organism (Jongejan and Thielemans, 1989a; Rossouw et al., 1990;
Mahan et al., 1993 van Kleef, Neitz and De Waal, 1992, 1993).
Detailed characterisation of antigenic components of pathogenic organisms
requires them to be broken down into individual constituents which can be separated
and analysed. A number of well established physical and chemical methods can be
used, the choice of method depending on how the antigens are to be used. Physical
methods include freeze thawing, freeze fracture and sonication. Chemical methods
include those which utilise non-ionic and ionic detergents such as Triton X-100,
Nonidet, and sodium dodecyl sulfate (SDS) and low osmolarity buffers to lyse the
organisms. Physical and chemical breakdown of cells leads to the release of
proteases, amino-peptidases and metalloproteases. Enzymatic activity can be
controlled by addition of enzyme inhibitors (enzyme poisons) specific for classes of
proteases. These include Aprotinin, (Trasylol) which acts against serine proteases,
TLCK (tosyllysine-phenyl methyl sulfonyl fluoride) for serine and cysteine proteases
and EDTA to inhibit metalloproteases. Solubilisation in solutions containing
reducing agents such as dithiothreitol or mercaptoethanol, ionic detergents such as
1 % SDS solution and boiling destroy protease activity. After extraction the released
proteins have to be purified. The method used for purification depends on the
purposes for which the antigens are to be used. Where the native state of the antigen
should be retained, methods which do not require denaturing are employed. In
situations where the native state of the antigen is not critical a method of purification
which involves denaturing can be used. One of the most widely used methods for
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separating proteins is sodium dodecyl sulfate-polyacrylamide gel electrophoresis
(SDS-PAGE). SDS-PAGE method can be used to identify and monitor proteins
during purification and also for assessing the homogeneity of the purified fractions
(Garfin, 1990). The most commonly used SDS-PAGE is the discontinuous buffer
system of Laemmli (1970), consisting of a separating and a stacking gel. Following
SDS-PAGE the bands of fractionated antigens can be located, cut out of the gel,
electroluted from the acrylamide and used. Denaturing and non-denaturing
conditions were used in this study in order to compare their effects on the physico-
chemical nature of C. ruminantium antigens.
The aim of experiments described in this chapter were to characterise the
surface exposed antigenic components of C. ruminantium and to determine the effect
of reducing and non-reducing conditions and heat on the mobilities of these antigens
and their reactivity with antibodies from immunised animals.
4.2 Materials and Methods
4.2.1. Cowdria ruminantium stock.
The Welgevonden stock (Du Plessis, 1985a) was used in this chapter. It was
propagated in bovine endothelial cells as described earlier (Pow et al., 1993, section
3.4).
4.2.2. Antisera.
Sera obtained from two goats 28 days after immunisation by the infection and
treatment method and sera obtained from two another goat obtained 34 days after
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booster with inactivated elementary bodies as described earlier (Section 3.14), were
used for detection of surface antigens.
4.2.3. Biotin labelling and detection of surface exposed proteins of C.
ruminantium.
Fresh EBs were obtained by harvesting 50 ml of culture supernatant of a 10 to
14 day culture. The EB pellet was suspended in either 0.05M sodium carbonate
buffer (ELISA buffer) pH 9.6, or 0.1M sodium phosphate buffer (NaH2P04) pH 7.0
in volumes sufficient to bring the protein concentration to lmg/ml. The suspension
of EB was further diluted to 50, 25, 12.5 and 6.25 pg/ml EB protein by mixing the
suspension thoroughly, withdrawing 50 fil and adding it into 50 fil of fresh buffer.
Unlabelled EBs were used as controls.
Biotinylation was achieved using two methods: first, EB dilutions prepared in
sodium carbonate buffer pH 9 were mixed with 10 fig biotin (biotinamide caproate,
Sigma, USA) dissolved in DMSO and incubated at room temperature for 4 hours.
Second EB dilutions prepared in sodium phosphate buffer pFI 7. 0 were mixed with
20 fig of Sulfo-NHS biotin (ImmunoPure® , Pierce, USA) and incubated for 30
minutes at room temperature before storage at -20°C until used. For SDS-PAGE
analysis the method described in Section 3.8 was used with a few modifications.
Briefly, the biotinylated EBs were dissolved in 2 times of sample buffer (0.68M Tris
hydrochloride buffer pH 6.8, 2% sodium dodecyl sulfate, 10% glycerol, 5%,
2-mercaptoethanol and 0.05% bromophenol blue) and 10 fil per well of different
concentration were loaded (2.5 fig, 1.25 fig and 0.625 (Ig/EB antigen per well).
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The antigens were transferred onto nitro-cellulose membranes as described in
Section 3.9. After two 5 minute washes in phosphate buffered saline containing
0.1% Tween 20 (PBST) the membranes were incubated with a 1/500 dilution of
ExtraAvidin Peroxidase conjugate for 60 minutes with gentle agitation on a rocking
platform. After three washes of 1 x 15 minutes and 2x5 mins, the blots were
transferred into a container with a substrate solution (30 fig 4-chloro-l-N-naphthol in
10 ml ice cold methanol plus 50 ml, 20mM Tris buffered saline pH 7.5 with 30 pi ice
cold hydrogen peroxide). Membranes were incubated for 5 to 10 minutes and the
reaction was stopped by washing with distilled water after suitable colour
development. The blots were examined for protein bands and the molecular masses
of each band determined using a standard curve prepared by measuring the migration
of the pre-stained standards. The blots were photographed using a Polaroid film
(Type 55; Sigma, UK) in a Polaroid MP Land Camera with a 3A Kodak wratten
filter.
4.2.4. Detection of the antigenicity of biotin labelled surface antigens of C.
ruminantium using immune sera from I/T or IEB immunised goats.
To identify that the biotin labelled proteins were also antigens recognised by
antibody, SDS-PAGE and Western blotting of biotin-labelled EB samples was
carried out as described in Section 4.2.3. The blots were then incubated in a 1/50
dilution of a day 28 PI serum from an I/T goat (G69) or with serum obtained on 34 PI
serum from an IEB immunised goat (614) (Section 4.2.2). Then they were washed
three times (2x5 minutes, 1x15 minutes) in PBST and incubated with a 1/500
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dilution of peroxidase conjugate rabbit anti-goat IgG whole molecule (Sigma) in
PBST for 60 minutes before colour development.
4.2.5. Determination of the effect of reducing agents and heat on unbiotinylated
EB antigens of C. ruminantium.
Frozen EBs were divided into two fractions for different treatment prior to
SDS PAGE. They were mixed with equal volumes 2x sample buffer (Section 4.2.3)
with or without the reducing agent P-mercaptoethanol (BDH, UK). Each sample was
further subdivided into two fractions and one was heated for 5 minutes at 95°C,
while the other was kept at room temperature (22°C). All the samples were
subjected to SDS-PAGE and electroblotted onto nitrocellulose membranes as
described earlier (Section 3.8 and 3.9). Detection of antigens was achieved by
probing the blots with a 1/50 dilution of day 28 PI serum from I/T goat (G69) as
described in Section 4.2.4. Other procedures and reagents are as described in
Sections 4.2.3 and 4.2.4.
4.2.6. Fractionation of C. ruminantium antigens by SDS-PAGE.
A large SDS-PAGE gel (16 cm x 18 cm x 1.5 mm) composed of 12%
separating and 4% stacking gel was prepared as described in section 3.8 using a XL
Protean II Dual slab apparatus (BioRad). A total of 32.5 |ig of EB protein
solubilised in 2x sample buffer and loaded into a single preparative well.
Electrophoresis was performed at 200v/35mA for 1 hour until the sample was in the
separating gel, and then at 65v/35mA overnight using a power pack model
1000/500(BioRad). The following day, the voltage was increased to 200v to
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complete the electrophoresis, the gel was removed and kept in sterile de-ionised
distilled (ddH20) water.
4.2.6.1. Location ofprotein bands in SDS-PAGE gels.
Protein bands were located by slicing a longitudinal strip (3 cm x 16 cm)
from each side of the gel, one strip included the pre-stained protein markers. The
strips were electroblotted onto nitro-cellulose membranes as described by Towbin,
Staehelin and Gordon (1979) and the strip without the markers was immuno-blotted
with goat antiserum. The blotted strips were placed alongside the gel to locate the
position of protein bands.
Alternatively the whole gel was stained with copper stain using a copper
staining kit (BioRad) according to the manufacturer's instructions. Briefly, gels were
washed in distilled water, stained for 5 minutes, rinsed with de-ionised distilled water
and proteins were visualised as dark bands by placing against a black background.
Bands of interest were located and cut out of the gel and placed in universals. Six
protein bands with molecular masses of 24kDa, 27kDa, 32kDa, 39kDa, 45kDa, and
66kDa were selected and sliced from the gel using a sterile scalpel blade. Destaining
of the bands was carried out in two changes of a 1:10 dilution of copper destain for
5 minutes each and one change of a 1:20 dilution of destain for a further 5 minutes.
4.2.6.2. Electro-elution ofprotein frompolyaerylamide gels.
Elution of proteins from the slices of polyacrylamide gels was carried out
using a model 422 protein eluter (BioRad) following the manufacturer's instructions.
Briefly each gel slice was placed in a glass tube fitted with a frit, silicone adapter and
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membrane. The six tubes were placed in the electro-eluter assembly and the chamber
was filled with electro-elution buffer (25mM Tris, 192mM glycine, 0.1% SDS) to a
level just above the silicone adaptor. A magnet stir bar was placed into the chamber
and the whole assembly was placed on a magnetic stirrer. Elution was carried out at
60mA (10mA per tube) for 5 hours with constant stirring.
The electro-eluted proteins were dialysed for 24 hours against 25mM Tris,
192mM glycine, 0.01% SDS. The eluates (600 pi) were removed from the dialysis
membrane and placed in sterile Eppendorf tubes. SDS was removed from the eluates
by overnight dialysis against distilled water at 4°C followed by desalting in a Nap 10
colunm® (Sephadex G25, Pharmacia, Sweden) according to the manufacturer's
instructions as described in Section 3.8. Then the desalted eluates were freeze dried
overnight using a Virtis freeze drier (Virtis, EISA) and reconstituted in 100-pl of
ddH20. Ten microlitre aliqouts were removed and analysed for purity by SDS-
PAGE followed by Coomassie staining as described in Section 3.7. Samples
containing protein were immuno-blotted to check for antigenicity. The remaining




4.3.1. Biotin labelling of surface antigenic components of the Elementary Body
(EB) of C. ruminantium
Six major protein bands were identified by both methods of biotin labelling
(Figures 4.1a, 4.1b). These proteins had estimated molecular masses of 21kDa,
28kDa, 31kDa, 62kDa, 74kDa, and 115kDa. Several minor bands (15) appeared on
the blots but they were clearer with Sulfo-NHS biotin due to reduced background
staining (Figure 4.1b). Blots of the biotin-labelled proteins probed with immune sera
from I/T or from IEB immunised goats revealed six major immunogenic proteins of
the same molecular mass as those identified by biotin-labelling (Figure 4.2). Other
bands with molecular masses between 14.5kDa to 142kDa were also recognised by
immune serum.
4.3.2. The effect of reducing agents and heat treatment on the elementary body
antigens ofC. ruminantium.
4.3.2.1. Unheated and non-reduced samples.
Five antigenic bands were present on blots of non-reduced un-heated EB
samples (Figure 4.3, lane 2). Two bands migrating at 28kDa and 58kDa were
prominent. The strongest reaction occurred with the 58kDa antigen. Other bands
migrating at 31kDa and 14kDa were identified also. Two bands with higher
molecular masses appeared faintly. Bands of relative molecular masses of 24kDa,
27kDa, 45kDa, did not appear in these blots.
4.3.2.2. Heated and non-reduced samples.
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Eight dominant antigenic bands and three fainter ones were on blots of non-
reduced and heated antigens (Figure 4.3, lane: 3). A band of 31kDa antigen was
dominant, followed by 80kDa, 66kDa, 58kDa and 17kDa in order of descending
intensity, bleating of non reduced samples led to appearances of more antigens
migrating at higher molecular masses in particular a band migrating at about 80kDa
was quite prominent. Fewer band migrating at lower relative molecular masses
appeared on this blots. One band migrating between 20kDa and 28kDa was present.
4.3.2.3. Heated and reduced samples ofEBs.
Western blots of heated and reduced EBs showed 14 antigenic bands with
molecular masses ranging from 14kDa to 115kDa (Figure 4.3: lane 5). The major
antigens were those with molecular masses of 24kDa, 27kDa, 31kDa, 45kDa, 51kDa,
58kDa, 66kDa and 80kDa. The other antigenic bands were faint. Heating and
reducing generated more bands with lower relative molecular masses.
4.3.2.4. Unheated reduced samples.
Western blots with unheated but reduced EBs contained a total of 11
antigenic bands (Figure 4.4, lane 6). A band with a relative molecular mass of
28kDa was prominent in these blots. The other antigens of 18kDa 5 lkDa and 3 lkDa
appeared but were fainter. The 3 lkDa antigen was less thick than in blots of reduced
and heated antigens. Other bands appeared fainter than those seen on blots with the
heated and reduced sample.
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4.3.3. Electroelution ofselectedprotein bands from SDS-PAGE gels.
Western blot analysis of the eluted protein bands revealed two antigenic
bands of 24kDa and the other of 3 lkDa (Figure 4.4 lane 1 and 3). Other eluted bands
were contaminated with a 31kDa antigen. The 24 and 31kDa antigens were further
tested in lymphocyte proliferation tests (Section 6.2.3).
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4.4. Discussion
Surface exposed antigens of C. ruminantium EBs were identified by biotin
labelling and Western blotting. Antigens which reacted strongly with antibodies in
the serum of animals which had received either live or inactivated EBs had molecular
masses of 24, 31, 45, 58, 66 and 80kDa. Three antigens of 27kDa, 66kDa and
115kDa reacted weakly. There was background staining on blots with biotin labelled
proteins suspended in carbonate/bicarbonate buffer pH 9.6 which indicated that some
protease activity had taken place. Protease activity was reduced considerably by
using 0.1M sodium phosphate buffer pH 7.0 and Sulfo-NHS biotin. Antigens of the
same molecular masses as those identified by biotin labelling have been termed as
major antigenic peptides (Mahan et al, 1994b) due to their strong reactions with
antibodies from immune animals. Their strong reactivity with antibodies may
indicate that they are involved in protective immune responses to C. ruminantium.
This work has demonstrated for the first time that a number of the major antigenic
proteins of C. ruminantium are located on the surface of the EB and that they are
recognised by antibodies in serum from animals which have been immunised by I/T
or with inactivated EBs of C. ruminantium.
The effect of a reducing agent in the sample was to increase the number of
antigenic bands indicating that there may be 2-5 major antigens (polypeptides) on the
surface of the EB. These antigens may be composed of proteins with extensive
cross-linking, with perhaps 5 protein complexes or antigens present in 5 protein
complexes which are composed of up to 14 peptide subunits of which the 28 and
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58kDa are dominant. This situation has parallels with the structure of the chlamydial
EB. In Chlamydia the outer membrane of the EB consists largely of disulphide
cross-linked MOMP and two cysteine rich proteins (CRP) Storz and Kaltenboeck,
(1993). The MOMP is not cross-linked on the reticulate bodies, and MOMP is
identified as a pore-forming molecule whose activity is controlled by
oxidation/reduction of disulphide bonds. Since Cowdria has a Chlamydia-like life
cycle, with a similar pleo-morphic intracellular reticulate body stage, the effects of
reducing agents suggests that cross-linked proteins constitute important components
of the Cowdria EB. Cross linking of chlamydial proteins by disulphide bonds
determines the rigidity of the EB envelope (Storz and Kaltenboeck, 1993). After
entry of chlamydial EBs into the phagosome, the disulphide bonds are reduced,
making the membrane more fluid and allowing development of the larger forms
involved with multiplication (Storz and Kaltenboek, 1993).
The effect of heating was less marked, the migration of antigens was altered
but the total number of bands/antigens in reducing or non reducing conditions was
similar. These results indicate that tertiary and quaternary structures are present in C.
ruminantium EB antigens. It is possible that the 14.5/15kDa antigen present in each
treatment with similar migration may be similar to the LPS like antigen of 17kDa
present in the rickettsiae (Ingalls el al., 1995). LPS has been described in Ehrlichia.
Lee and Rikihisa (1996) identified a periodate sensitive component on Ehrlichia
chaffeensis important in monocyte responses. Periodate or protease treatments may
be used to identify whether the 15kDa antigen here is the homologue of rickettsial
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LPS. The antigenicity of the unreduced polypeptides indicated that they may have
conformational epitopes in addition to the linear ones which were observed in heated
and reduced samples.
Barbet et al. (1994) reported that the molecular mass of the 31kDa antigen
was variable. In this study the 31/32kDa antigen was not dominant in blots with
reduced but unheated samples, instead a 28kDa antigen was dominant, the presence
of disulphide bonds between peptides, folding and non-covalent interactions could
explain this observation.
C. ruminantium contains a complex mixture of extracellular and intracellular
detergent soluble and insoluble antigenic components (Paxton, Sumption, Lally, and
Pow, 1993, unpublished data). Among the 6 surface exposed antigens identified in
this study, the 28kDa is soluble, while the 21 and 31kDa are present in the soluble
and insoluble fractions. These antigens are also cross reactive with sera from
animals infected with Ehrlichia phagocytophila and E. ondiri.
Rossouw et al. (1990) identified 20 antigenic components of the
Welgevonden stock, 12 in the Ball 3 reference stock and 9 for the Kwanyanga stock
using homologous and heterologous antisera from immunised animals. They
reported that two antigens of 27kDa and 31kDa were common in all of antigenic
profiles of the 9 stocks they examined. In this study two antigens of 28kDa and
31kDa were identified on the surface of the EB and it is likely that they are the same
as those reported by the above workers.
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C. ruminantium antigens of 21kDa, 32kDa, 40kDa, 45kDa, 58kDa, 85kDa
and 160kDa have been referred to as major antigenic peptides (Mahan et al., 1994b)
and are shared between stocks. Among these antigens the 21, 32 and 58 are on the
surface of the EB. The 32kDa Major Antigenic Protein 1 (MAPI) formerly referred
to as Cr32 (Jongejan and Thielemans, 1989a; Rossouw et al., 1990) is
immunodominant and conserved among several stocks of C. ruminantium and
Ehrlichia species (Jongejan et al., 1989). The methods used to prepare these
antigens did not affect their reactivity to antibody. Antigens were prepared from
crude tissue extracts of infected animals (Jongejan and Thielemans, 1989a), infected
cell suspensions (Rossouw et al., 1990) and from pure elementary bodies (Paxton et
al., 1993). In all cases it was possible to separate them by SDS-PAGE and identify
them with polyclonal antisera obtained from infection-treatment animals (Paxton et
al., 1993), or those immunised with inactivated immunogens emulsified in an
appropriate adjuvant (Jongejan and Thielemans, 1989a; Rossouw et al., 1990). In
this study surface exposed antigenic components of the elementary body of C.
ruminantium were identified by biotin labelling and it was demonstrated that specific
antibodies to them are developed by animals which have received live or inactivated
immunogens respectively. The role played by these antigens in protective immune
responses to C. ruminantium is not known. In view of their location and strong
reactions with antibody these proteins may be targets for inducing protective
immunity individually or in various combinations. Immunisation with the reduced
32kDa antigen which is a major structural protein (Mahan, 1995) does not confer any
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protection on animals (van Vliet et al., 1994). Immunisation with the surface 21kDa
antigen has not been attempted.
The 58kDa antigen probably belongs to the family of heatshock proteins
(Hsp) designated Hsp 10 and Hsp 60. Hsps are highly conserved among eukaryotic
and prokaryotic organisms and are major targets of antibody responses (Kaufmann,
1993). The gene coding for the 58kDa protein termed GroEL has been cloned and
expressed in E. coli (Lally et al., 1995) and immune responses to the recombinant
58kDa Hsp in sheep and mice were investigated (Chapter 7). Two other recombinant
antigens have been produced the MAPI (van Vliet et al., 1994) and 21kDa proteins
(Mahan et al., 1994b). The value of these antigens for diagnostic purposes and
immunogenicity has being investigated in other laboratories (van Vliet et al., 1994;
Mahan et al., 1994b).
Individual antigenic proteins have been used successfully to induce protective
immunity in other rickettsial diseases. Two protein antigens of Anaplasma
marginale with molecular masses 105kDa (Palmer, et al., 1986) and 36kDa (Palmer,
et al., 1988) have been used to induce protective immunity to homologous and
heterologous challenge. Identification of surface protein antigens of C. ruminantium
could lead to the isolation of cross-protective antigens for immunisation and for the
development of specific serological tests. This is particularly important in situations
where cross-reactions occur between closely related organisms due to the presence of
shared epitopes among conserved antigens (Jongejan, et al., 1993a). This study has
demonstrated that several of the major immunogenic antigens of C. ruminantium are
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located on the surface of the EB and the fact that it was possible to purify some of
these antigens by SDS-PAGE enables the investigation of their role in immune
responses to heartwater.
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Figure 4.1a. Biotin labelled surface EB proteins of C. ruminantium.
Lanes were loaded with proteins in carbonate buffer (pH 9.6) as follows: lane 1,
50 pg/ml ofEB protein; lane 3, 12.5 pg/ml and lane 2, 25 p.g/ml ofEB protein.
The arrows indicate bands of dominant surface proteins.
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Fiigure 4.1b. SDS-PAGE of biotin labelled surface proteins of the EB of
C. ruminantium.
Lanes were loaded with antigens in sodium phosphate buffer (pH 7.0) as follows:
lanes 1 to 3, 50 pg/ml of ofEB protein and lane 4 with 25 pg/ml EB antigen.
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Figure.4 2. Western blots demonstrating recognition ofbiotin labelled EB proteins
of C. ruminantium by antibodies in serum of goats immunised with live (I/T) and
inactivated EBs (IEB).
Lanes 1 and 2, immunoblots ofEB proteins tested with day 28 PC serum from an I/T
goat G69; lane 3 and 6, SDS protein standards; lanes 4 and 5, were tested with day
34 serum from IEB goat (G614); lanes 7 and 8, tested with ExtraAvidin peroxidase.
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Figure 4.3. Western blot analysis of C. ruminantium EBs showing the effect of
reducing and non reducing conditions with and without heating.
Lane 1, SDS-PAGE protein standards; lane 2, non-reduced and un-heated EB
antigens; lane 3, heated non-reduced antigens; lane 4, protein standards, lane 5,






24 kDa 31 kDa
Figure 4.4. Western blot analysis of SDS-PAGE purified antigens of C.
ruminantium blots were tested with day 28 sera from I/T goat (G69).
Lane 1, 24kDa SDS purified antigen; lane 2, control containing EB antigens
ofC.ruminantium and lane 3, SDS-purified 32kDa antigen.
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CHAPTER FIVE.
IMMUNOGLOBULIN G RESPONSES OF RUMINANTS AND MICE TO
IMMUNISATION WITH LIVE AND INACTIVATED ANTIGENS OF C.
RUMINANTIUM
5.1. Introduction
Animals which recover from heartwater infection develop antibodies to
Cowdria ruminantium (Neitz et al., 1986; Du Plessis and Malan, 1987b; Semu et al.,
1992).
Detection of the antibody responses of naturally infected ruminants and those
inoculated with either live C. ruminantium or with inactivated EBs can be carried out
by a number of serological tests. These include the indirect fluorescent antibody test
(IFAT) (Du Plessis, 1981; Brown, et al., 1989; Du Plessis et al., 1993b; Lawrence et
al., 1993), the enzyme linked immunosorbent assay (ELISA) either as an indirect
assay (Neitz et al., 1986; Soldan et al., 1993) or as a competitive assay ( Du Plessis
et al., 1993 Jongejan et al., 1991a), and Western blotting (Jongejan and Thielemans,
1989a; Rossouw et al., 1990; Mahan et al., 1993).
Circulating specific antibodies to C. ruminantium were detectable by indirect
ELISA in serum of goats 10 days after experimental infection or immunisation with
inactivated elementary bodies of C. ruminantium (Tafesse, 1992; Viljoen et al.,
1987). In mice antibodies were detected 14 days post inoculation by IFAT (Byrom
et al., 1993). IFAT has been used for the diagnosis and monitoring of serological
response to heartwater immunisation (Lawrence et al., 1993, 1995) and ELISA has
been used for epidemiological studies (Kobold et al., 1992). However cross-
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reactions with Ehrlichia spp. are a drawback to the use of crude antigen preparations
(Du Plessis Boersema and van Strijp, 1994). Western blotting is used for the
identification of specific antigenic components of C. ruminantium which may have a
role in protective immunity to the host (Jongejan and Thielemans, 1989a; Rossouw et
al., 1990; Mahan et al., 1993).
There are four major immunoglobulin classes in the ruminant, IgG, IgM, IgA
and IgE. Immunoglobulin M appears early (9-12 days) after infection with
heartwater with titres peaking between 15 to 18 days (Afonso, 1995). IgG appears
about the same time as IgM but it peaks around 28 days post infection and persists
for longer periods than the other immunoglobulin classes. There are two major
subclasses of ruminant IgG, IgG] and IgG2 ofwhich IgG] is the predominant in sheep
(approximately 2/3 of total serum IgG) (McQuire, Musoke and Kurth, 1979).
Immunisation of sheep with protein antigens generates antibody responses of both
isotypes (Bird et al., 1995). The role played by the IgG isotypes in immunity to
pathogenic organisms has been investigated by several workers. For example, IgG2
is important in protection against Staphylococcus aureus mastitis in sheep (Watson,
1988). There are two high affinity FcyR receptors on ruminant cell surfaces, one for
IgG2 and the other for IgG,. High affinity receptors for IgG2 are found on neutrophils
and monocytes/macrophages, while those with high affinity for IgG] are expressed on
alveolar macrophages and cultured monocytes (Howard, Taylor and Brownlee,
1980). The major effector cells of antibody-mediated cytotoxicity (ADCC) in the
ruminant are neutrophils and monocyte/macrophages (Grenwal and Rouse, 1979).
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Immunisation of mice with soluble protein antigens leads to two types of CD4+ T
helper lymphocyte responses referred to as Thl and Th2 that are differentiated by the
cytokines that are produced (Mosmann and Coffman, 1989).
In Thl type responses CD4+ T cells produce interferon gamma (IFN-y), interleukin-2
and tumor necrosis factor alpha (TNF-a). Their effect is to promote cell-mediated
immunity and support production of IgG2 antibodies. In Th2 type responses CD4+ T
cells secrete IL-4, IL-5, IL-6 and IL-10. Their effect is to support IgE, IgG] and IgA
production and to promote eosinophilia. Immunity to intracellular bacteria is thought
to be mediated principally by cell-mediated immunity. The IgG isotype antibody
which is associated with these infections would be IgG2. However this seems to be
only true for some infections caused by some intracellular bacteria. Dominance of
IgG! or IgG2 responses in ruminants infected naturally or experimentally with certain
intracellular bacteria or those vaccinated has been reported in cattle and goats.
Schmeer, Schnorr, Perez-Martinez and Storz (1987) used indirect ELISA to
differentiate Chlamydiapsittaci specific IgG! and IgG2 levels in serum samples from
cattle with natural chlamydiosis and those which were experimentally infected. The
mean IgGiTgG2 ratios of the naturally infected cattle was 1:4 indicating a significant
IgG2 dominance, similar ratios were obtained with serum from experimentally
infected cattle. In contrast significant IgG] but lower IgG2 levels were associated
with natural Coxiella burnetti infections, but vaccination of cattle with formalin
inactivated C. burnetti vaccine led to the development of a highly significant
IgG2 response (Schmeer, Kraus, Lorbach and Weigand, 1986). Natural infections of
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Chlamydia psittaci in goats were characterised by high IgGj responses whereas
vaccination led to mixed responses of IgG] and IgG2 although IgG, was predominant
(Schmeeer, et al., 1987). Vaccination of goats with inactivated C. burnetti produced
a dominant IgG2 response. Butler, Seawright, McGivern and Gilsdorf (1981)
demonstrated that IgG! was dominant in sera from infected cattle, after immunisation
and subsequent challenge with Brucella abortus SI9.
IgG isotype predominance in virus infections of sheep has also been
demonstrated. Bird et al. (1995) demonstrated dominance of IgG! in serum from
sheep infected with the Maedi-Visna virus, they also found that sheep infected with
the parapox orf virus developed a predominant IgG2 response.
Cowdria ruminantium has a life cycle similar to that of the obligate
intracellular rickettsia C. psittaci, and given this similarity I examined the IgG whole
molecule, IgG] and IgG2 responses of cattle, sheep, goats and mice to C. ruminatium
EB antigens following experimental infection (I/T), field challenge, and
immunisation with inactivated EBs or recombinant antigens.
5.2. Materials and Methods
5.2.1. Antigens.
The antigens used for Western blotting and ELISA tests in this chapter were
from Elementary bodies (EBs) of C. ruminantium (Welgevonden stock). Two
recombinant antigens, (Ags) a 58kDa Hsp and its subclone a 35kDa protein were also
used. The 35kDa recombinant protein was expressed in E. coli and purified as
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described in Section 3.7 and used for ELISA tests to detect IgGl and IgG2 responses
ofmice and sheep immunised with the 58kDa recombinant Ag.
5.2.2. Sera. Sera from five groups of goats, two groups of sheep, 3 groups of cattle
and three groups of mice were examined for Cowdria specific IgG antibodies by
Western blotting and ELISA.
Caprine sera
Goats in groups C1, C2 and C3 (6 goats each) were part of a previous vaccine
trial (Tafesse, 1992). They had been immunised with inactivated EBs (IEB) or
detergent extracted soluble antigens followed by challenge with live virulent blood
stabilate.
Goats in group CI were inoculated once with IEBs and those in group 2 were
inoculated 2 times with IEBs 21 days apart. Antigens used for primary immunisation
were mixed with equal volumes of FCA and inoculated intramuscularly and those
used for booster were mixed with equal volumes of FIA or PBS as described earlier
in Section (3.14) and administered subcutaneously 21 days later. Goats in group C3
were treated as those in group C2 except that they had been inoculated with detergent
extracted EB antigens.
Sera were collected sequentially from each group at days 0, 7, 14, 21, 28, and
day 34 PI. On day 36 PI, 3 goats from each group were challenged by intravenous
inoculation of 5 ml of virulent blood stabilate of the Welgevonden stock. Four of the
goats survived challenge and serum was collected at day 28 post challenge (PC)
(which is day 64 PI). Detection of Cowdria specific IgG antibodies was carried out
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using 8 sera (5 from group 1 and 3 from group 2) collected after immunisation
(= day 34 PI) and 4 sera collected at day 28 PC (= day 64 PI) from 4 survivors of the
challenge and 3 sera obtained day 34 PI from group 3.
Sera in the fourth group (group C4) came from two goats which were as part
of an I/T immunisation study (Section 4.2.2) Two serum samples collected at day 28
and day 80 post infection were examined for Cowdria specific IgG, and IgG2
antibodies.
Sera in the fifth group (group C5) were from 2 goats (G107, G108)
immunised with IEB as described in Section 3.14.1. Western blot analysis was used
to examine sequential sera collected from these goats on day 0, 14, 21, and day 28 PI.
The control sera from an I/T goat (G69 day 28 PI)) and from an uninfected
goat (G106) were included in all tests.
Ovine sera
Group S1. There were 6 sera in this group obtained from three sheep infected
with the Mara and Nonile stock of C. ruminantium. They were obtained at day 0, 14
and 28 after infection.
Group S2. Sequential serum samples obtained post immunisation (day 0, 14,
21, 28, 64, and day 143 PI) from 6 sheep immunised with 58kDa Hsp recombinant
antigen and from 6 controls (Section 3.2) were examined for Cowdria specific IgG,




Sera from three groups of cattle were examined for Cowdria specific IgG,
and IgG2 antibodies. Sera in group 1 and 2 were donated by Dr. J. Du Plessis of
Onderstepoort Institute South Africa and sera in group 3 were donated by Dr. Philipe
Totte from International Research Institute (ILRI) Nairobi Kenya.
Group B1. Sera were raised by experimental infection using blood stabilates.
There were seven sera in this group, which were obtained from 7 cattle immunised
by I/T with Ball 3, Kwanyanga and Mara stocks of C. ruminantium.
Group B2. Sera came from animals which received field exposure. There
were 10 sera in this group. They were collected from cattle (B196, B199, B200 to
B206, B210 and B211) in a heartwater endemic area of South Africa.
Group B3. Sera in this group were from cattle immunised with IEB's and
subsequently challenged. There were 13 sera in this group which came from a
vaccine trial conducted in Kenya (ILRI) by Dr. Philippe Totte. Nine sera were
obtained from 3 cattle (S295, S296, and S304) immunised with IEBs of the Gardel
stock. They were collected at day 0, 36 PI and at day 31 PC. The remaining 4 sera
were from two control cattle (S234 and S264). They were collected at day 0 and day
11 PC.
Murine sera
Sera from 4 mice infected with C.ruminantium then treated (I/T) and from 5
mice immunised with IEBs were collected the same occassion (day 34 PI) post
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immunisation and examined for IgG, and IgG2 antibody responses to C.
ruminantium.
Pooled sequential mouse sera (day 0, 14, 21 and day 34 PI) obtained from mice
which had been immunised with recombinant 58kDa Hsp (Section 7.2.1.2, 7.2.1.4,
Table 7.1) were also examined for IgG[ and IgG2 antibodies to a recombinant 35kDa
subclone protein of C. ruminantium by ELISA.
5.2.3. Detection of Cowdria antigens recognised by antibodies in goat sera by
Western blotting.
Western blot analysis was used to determine antigens recognised by
antibodies in sera obtained after immunisation from goats in groups CI, C2, C3, C4
and C5. It was carried out as described in Section 4.2.4. The Molecular masses of
the bands were estimated as described in Section 4.2.3 and the blots were
photographed for permanent record as described in Section 3.11.
5.2.4. Detection of IgGj and IgG2 isotype responses of goats, sheep and mice
immunised with C. ruminantium antigens by indirect ELISA.
The method given below is a modification of that described by Soldan et al.,
(1993) to enable specific isotype responses to be identified. 96-well flat-bottomed
microtitre ELISA plates (Immulon 1, Dynatech Laboratories) were coated with 50pl
of a 1/1000 dilution of ELISA antigen in coating buffer (0.05M
carbonate/bicarbonate buffer pH 9.6). The plates were covered with cling film and
incubated at 4°C overnight. The contents were discarded and the plates were washed
three times (3 mins/wash) in 0.9% sodium chloride containing 0.05% (v/v) Tween 20
(0.9% NaCl/PBST). After washing, the plates were incubated with 100 pi per well
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of 4% normal rabbit serum in PBS containing 0.05% Tween 20 (PBST/4% NRS) for
1 hour at room temperature and the buffer was discarded. Fifty microlitres of sera
diluted at 1/50 in blocking buffer were added to the wells, the plates covered with
cling film and incubated at 37°C for 1 hour. After 3 washes, 50pi of rat anti-sheep
IgG] (IRS) or IgG2 (2RS) monoclonal antibody diluted to 1/20 in blocking buffer
was added to all wells prior to incubation at 37°C for 1 hour. For tests with mice
sera, rat anti-mouse IgG! and IgG2 monoclonal antibodies (Serotech, UK) were used.
The plates were washed 3 times as above. This was followed by the addition of 50 pi
of goat anti-rat IgG whole molecule HRP (Sigma) conjugate diluted 1/1000 dilution
in blocking buffer to all wells and incubated at 37°C 1 hour. The plates were washed
3 times and 50 pi of the peroxidase substrate, tetramethyl benzidine (TMB,
Kirkegaard and Perry laboratories) was added to all wells. The reaction was stopped
after 15 minutes by the addition of 50 pi of 0.2M sulphuric acid. The absorbance
(Optical density/ODs) at 450 nm were read using a plate reader (Multiscan plus,
Version 2.03, Labsystems). The mean of 2 tests was calculated, then the OD of the
negative control was subtracted from this value to remove background absorbance.
The results were expressed as the mean OD value of 2 tests
5.2.5. Detection of IgG isotype responses of immunised goats to C. ruminantium
by Western blotting.
EBs of the Welgevonden stock of C.ruminantium were used as antigens.
SDS-PAGE and Western blotting was carried out as described in Sections 3.5 and
4.2.5 with the following modifications to enable specific isotype responses to be
detected:
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Following blocking of the membranes and incubation with primary sera, the blots
were reacted with monoclonal antibodies to sheep IgG] and IgG2. The monoclonal
antibodies (IRS and 2RS) were in culture supernatants obtained from Dr. John
Hopkins, Department of Veterinary Pathology, University of Edinburgh and were
specific for isotypes IgG, and IgG2 respectively.
Optimal working dilutions of each MoAb used in Western blot analysis were
established to be 1/10 for 2RS and 1/20 for IRS. Following incubation for 60
minutes colour was developed in the usual way.
5.2.6. Detection of IgG isotype responses of cattle to C. ruminantium by indirect
ELISA.
The method used was a modification of that used for goat sera (section
5.2.4).
Mouse anti-bovine IgG2 monoclonal was obtained from Sigma (Sigma, UK), and
HRP conjugated sheep anti-bovine IgG| antibody was obtained from Bethyl
Laboratories (USA). The working dilutions of the antibodies were determined by
carrying out a checkerboard titration.
For performance of the test proper volumes of 100 pi per well for all reagents were
used, antigen dilutions of 1/4000 and 1/6000 in carbonate buffer pH 9.6 for Gardel
and Welgevonden respectively was used to coat the plates. Plates were blocked for
1 hr at room temperature with PBST containing 4% Normal goat serum (PBST/4%
NGS). Plates were washed manually 3 times in PBS, with 0.05% Tween (3 minutes
each).
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The plate was divided into two equal halves. Wells in columns 1-6 of rows A
to G were used to screen sera for IgG, and wells in columns 7-12 used for screening
for IgG2. Wells in row H were used for the controls. Each test was incubated in
duplicate using serum dilutions of 1/800 prepared in PBS containing 4% NGS serum.
Mouse anti-bovine IgG2 monoclonal antibody (Sigma) was used at 1/10,000 to detect
IgG2 responses, then goat anti-mouse IgG whole molecule HRP conjugate (Sigma)
was used at 1/2000 to detect binding of the monoclonal antibody. Sheep anti-bovine
IgG, HRP conjugated polyclonal serum (Bethyl Labs) was used at 1/50,000 to detect
IgG,. All dilutions were carried out in blocking buffer. The chromogen, reaction
times and stopping of the tests was as described earlier (Section 5.2.4).
5.2.7. Statistical analysis.
The student's t test was used to analyse for differences between IgGl and




5.3.1. Antigens ofCowdria elementary body recognised by immune sera
Antigens recognised by antibodies after I/T immunisation.
Sera from goats immunised by live (group C4) reacted to between 5 and 7
antigens in Western blots of the EB (Figure 5.1, lanes 2 and 3). The 5 predominant
antigens were of molecular masses 21kDa, 24kDa, 28kDa, 32kDa, and 58kDa. A
66kDa antigen was usally observed but was faint.
Antigens recognised by antibodies following immunisation with IEBs.
Goats immunised with inactivated EB's (groups CI, C2 and C5) had
antibodies by the 14 day post immunisation which recognised at least 5 to 6 antigens
of the EB (Figure 5.1, lanes 4, to 7 and Figure 5.2, and 5.3 lanes 1, to 3, and 5, Table
5.1). The predominant 5 antigens were 21kDa, 24kDa, 28kDa, 32kDa, and 58kDa.
Sequential sera from two IEB immunised goats (group C5) showed positive
reactions with five EB antigens of C. ruminantium from day 14 PI onwards (Figure
5.2). These sera detected antigens with molecular masses of 24kDa, 27kDa, 28kDa
32kDa and 58kDa. Sera from G108 reacted strongly with the 58kDa antigen and
weakly with the 66kDa antigen (Figure 5.2 lanes, 6 and 7). The reactions of serum
from G107 were weaker than those from G108 (Figure 5.2 lanes, 2 and 3).
Antigens recognised by antibodies following live infection (challenge) of IEB
immunised goats.
Post-challenge sera from 4 goats in groups CI and C2 (G476, G601, G614
and G668) which survived challenge developed antibodies which reacted with 4 to 5
more antigens than those recognised by post immunisation sera from the same
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animals (Figure 5.4 lanes:l, 2, 3, and 4, Table 5.1). Sera from one goat (G614) had
antibodies which reacted with up to 15 antigens (Figure 5.4 lane: 2 indicated by the
arrow). The antigens which were recognised by antibodies in these sera but not by
pre-challenge sera from the same animals were of molecular masses 15kDa, 36kDa,
45kDa, 66kDa, and 80kDa. Weaker reactions were also observed with antigens of
higher molecular masses.
Sera obtained from 2 goats (G614 and G668) at 18 mo and 24 mo post-
challenge recognised between 7 and 15 antigens of the EB (Figure 5.5). Sera
collected 18 mo and 24 mo post challenge from G614 reacted with at least 15
antigens with molecular masses similar to those of day 28 PC (Figure 5. lanes 5 to 8).
Antibodies in sera from goat G688 reacted with at least 9 antigens (Figure 5.5 lanes:
8 to 12). The antigens recognised by these antibodies were between molecular
masses 15kDa and 80kDa.
Antigens recognised by antibodies following immunisation with soluble antigens
(Sags).
Three antigens were detected by sera from goats immunised with soluble
antigens (group C3) (Figure 5.1, lanes 8 and 9, Figure 5.3 lanes 7 and 8, Table 5.1).
These antibodies reacted strongly with a 32kDa antigen and weakly with antigens of
21kDa, 24kDa, and 28kDa.
The four antigens detected by sera from all 4 groups were those with molecular
masses of 24kDa, 27kDa, 28kDa, and 31 kDa. Two additional antigens with
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molecular masses of 58kDa and 66 kDa were detected by sera from I/T and IEB
immunisation.
5.3.2. IgG, and IgG2 responses goats of immunised by I/T or with IEB's.
IgG, and JgG2 responses of immunised goats measured by ELISA,
Goats immunised with inactivated EB's developed a predominant IgG,
response before challenge (Figures 5.6 lanes and Table 5.3). There were significant
differences between the ELISA OD values of IgG, and IgG2 isotypes following IEB
immunisation (t=3.182, p<0.05). IgG, was dominant in these responses. The
IgG,:IgG2 ratios for 4 goats in groups 1 and 2 were 5:1 for (G476), 2:1 (G614, G668)
and 1.5:1 (G601) (Table 5.2).
After live challenge of the IEB immunised goats, the level of IgG2 isotype as
measured by OD value in ELISA, rose to between 7 and 10 times their pre-challenge
levels and IgG, ODs in post challenge sera increased by a factor of 3 to 6 times
(Figure 5.6). Analysis for differences between IgG2 responses pre-challenge and
post-challenge indicate that the levels of IgG2 had increased after challenge (t=2.353,
p<0.05).
The rise in IgG2 had the result that the differences in IgG, and IgG2 levels was no
longer significantly different (t=3.182, p>0.05). After challenge the ratio between
IgG, and IgG2 responses had changed to between 2:1 to 1:1.6.
In contrast to to the effect of live challenge on IEB immunised goats the responses to
live infection (I/T) of naive goats (G69, G74 group 4) resulted in a very marked IgG,
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response and no significant detection of IgG2 when sera collected on days 28 and 80
were tested.
The IgG, and IgG2 responses of sheep (group S2) immunised with recombinant
antigens were similar to those of sera from I/T goats and those of pre-challenge from
IEB immunised goats. They were characterised by higher IgG! OD values and an
IgG!:IgG2 ratio of 2:1.
IgGL and IgG^antibodies in post immunisation and post-cliallenge sera from IEB
immunised goats recognise specific antigens of the EB in Western blots.
To confirm that IgG[ and IgG2 responses following IEB immunisation were
to Cowdria antigens and not to endothelial cell antigens which contaminate IEB
preparations, Western hotting was performed. Sera collected at day 28 from an I/T
goat (G74) reacted strongly with EB antigens of molecular masses of 21kDa, 24kDa
28kDa 32kDa and others of higher molecular masses which reacted weakly (Figure
5.7 lanes: 2 and 3). These reactions were however only with IgG, but not to IgG2
(Figure 5.8, lanes 4 and 5).
The IgG] and IgG2 responses of sera collected on day 34 PI (pre-challenge)
from an IEB goat (G668, group C2) were the same as those of the I/T goat
(Figure 5.7, lanes: 8 and 9). The very significant IgG2 response after challenge of
IEB immunised goats was confirmed by the presence of reactions to Cowdria
antigens (Figure 5.8, lanes 4, to 6).
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5.3.4. IgGl and IgG2 responses of immunised sheep determined by ELISA.
Infection of sheep with live organisms by blood resulted in a predominant
IgG, response and an apparent absence IgG2 response (Appendix B Table 19a). They
were similar to those observed to live infection of goats I/T goats (section 5.3.8).
The IgG responses of sheep (group S2) immunised with recombinant 58kDa Hsp
were also characterised by a predominant IgG, response with a ratio of at least
2:l(Appendix B Table 17) with a non detection of IgG2 in 3 out of 6 animals.
5.3.5. IgGj and IgG2 responses of cattle to live and inactivated antigens of C.
ruminantium.
IgGl and IgG2 responses following live infection by experiment (I/T) or by field
exposure.
The Cowdria specific IgG, and IgG2 responses to experimental infection of 7
cattle (group Bl) with 3 different stocks of C. ruminantium were characterised by a
dominant IgG! but, in contrast to sheep and goats specific IgG2 was detectable above
background. The IgG!:IgG2 ratio had a median of 5:1 (range 1:1 to 8:1, Table 5.3).
The IgGpIgG;^ ratios of field sera from S.Africa (group B2) were
characterised by IgG!:IgG2 ratios greater than 1 (Table 5.4) with a range from 3:1 to
56:1 (mean 5:1). except for one sample (B200) which had a ratio of 1:2. These ratios
were similar to those obtained following experimental infection (Table 5.4) although
higher IgG2 levels were observed with 3 sera than observed for any of the animals
after experimental infection.
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IgG; and IgG2 responses following immunisation with IEBs.
In contrast to goats both IgG! and IgG2 were detected in sera following
immunisation of cattle with IEB's of C. ruminantium (Figure 5.9). In addition, the
level of IgG2 was much higher after immunisation with IEBs than that obtained in
cases of the experimental infection and field sera (Figure 5.9, Table 5.5). Also in
contrast to goats the IgGl:IgG2 ratio did not significantly alter after live infection.
The IgG|TgG2 ratios in serum samples of three immunised cattle (S295, S296, S304)
were the same pre-challenge and post challenge (1), although there was an increase in
OD values of both isotypes in serum after challenge. In contrast to goats the increase
in OD value of the two IgG isotypes was of a similar magnitude (Figures 5.9), and
did not show greater increase in IgG2. The mean OD values of sera obtained before
immunisation of the immunised group and those from two control cattle (S234,
S264) remained low and their IgG!:IgG2 ratios were same or IgG! ratio was higher
than 1 (Table 5.5). The control animals did not develop an antibody response prior
to death (Table 5.5).
5.3.6. IgGj and IgG2 responses of mice to C. ruminantium after immunisation
with I/T, with IEBs or recombinant antigens.
Immunisation of mice with live C. ruminantium was observed to result in a
dominant IgG2 isotype response, in contrast to that obtained in live infection of
ruminants. Sera obtained on day 34 PI from 4 mice infected with live EBs had
higher IgG2 OD values in comparison to sera from mice inoculated with IEBs and
collected at day 34 after immunisation (Figure 5.10). The IgGj:IgG2 ratios of the
sera from I/T mice was 1:2 and that of sera obtained from the inactivated EB
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immunisation was 2:1. The antibody responses of mice immunised with
recombinant 58kDa Hsp were observed to be predominantly of IgGj (Figure 5.11)
isotype in specific response, as determined using the 35kDa GroEL antigen.
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5.4 Discussion
Immunisation of goats by infection/treatment or with inactivated elementary
bodies of C. ruminantium led to the development of antibodies to between 7 and 15
EB antigens. The antibodies obtained by immunisation using the two methods
detected the same antigenic components of EBs. In contrast, after immunisation with
detergent extracted soluble antigens of C. ruminantium, antibodies which detected
three or four antigenic components developed. This suggests that detergents either
destroyed some B cell epitopes or altered the antigenic structure of certain EB
components. It may also indicate that detergents are efficient only in extracting four
antigenic components of EBs. Alternatively the presentation of soluble antigens may
be less efficient at inducing antibody production.
Immunisation with EBs generated antibodies to components of C.
ruminantium which have been referred to as major antigenic components, their
molecular masses being given as 24kDa, 27kDa, 28kDa, 32kDa, 45kDa, 58kDa, and
66kDa in previous studies (Mahan, 1995). Sera from goats immunised with IEB at
the CTVM produced antibodies specific to five EB antigens by day 14 post
inoculation with molecular masses of 24kDa, 27kDa, 28kDa, 32Da, and 58kDa. This
indicates that these antigens are important targets for antibody responses.
Furthermore, three of them (28kDa, 32kDa, and 58kDa) are surface antigens as
determined by biotin labelling (Section 4.3.2).
Sera obtained after challenge of immunised goats detected more antigens than
those obtained before challenge. The appearance of additional antigens after
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challenge indicates that these antigens are either expressed by live C. ruminantium,
or that live infection leads to more efficient antigen presentation. Sera obtained 18
months and 2 years after the last challenge reacted strongly with more antigens of the
EB which indicates that a carrier status may have developed after recovery. Carrier
status in ruminants which recover from heartwater has been reported in cattle, sheep
and African buffalo (Andrew et al., 1989b) and in Creole cattle and goats (Camus,
1992). Furthermore persistence of antibodies for a long period after recovery of
ruminants following experimental infection of heartwater has been observed (Semu
et al., 1992).
Immunisation of goats with inactivated EBs led to the development of
stronger IgG] than IgG2 responses pre-challenge. After challenge the ELISA OD
values of both isotypes were 7 and 10 times those of pre-challenge levels. The
increase in IgG2 titres after challenge was such that in two of four goats which
survived challenge, the IgG2 OD values were higher than those of IgGj, indicating
that this isotype was being preferentially produced. The shift in antibody isotype
from IgGj to IgG2 or an increase in IgG2 after challenge indicated that a Thl type
response was stimulated by the challenge infection. During a Thl type response
CD4+ lymphocytes secrete the cytokines IFN-y, IL-2 and TNF-a, promoting cell-
mediated immunity and IgG2 production. These findings are in agreement with the
evidence that stimulation of bovine B cells sorted for IgM with IFN-y induces
secretion of IgG2 in vitro (Estes et al., 1994). In contrast immunisation of cattle with
IEB stimulated production of both IgG, and IgG2, and challenge of the immunised
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cattle led to a further increase in the titres of both isotypes. The differences in IgG
isotype responses in goats and cattle to C. ruminantium may be associated with the
greater resistance of cattle to heartwater (Uilenberg, 1983; Camus and Barre, 1988;
Camus et al., 1996).
Sera from two I/T goats (Group 4, G69, G74) infected with the Welgevonden
stock and treated to prevent death, had higher levels of IgG! responses. The reason
for these exceptions is not clear. However it suggests that C. ruminantium may be
inducing production of IL-4 or IL-10 at the beginning of infection which drives the
immune responses to a Th2 type antibody responses rather than a Thl type IgG2/cell
mediated immune response.
Cattle immunised by I/T (group 1) and field sera (group 2) had dominant
IgG] responses. It is possible that live infection and immunisation by I/T does not
lead to a classical Thl response but to an IL-4/IL-10 driven response since bovine
IL-4 upregulates production of IgG], IgM and IgGE in the presence of a variety of
costimulators (Estes, et al., 1995). Immunisation of cattle with IEBs induced a
strong IgG2 response in addition to IgGb which suggests that a mixed Thl type and
Th2 type response was induced by killed bacteria in contrast to live, or natural (tick
mediated) infection. The results suggest live Cowdria shifts responses towards Th2.
The fact that natural infection and I/T may lead to an IL-4 driven Th2 responses
indicates that C. ruminantium may avoid the host immune system by directing it
towards a Th2 T cell response. However, I/T leads to solid immunity which
indicates that other effector mechanisms such as cell-mediated immune responses
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mediated by cytotoxic T cell, IFN-y and NK cells are probably involved in protective
immunity. Other workers have found that cytotoxic T cell populations are induced
by Cowdria infection but only at a suprisingly late stage (Ben Said, Personal
Communication Section 6.3.6). This supports the idea that CMI responses are
delayed in live infection, an observation made in Section 6.3.6.
The IgG] response of mice immunised with inactivated EBs was
characterised by higher titres of IgG, whereas that of I/T mice had higher IgG2 titres.
These findings are in agreement with those of Du Plessis et al. (1991, 1992) who
showed that following I/T immunity is cell mediated and that CD8+(Lyt2+) T cells
were responsible for protection as indicated by adoptive transfer of immune cells to
unimmunised mice. The situation in ruminants appears different in that natural
infections and I/T leads to a Th2 type response characterised by a dominant IgG]
response.
The role of antibodies in immunity to heartwater is not clear. Experimental
transfer of serum or gamma globulins by in vivo or in vitro neutralisation tests have
given variable results (Du Plessis, 1993a; Uilenberg, 1983). Du Plessis et al. (1984)
found no correlation between antibody titres and immunity to heartwater in calves.
Futhermore Martinez et al. (1993b) observed that sera from survivors of a challenge
experiment after immunisation did not neutralise C. ruminantium infection of
endothelial cell cultures in vitro. However the same authors observed that serum
from immune mice and cattle inhibited adhesion and entry of endothelial cell cultures
by C. ruminantium. In other experiments, Byrom et al., (1993) used mouse serum
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with or without complement or purified antibodies administered simultaneously into
mice with C. ruminantium during incubation or clinical reaction. They observed each
treatment did confer immunity or alter the course of C. ruminantium infection in
mice. In contrast addition of complement to immune serum which was subsequently
mixed with infectious C. ruminantium (Kumm) inhibited their infectivity (Du Plessis
1993a). The Kumm stock however appears to have a tropism for macrophages and
this may be responsible for the different results.
Antibodies are known to be protective in some rickettsial infections.
Antibodies enhanced opsonisation and destruction of rickettsiae by neutrophils and
macrophages (Gambril and Wisseman, 1973). Experimental transfer of immune sera
from mice which had recovered from infections of E. risticii prevented disease in 22
out of 24 recipients and purified IgG from immune serum protected mice from
infection whereas IgG from non immune mice did not (Kaylor et al., 1991). Further
investigation with purified IgG2 may clarify the role played by antibodies in
heartwater immunity. Since macrophages and neutrophils have receptors for IgG2
but not IgG] this may enhance uptake and presentation of Cowdria. Further, in
Chlamydia antibodies to surface MOMP affect intracellular fate, increasing
phagolysosome fusion and reducing infectivity (Friis, 1972).
Live immunisation by infection and treatment leads to development of very
low IgG2 antibodies in the ruminant whereas it leads to development of a high
amounts in the mouse. This indicates that the two species respond differently to live
infections of C. ruminantium and calls into question the use mice to study immune
responses to C. ruminantium.
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Table 5.1 Antigens of the Cowdria EB detected by antibodies in sera from goats
immunised with IEB (groups CI and C2) and those immunised with soluble
antigens (group C3) after immunisation and after virulent challenge.
Antigens detected and
Relative mass groups C1+C2 (n= 6) group C3 (n=3l






31 6+ 4+ 3+
27 6+ 4+ 3+




** weak reactions with sera of two animals that did not survive challenge
Numbers indicate animals in groups whose sera contained detectable antibodies to
Cowdria antigens.
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Table 5.2. The IgGi and IgG2 responses and ratios of IgG:IgG2 antibodies in sera
from goats immunised with IEBs (gps CI & C2) after immunisation (day 34
PI) and after challenge (day 28 PC) with virulent blood stabilate of C.
ruminantium. ELISA absorbance values given are the mean of duplicate
tests.
absorbance values at 450nm and ratios of isotypes and day serum was
collected.
Day 34 PI Day 28 PC
Ratios Ratios
Goat Nos. IgG, IgG? IgCh:IgG2 IsG, IgCr2 IgG,:IgG2
G476 0.28 0.06 5:1 0.97 0.42 2:1
G601 0.21 0.142 2:1 0.845 1.067 1:1
G614 0.232 0.10 2:1 0.625 1.031 1:2
G668 0.11 0.059 2:1 0.69 0.42 2:1
Key
PI = post immunisation
PC = post challenge
Absorbance values given are the mean of 2 tests.
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Table 5.3. The mean ELISA absorbance values of Cowdria specific IgGi and
IgG2 of antibodies and IgGi:IgG2 ratios in sera from South African cattle
immunised by infection and treatment method (gp Bl).
Sample/immuning
Mean absorbance at 450nm of isotvpes
No/stock used IgGi IgG2 IgGi:IgG2 ratios
B9/Ball 3 0.580 0.068 8:1
B155/Ball 3 0.237 0.200 1:1
B 10/Kwanyanga 0.747 0.146 5:1
B25/Mara 0.324 0.018 18:1
B61/Mara 0.302 0.134 2:1
Key
Absorbance values given are the means of two tests
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Table 5.4. The mean ELISA absorbance values of Cowdria specific IgGi and
IgG2 antibodies and ratios IgGi:IgG2 in sera collected from naturally
challenged cattle in South Africa (gp B2).
Mean ELISA absorbance values at 450nm of isotvpe
Sample No. IgGi IgG2 IgGi:IgG2 ratios
B196 0.122 0.338 3:1
B199 1.746 0.529 3:1
B201 1.627 0.426 4:1
B202 0.829 0.057 14:1
B203 0.765 0.126 6:1
B204 0.449 0.008 56:1
B205 0.945 0.076 12:1
B206 0.193 0.062 3:1
B211 0.327 0.031 10:1
Key
Absorbance values given are the means of two tests.
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Table 5.5. The mean ELISA absorbance values of Cowdria specific IgGl and
IgG2 antibodies and ratios between the isotype responses in sera collected
post immunisation (day 36 PI) and post challenge (day 31 PC) from cattle
immunised with IEBs (gpB 3) of C. ruminantium and challenge with live
Gardel stock.
Mean ELISA absorbance values at 450nm
Days serum ratios of
Animal No. was collected IgG, IgG2 IgGi:IgG2.
immunised
S295 -1 0.044 0.005 NA
36 PI. 1.319 0.881 2:1
31 P.C. 1.554 1.149 1:1
S296 -1 0.022 0.004 NA
36 P.I. 0.889 0.714 1:1
31 PC. 1.347 1.304 1:1
S304 -1 0.013 0.006 NA
36 P.I. 1.116 0.995 1:1
31 PC. 1.347 1.260 1:1
control infections
S234 C1 0 0.014 0.016 NA
11 0.035 0.016 NA
S264 C2 0 0.036 0.039 NA
11 0.014 0.022 NA
positive control 0.609 0.044 14:1
serum B149
negative B87 0.038 0.015 NA
Key
PC = post challenge
PI = post inoculation
Absorbance values given are the means of two tests.
NA= not applicable.
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Figure 5.1. Western blots showing antigens of C. ruminantium EB detected by
antibodies in sera from goats after immunisation infection/treatment (I/T), or with
inactivated EBs (IEB) or with detergent extracted soluble antigens (Sags).
The lanes were tested with representative sera from different immunisation regimes
as follows: lane 1, negative control serum (G106); lanes 2 and 3, day 28 PI serum
from I/T goat (G69); lanes 4 and 5, day 34 PI serum from groupl (IEB); lanes 6 and
7, day 34 PI serum from group C2 (IEB) and lanes 8 and 9, day 34 PI serum from
group C3 serum (soluble antigens/Sags).
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Figure 5.2. Western blots of C. ruminantium EB's showing antigens detected by sera
from animals after immunisation with inactivated elementary bodies (IEB's).
Lanes 1 to 3 were tested with sera from IEB goat G107; lane 1, day 0; lane 2, day
14 PI, lane 3, day 21 PI; lane 4, negative control (G106)
Lanes 5-7 were tested with sera from IEB goat G108; lane 5, day 0; lane 6, day 14
PI; lane 7, day 21 PI and lane 8, negative control serum (G106).
The figure shows that antibodies were detectable by day 14 PI in both goats.
121





Figure 5.3. Western blots showing antigens ofC.ruminantium EB recognised by
post immunisation (PI) and post-challenge (PC) sera from goats immunised with IEB
or soluble antigens (Sags).
Lanes 1 to 3, were tested with day 34 PI sera from an IEB goat (group CI, G476);
lane 4, day 28 PC serum (G476); lane 5, post immunisation sera from an IEB goat
(group C2, G668), lane 6, day 28 PC serum (group C2 G668), lanes 7 and 8, post
immunisation from Sags goat (group C3, G600). Lane 9, negative serum (G106),
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1 2 3 4 5 6 7 kDa
Figure. 5.4. Western blots showing antigens of C. ruminantium EB recognised by
antibodies following live virulent challenge of IEB immunised goats.
Lanes 1 to 4 were tested with sera from day 28 post challenge of goats in groups CI
and C2 as follows: lane 1, goat 476; lane 2, G614; lane 3, goat G604 and lane 4,
G668 Lanes 5 and 6, were tested with with day 57 PI sera from animals immunised
with soluble antigens (group C3) and lane 7, tested with sera from negative control.
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Figure 5.5. Western blots showing reations of goat sera with C. ruminantium EB
upto 2 years after challenge of IEB immunised goats (G614 and 668).
The lanes were tested with sera as follows: lanes 1 and 2, sera from a naive control
goat (G106); lanes 3 and 4, day 28 PI sera from an I/T goat (G74); lanes 5 and 6, sera
obtained 18mo PC from G614, lane 7 and 8, sera obtained 18mo PC from G668,
lanes 9 and 10, sera obtained 24mo PC from G614; lane 11 and 12, sera obtained 24
mo from (G668). Note the strong reactions with several antigens of 18mo sera







G476 G601 G614 G668
Goat Numbers
Figure. 5.6. The post immunisation (PI) and post challenge (PC) IgGi and lgG2
responses of 4 goats immunised with IEB of C. ruminantium detected by ELISA.
Post immunisation and post-challenge sera were collected day 34 PI and day 28 PC
(=Day 64 PI) from each animal.
The bars show the mean OD of 2 tests and the error bars show the Standard error of
the mean.
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Figure 5.7. Evidence of specific IgGj response against Cowdria antigens following
immunisation by infection/treatment and by IEB immunisation.
Lanes: 1 and 10, SDS low range molecular weight protein standards;
Western blots were reacted with sera in duplicate and then tested with anti-IgGj or
anti-IgG2 monoclonal antibodies. Lanes 2 to 5, day 28 PI sera from an I/T goat (G
74) lanes 6 to 9, day 34 PI serum from IEB goat (G668).
Lanes 2, 3, 6 and 7 were reacted with anti-IgGj Mab; lanes 4 and 5 with anti-IgG2
Note the lack of detectable IgG2 following I/T or IEB immunisation.
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Figure 5.8. Evidence for Cowdria specific IgG2 responses following challenge of
IEB immunised goats with virulent homologous stock of C. ruminantium.
Lanes 1 to 3, negative control serum (G106); lanes 4 to 6, serum collected day 28
post challenge of IEB immunised goat (G476); lane 7 SDS protein standards.
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S295
Figure 5.9. IgGi and lgG2 responses of pre-challenge (day 36 PI) and
post-challenge(day 31 PC) sera of two Kenyan cattle (S295, S296) immunised
with lEBs (gp B3) of C. ruminantium (Gardel).
lgG1 responses (□) andlgG2 responses ( |§i ).





Figure 5.10. The IgG! and lgG2 responses of mice
immunised by l/T or with IEB of C. ruminantium. Sera were collected
34 days after infection or immunisation, pooled and tested for IgG 1 and lgG2.
IgG 1 responses (Q)and lgG2 responses ((||).
Results are expressed as the mean OD 450nm of 2 tests.




Figure 5.11. IgG! and lgG2 response ofsequential sera from mice (10) immunised with recombinant
58-kDa Hspantigen of C. ruminantium at days 21, 28 and 34 after immunisation.
lgG1 responses ( □ ) and lgG2 responses ( m) were detected by ELISA.
Bars represent the mean of two tests and the error bars show the standard error of the mean.
130
CHAPTER SIX
IN VITRO AND IN VIVO RESPONSES OF LYMPHOCYTES
FROM GOATS IMMUNISED BY INFECTION AND
TREATMENT ORWITH INACTIVATED ELEMENTARY
BODIES TO C. RUMINANTIUM
6.1. Introduction
Animals which recover from natural and experimental C. ruminantium
infection are solidly immune to homologous challenge and show a variable degree of
resistance to heterologous challenge (Oberem and Bezuidenhout, 1987a). Animals
which are immunised with inactivated organisms are immune to homologous
challenge (Martinez et al., 1994; Mahan et al., 1995). The specific mechanisms
responsible for protective immunity in ruminants to C. ruminantium are not clearly
understood (Du Plessis, 1993; Uilenberg and Camus 1993; Camus et al., 1996).
However, the relative roles of antibodies were investigated (Section 5.3.7 & 5.3.9)
and there was an indication that antibodies (IgG2) may be important in protective
immunity. In mice immunity is mediated by cytotoxic Lyt-2+ T cells (Du Plessis et
al., 1991; Du Plessis et al., 1992).
C. ruminantium is an obligate intracellular bacterium found in membrane
bound vacuoles in the cytoplasm of endothelial cells (Cowdry, 1925a, 1926;
Prozesky and Du Plessis, 1987) and neutrophils (Logan et al., 1987b). It is partially
protected from the direct effects of antibody by its intracellular location. Immunity
to intracellular bacteria is mediated by cellular immune responses that are generated
following antigen presentation by professional and non-professional phagocytes
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(Kaufmann, 1993). The specific cell types which carry out antigen presentation in
vivo include macrophages/monocytes, dendritic cells, B cells and gut epithelial cells
(Grencis, 1990). Antigen capture by antigen presenting cells (APC) is facilitated by
cell surface receptors which include Fc receptors and immunoglobulins
(Lanzavecchia, 1996). Intracellular pathogenic organisms adhere to, enter or invade
macrophages situated in the skin, gastro-intestinal tract and lungs or in the liver and
spleen if the organism is blood-borne. Phagocytosed bacteria undergo degradation in
the phagolysosome by proteases resulting in the generation of immunogenic
fragments (peptides) that form a complex with MHC class II molecules. The
peptides are then expressed on the surface of the APC and presented to T cell
receptors (TCR) on the surface of T lymphocytes (Ojcius et al., 1996). The TCR is a
heterodimer of alpha/beta glycoprotein chains on CD4+ and CD8+ T cells (Fitch,
1986). T cells play a key role in determining the direction of the immune response
by secreting various cytokines. The CD4+ T-helper cells are capable of two distinct
responses: T-helper 1 (Thl) and T-helper 2 (Th2). CD4+ T cells are very important in
the development of acquired immune resistance to pathogenic bacteria (Hahn and
Kaufmann, 1981). The CD4+ Thl T cells play a key role in immune responses to
intracellular bacteria by secreting cytokines such as IFN-y which activate
mononuclear phagocytes into potent effector cells. IFN-y is also produced by other
mediators of acquired resistance such as CD8+ T cells, y/8 T-cells and natural killer
(NK) cells (Kaufmann, 1993). Th2 T cells are responsible for antibody-mediated
responses which are driven by interleukin-4 (IL-4) and interleukin-10 (IL-10). CD8+
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T cells recognise antigen presented by MHC class I antigens and effect cytotoxic
activities on virally infected cells and those infected by some protozoan parasites
(Howard and Morrison, 1994). Certain microbial components trigger the release of
cytokines such as TNF-a and IL-12 from macrophages and other professional
phagocytes (Cheers and Zhan, 1996). These two cytokines have several protective
effects enhancing non-specific anti-microbial activity. TNF-a and IL-12 cause NK
cells to release IFN-y which promotes microbicidal activity of macrophages and
neutrophils, causes changes in endothelial cells and phagocytes which results in
greater adhesion of phagocytes to blood vessel wall thereby facilitating entry of the
phagocytes into sites of inflammation (Delanoy et al., 1993). IFN-y cause CD4+ T
cells to differentiate into Thl type cells which effect cell mediated immune responses
and supports IgG2a production in mice (Mosmann and Coffman, 1989).
In view of the fact that protective immunity against C. ruminantium in mice
is mediated by Lyt-2+/CD8+ T cells, I attempted to characterise the role of cellular
responses of ruminants in protective immunity to C. ruminantium.
The aim of experiments in this chapter was to investigate T cell mediated
responses of goats immunised with live EBs or with inactivated elementary bodies
(IEBs) of C. ruminantium by studying:
1. The blastogenic responses to EBs of peripheral blood mononuclear cells
(PBMC) from immunised animals.
2. Changes in lymphocyte sub-populations in peripheral blood of immunised
animals following stimulation with EBs in vitro.
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3. Changes in lymphocyte populations in the peripheral blood of immunised
animals following challenge with virulent homologous stock of C.
ruminantium.
6.2. Materials and Methods
6.2.1. Antigens
Inactivated elementary bodies (EBs) of three stocks of C. ruminantium were
used. The stocks were: Ball 3 (Haig, 1952), Gardel, (Jongejan et al., 1984) and
Welgevonden (Du Plessis, 1985a). They were propagated in bovine endothelial cell
cultures as described by Pow et al. (1993), then 10-14 day old cultures were
harvested by centrifugation as described in Section 3.4. The EBs were washed,
re-suspended in sterile PBS and inactivated with 0.15% formalin for 30 minutes at
room temperature. Protein was determined by the Bicinchoninic acid assay (BCA,
Protein Assay kit, Pierce, USA) as described in Section 3.13 and five dilutions of
inactivated EBs (lpg, 5jag, lOjag 15jag and 20pg/ml) were prepared in complete
RPMI 1640 medium and used to stimulate PBMC.
6.2.2. Experimental animals
Six British Saanen goats aged 18 to 24 months old were used in these
experiments. They belonged to three groups of two goats each; infection and
treatment immunised goats (G69, G74) described in Section 4.2.2, goats immunised
with inactivated elementary bodies (G107, G108) described in Section 3.14.1 and
naive controls (G109, G110).
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6.2.3. Isolation, culture and in vitro stimulation ofperipheral blood mononuclear
cells (PBMC) from goats with C. ruminantium antigens.
PBMC from the six goats described above (6.2.2) were used for cell
proliferation assays or flow cytometric analysis. The PBMC were collected from the
different immunisation groups on the same occasion (being day 14, and 21 PC for
the I/T goats and day 28, 48 and 143 PI for the IEB goats). The IEB goats received
boosters then 7 days later PBMC were taken for proliferative tests. PBMC were
prepared and counted as described in Section 3.2.
One millilitre stock cultures of PBMC containing 2 x 106 cells were prepared from
each goat, then antigen or mitogen was added respectively.
In order to determine which test was to be used for subsequent in vitro cell
proliferative responses, stocks of PBMC cultures from the two I/T goats (G69 and
G74) were stimulated with 1,5, 10, 15 or 20 pg/ml of inactivated homologous EB
(Welgevonden stock) antigen in duplicate. Unstimulated controls from each animal
were included. The cultures in aliquts of 200 pi in 96 well sterile tissue culture
plates (Nunc, Denmark) and incubated as described in Section 6.2.4 then, one set of
cultures was used to determine proliferative responses by blastogenesis and the other
set by MTS assay.
Experiment 1.
The aim of this experiment was to determine the effect of mitogen
(Concanavalin), homologous (Welgevonden) or heterologous EB antigens (Ball 3,
Gardel) of C. ruminantium on the in vitro proliferative responses of PBMC from two
goats immunised with inactivated EBs (G107 and G108) and a control goat (G109).
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PBMC cultures were stimulated with 5 |ag/ml of the mitogen Concanvalin A, or with
1, 5, 10, 15 or 20 pg/ml of inactivated EBs. Unstimulated control cultures were
included. Four tests were performed and their median responses were used.
Experiment 2.
The aim of this experiment was to compare the proliferative responses of PBMC
from goats immunised by I/T (G74) or those immunised with IEB (G107, G108)
following in vitro stimulation with 10 |ug/ml of homologous EBs or 5 pg/ml of
mitogen Concanavalin A. PBMC were obtained 21 PC from the I/T goat at day 28
PI from the IEB goats purified as described earlier (Section 3.2) and stimulated with
respective stimulant.
Experiment 3.
This experiment was carried out to determine if SDS-PAGE purified EB antigens of
24kDa and 32kDa (Section 4.2.6) or purified 35kDa recombinant antigen could
stimulate proliferation of PBMC from immune goats. PBMC was collected from the
on day 21 PC from two I/T goats (G69 & G74) and from a naive control (G109)
purified as described earlier and stimulated in vitro with 1 or 5 pg/ml of the
SDS-PAGE EB antigens, 2.5pg/ml or 5 p.g/ml of a purified 35kDa recombinant
subclone protein antigen (Section 3.7). The responses of these cultures were
determined by counting blasts using cytospins.
For determination of IFN-y produced in vitro by stimulated cultures, PBMC from the
I/T goats (G69, G74) on day 21 PC, IEB goats (G107, and G108) day 28 PI and one
naive control goat (G110). After purification they were stimulated with 15 pg/ml of
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EB protein of the homologous stock (Welgevonden), or 5 pg/ml of recombinant
35kDa subclone protein (Section 3.7) of C. ruminantium. The cultures were
incubated as described earlier (Section 3.2) for 72 hours. The PBMC from these
cultures were used for flow cytometric analysis to determine any changes in the
proportions ofCD4+ or CD8+ after stimulation.
6.2.4. Cellproliferation assays
After 72 hours, 100 pi of culture supernatant was withdrawn from each well
and replaced with fresh 100 pi of medium, the cultures were then incubated for a
further 48 hours under the same conditions. Proliferation was detected by a
metabolic assay using the Cell Titre 96® Non-Radioactive MTS assay (Promega
Madison, USA) or by blastogenesis. The MTS assay detects the enzymatic activity
of mitochondrial dehydrogenases produced by dividing cells on the tetrazolium salt
(MTS/Owens reagent 3 -(4,5 -dimethylthiazol-2-yl)-5 -(3 -carboxymethoxyphenyl)-2-
(4-sulfophenyl)-2H-tetrazolium), which is reduced into coloured formazan salts
soluble in tissue culture medium and which can be measured spectroscopically.
Twenty microlitres of the MTS with 5% v/v of solubising solution (Phenazine
methasulfate/PMS) was added to each well and the plates incubated for 4 hours to
allow solubilisation. The absorbance (optical density/OD) 570nm was taken after
incubation using a plate reader (Multiscan Plus, Labsystems). The corrected median
OD values were calculated by subtracting the median OD values of
unstimulatedcultures from the median OD value of test cultures. The corrected ODs
were used to plot dose response curves.
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The proliferative responses determined by blastogenesis were carried out by
examination of cytospin slides stained with Giemsa. The cytospin slides were
prepared by taking 100 pi aliquots from three cultures, cytospining them onto slides,
fixing in methanol for 5 minutes and staining them for 40 minutes in 5% Giemsa.
They were washed in tap water, dried in air and examined at 400x magnification for
lymphoblasts using a Labofluor microscope (Leitz). The number of lymphoblasts
per 200 cells examined on each slide were determined and the means three slides was
calculated. The corrected mean cuonts used for the were obtained by subtracting
number of lymhoblasts in unstimulatedcontrol cultures these means were
transformed into percentages and used in the results.
6.2.5. Determination of the effect of live or inactivated EBs on the proliferative
responses ofPBMCfrom an infection/treatment goat (G74).
A preliminary study was carried out to determine the effect of live or
inactivated EBs on the proliferative responses of PBMC collected 21 days PC from
one I/T goat (G74) in vitro.
EBs were prepared as described in Section 3.4, half of the washed EBs was
inactivated and the other half was left untreated. Serial ten-fold dilutions were
carried out on each EB fraction (to give 190 pg/ml, 19 pg/ml, 1.9 pg/ml and 0.19 p
g/ml EB protein) and used to stimulate PBMC collected day 28 PC. The cultures
were incubated as described in Section 6.2.4, and their proliferative responses were
determined by the MTS assay or by examination of Giemsa-stained cytospins as
described in Section 6.2.4. The mean of three tests was calculated and the effect of
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antigen concentrations was analysed by the paired student t-test using only results
obtained by MTS.
6.2.6. Detection ofgamma interferon (IFN-y) in culture supernatants
Assays for IFN-y were carried out using supernatants taken from 72 hour
cultures and preserved at -70°C (Section 6.2.4).
IFN-y detection was carried out using a commercial capture ELISA kit for the
detection of bovine IFN-y (Bioscience, Australia) following the manufacturer's
instructions. Supernatants from unstimulatedcultures or cultures stimulated with
5 pg/ml of Concanavalin A, 15 pg/ ml of EB (Welgevonden stock) or 5 pg/ml of
recombinant 35kDa protein were tested in triplicate, using 50 pi aliquots of
supernatant per well. Supernatants from PBMC of control goats were included in
each assay. The absorbance (OD) was read at 450nm using a plate reader (Multiscan
Plus, Labsystems) and the mean absorbance values of three tests was calculated. The
corrected mean OD values of IFN-y were obtained by subtracting the mean IFN-y
OD valueof unstimulated cultures (background) from that of the stimulated cultures.
The corrected OD values were used to plot graphs and for statistical analysis using
the student t-test.
6.2.7. Preparation of lymphocytes after in vitro stimulation with IEBs for flow
cytometry using a fluorescence activated cell scanner.
PBMC from cultures described earlier for determinanation of of IFN-y
production (Section 6.2.3) were used for flow cytometric analysis. Five day cultures
were harvested by centrifugation at 350 x g for 6 minutes. The supernatants were
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discarded and the cells were washed twice in FACS buffer (PBS containing 0.1%
sodium azide, 1% bovine serum or bovine serum albumin and lOu heparin/ml/).
Washed cells were suspended in 1 ml of buffer, cell viability and counting were
carried out and the cell concentration adjusted to lxlO6 cells/ml as described earlier
(Section 3.2). Two hundred microlitres of each sample were aliquoted into three
labelled tubes. Fifty microlitres of undiluted mouse monoclonal antibodies to ovine
T-cell surface antigens (CD4+, CD8+ and y8) were added to each tube. Monoclonal
antibodies to T cell subsets (Table 6.1) were obtained as culture supernatants from
Dr. John Hopkins, Dept. Veterinary Pathology, Royal (Dick) Scho ol of Veterinary
Studies, Edinburgh.
Following incubation at room temperature for 30 minutes the cells were
washed twice with FACS buffer. Labelled cells were stained by the addition of 50 pi
of a 1/1000 dilution of sheep anti-mouse fluorescein conjugated antibodies (Table
6.1, Binding Site, Birmingham, UK) to the respective isotype antibodies prepared in
FACS buffer. The cells were incubated for 30 minutes in the dark at 4°C washed and
10,000 cells were analysed by flow cytometry as described by Woldehiwet and
Sharma (1990) using a FACScan (Becton Dickinson, Cowley, UK), gating for
mononuclear cells.
6.2.8. Challenge of immunised and control goats.
Five goats (one I/T, 2 IEB, and 2 controls) challenged with a virulent
Welgevonden stock of Cowdria ruminantium as described earlier (Section 3.16).
Goats were placed in isolation unit of the CTVM before challenge and on the day of
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challenge, (day 7 after the last booster for the IEB goats and 3 months PC for the
(I/T) each goat was inoculated with 3 x 105 EBs intravenously through the jugular
vein in 2 ml of culture medium. The EBs used for challenge were propagated and
counted as described earlier (Section 3.4 and 3.15 respectively).
6.2.8.1. Sample collection and monitoring ofgoats during challenge.
Prior to and after challenge, two blood samples were taken from each goat,
one was used for routine haematology and the other for isolation of lymphocytes for
flow cytometry. Haematology samples were collected in EDTA and used to
determine total white blood cell count (WBC) and differential white cell counts.
Total WBC was determined using an automated hematology analyser (Biochem
Immunosystems, Allentown, PA, USA). Differential counts were determined by
preparation of blood smears, staining with modified Wright's stain, using a Hematex
2000 slide stainer (Bayer Diagnostics, UK) and the cells were counted using a
standard reference technique. The haematology samples were analysed at the
Haematology laboratory of the Department of Veterinary Clinical Studies, Royal
(Dick) School of Veterinary Studies, Edinburgh. Further blood sampling was carried
out from each goat on days 3, 7 and 10 post challenge and additional blood samples
were taken from the I/T goat (G74) on days 17, 21 and 32 post challenge. PBMC for
flow cytometric analysis were prepared and stained for CD4+, CD8+ and y5 TCR
positive cells using the monoclonal antibodies and FITC conjugates shown on Table
6.1. The proportion of positive T lymphocytes for each surface antigen were
transformed into absolute numbers using the total and differential counts as described
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by Woldehiwet and Sharma (1990). The absolute numbers of T cells were used to
determine CD4+ and CD8+ ratios. Animals which developed severe clinical signs
were euthanised by intravenous administration of pentobarbitone. Rectal
temperatures were recorded daily for 5 days before challenge until the end of the
experiment. Confirmation of heartwater was carried out by making brain crush
smears from dying goats as described by Purchase (1945).
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6.3. Results
6.3.1. Proliferative responses ofPBMC of immunised goats to inactivated EEs
PBMC from I/T goats (G69 and G74) proliferated in a dose-dependent
manner in the presence of homologous EB antigens of the Welgevonden stock
(Figure 6.1a and b). This dose response was observed by the MTS assay and
examination of cytospins. The MTS assay was used for majority of cell proliferation
responses hereafter.
Experiment 1
PBMC from I/T or IEB goats responded in a dose-dependent manner to EBs
from the homologous (Welgevonden) and heterologous (Ball 3 and Gardel) stocks.
Lower concentrations of EB antigens (5 pg/ml and 1 pg/ml for G107 and G108
respectively) of the homologous (Welgevonden) stock produced larger
transformation response (Figure 6.2a and b) and higher concentrations of antigen
were inhibitory (Figures 6.2a and b). Twenty micrograms per millilitre of EB
antigens of the Ball 3 stock stimulated the highest responses. Responses to the
Gardel stock were greatest at 5 pg/ml and 20 pg/ml of EB for G108 and G107
respectively (Figure 6.2a, 2b). Proliferative responses of PBMC from the control
goat (G109) were much lower than those of the IEB goats (Figure 6.2c.), although
they had a similar pattern of dose responses.
Experiment 2
Stimulation of PBMC obtained from the I/T goat (G74), or IEB goats (G107
and G108) with 10 pg/ml ofWelgevonden EBs or 5 pg/ml of Concanavalin A
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showed that the three mmunised goats responded to EBs whereas the control did not
(Figure 6.3). The proliferative responses of the I/T goat (G74) and IEB goat (G108)
were similar but those of IEB goat (G107) were lower. Interestingly EB had an
inhibitory effect on proliferative responses from control goat (G110) (Figure 6.3).
PBMC from all the animals proliferated in the presence of Concanavalin A with the
highest OD values being shown by PBMC from the negative control goat (G110).
Experiment 3.
PBMC obtained from two I/T (G69 & G74) did not proliferate in the presence
of SDS-PAGE purified antigens of molecular masses 24kDa and 32kDa of the
homologous stock (Welgevonden). Similarly PBMC from immune goats did not
proliferate in the presence of 2.5 or 5 pg/ml of purified 35kDa subclone protein but
they proliferated in the presence of the mitogen Concanavalin A and homologous
EBs (Figure 6.4).
6.3.2. Live elementary bodies lowered the proliferative responses of PBMCfrom
an Infection/treatment (I/T) goat.
Stimulation of PBMC from I/T goat (G74) with live or inactivated
elementary bodies showed that live EBs stimulated lower responses than inactivated
EBs (Figure 6.5a and b). However there were no significant difference between the
responses stimulated by the two preaparations (t =1.02, p>0.005). The OD values of
cultures stimulated with 190 pg/ml and 19 pg/ml of IEB protein were higher than
those stimulated with the same concentrations of live EBs in the MTS proliferative
the assays (Figure 6.5a). The same effect was observed the blastogenic responses
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although cultures stimulated with 0.19 fag/ml protein of inactivated elementary
bodies stimulated the highest proportion of cells.
6.3.3. Production of interferon gamma (IFN-y) by PBMCfrom I/T and IEB goats
stimulated with EBs ofC. ruminantium in vitro.
Homologous EBs stimulated PBMC from 3 of 4 goats immunised by I/T or
with IEBs of C. ruminantium to secreted IFN-y in vitro. However there were no
significant differences between the IFN-y responses of I/T and the IEB group
(t =2.38, p>0.05). The OD values of IFN-y from PBMC of goats immunised with
live C. ruminantium were up to 2.6 times higher than those obtained from goats
inoculated with inactivated EBs (Figure 6.6 and Table 6.3). The responses varied
between individual goats that had received the same treatment. Supernatants from
G69 had higher amounts of IFN-y than those from G74, and within the IEB goats
supernatants from G107 had higher amounts of IFN-y than those from G108. IFN-y
responses of PBMC from the control goats (G110) were very low. Culture
supernatants of PBMC from goats stimulated with recombinant 35kDa subclone of
GroEL antigen of C. ruminantium contained little or no IFN-y.
6.3.4. Effect of in vitro stimulation with EBs ofPBMCfrom immunised goats on
the proportion ofCD4+ and CD8+ T cells.
Flow cytometric analysis of lymphocytes following in vitro stimulation with
EBs showed that CD4+ T cells increased by 1 to 3 percent after stimulation whereas
CD8+ T cells decreased by 7% in stimulated cultures (Table 6.2) as compared to
unstimulated The CD4:CD8 ratios ranged between 1.2 and 1.4:1 in EB stimulated
cultures. In contrast in cultures stimulated with Concanavalin A, the ratios ranged
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between 1:1.3 to 1:2. In all the goats Concanavalin A stimulated a higher proprtion
of CD8+.
6.3.5. Clinical responses ofgoats to homologous challenge.
Four of five goats reacted with high fever 8 to 9 days after challenge
(Figure 6.8), with the exception of the I/T goat (G74) which did not develop fever or
other clinical signs of heartwater. Fever continued until the goats died 3-5 days later
showing clinical signs of heartwater. One IEB goat (G108) and one control goat
(G110) died suddenly without clinical signs except fever. At post mortem classical
pathological changes including hydrothorax, lung oedema and hydropericardium
were present in all animals and petechial haemorrhages were present on the mucosa
of the abomasum of two goats (G110 and G107). Examination of brain impression
smears revealed the presence of abundant C. ruminantium in the cytoplasm of
endothelial cells of blood capillaries in.
6.3.6. Changes in counts ofPBMC in the peripheral blood ofI/T IEB and control
goats after challenge with virulent homologous isolate of C. ruminantium
(Welgevonden stock).
The absolute numbers of CD4+ and CD8+ T cells in peripheral blood of the
I/T goat (G74) remained relatively constant up to day 10 PC (Figure 6.8a). On day
17 PC, there was a dramatic rise in the absolute numbers of CD8+ T cells ( Figure
6.8a, Appendix B, Table 2). The CD4:CD8 ratio in the first 10 days of infection was
between 2:1 to 1:1 but as a result of the dramatic increase of CD8+ T cells on day 17
PC the ratio between the two T cell types was 1:5 in favour of CD8+ T cells. The
CD8+ T cells counts remained higher than those of CD4+ T cells for another one
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month although it dropped with time to 1:2 on the last day of analysis. The CD4+
and y5 T cell counts of this goat did not alter significantly from pre-ch allenge counts
throughout the challenge period (Figure 6.8a).
The CD4+ and CD8+ counts in peripheral blood of the IEB goats were
characterised by a general decrease in cells numbers from pre-challenge counts
except those of G107 which increased slightly on day 3 PC (Figure 6.8b, c). The y8
counts remained unchanged after challenge except those of G108 which decreased
after day 3 PC and remained about the same until the last day of analysis (Figure
6.8b).
The CD4+ and CD8+ counts in the peripheral blood goats in the control group
behaved in a similar manner to those of one IEB goat (G108), they declined from
pre-challenge counts after challenge except for the CD8+ counts of G110 which
increased on day 7 PC and continued to rise to the highest counts on day 10 PC
(Figure 6.8e, d). The high number of CD8+ in peripheral blood of G110 at day 7 PC
was surprising, it was most likely to be caused non-specific factors since this was a
naive animal. The y8 counts also declined after challenge (Figure 6.8d, e)
Analysis for differences between the CD4+, CD8+ and y5 T cell counts of IEB and
those of the controls showed that there were no significant differences between them
(t= 0.67, p> 0.05; t=-1.70, p>0.05; t= -1.53, p>0.05).
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6.3.7. Changes in monocyte and neutrophil counts in peripheral blood of goats
immunised with IEBs and controls after challenge with virulent homologous
stock.
The monocyte counts of the I/T goat (G74) increased from pre-challenge counts to
the highest numbers on day 7 PC, and remained almost the same until the last day of
analysis (Figure 6.9a). The monocyte counts of the IEB goats increased to 4 times
pre-challenge counts by day 10 PC. On the other hand the counts of the controls
decreased below pre-challenge counts on day 3 PC followed by an increase in
numbers attaining the highest counts on day 10 PC (Figure 6.9a). Analysis for group
to group differences between the monocyte counts of the IEB and control groups
showed no significant differences (t =0.94, p>0.05).
The neutrophil counts of the I/T goat and controls were characterised by fluctuations
(Figure 6.9b). Their counts increased above pre-challenge counts on days 3 and 10
PC but decreased on day 7 PC (Figure 6.9b). On the other hand those of the IEB
goats increased to the highest counts on day 7 PC, and decreased slightly on day 10
PC (Figure 6.9b). There were however no significant differences between the mean
counts of the IEB and controls n=2 revealed (t=0.15, p=>0.05).
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6.4. Discussion.
Elementary body antigens of C. ruminantium induced an antigen specific T
cell responses in PBMC obtained from goats previously immunised with C.
ruminantium antigens. Low concentrations of homologous antigens produced the
maximum proliferative response whereas high concentrations of heterologous stocks
were needed to stimulate maximal responses. These results indicate that differences
in the responses to heterologous and homologous antigen occur which, may be an
important component of the lack of cross-protection between strains of Cowdria.
However cross-protection between IEB immunised animals is not yet determined.
The presence of epitopes in heterologous EB antigens which induce responses may
indicate the presence of conserved epitopes between strains which stimulate T cell
responses these, could be utilised in vaccine development. Antigenic fractions could
be investigated to determine antigens which induce similar responses in animals
immunised with homologous and heterologous stocks.
Stimulation of PBMC from goats immunised with live or inactivated antigens of C.
ruminantium with homologous EBs induced similar T cell responses. The proportion
of CD4+ slighty increased after in vitro stimulation but those of CD8+ decreased
suggesting that the EBs stimulated a T helper T cell response and not a T cytotoxic
one.
Stimulation of PBMC obtained from the two treatment groups (I/T and IEB
immunisation) with homologous EB antigens led to IFN-y production. This indicates
that immunisation by I/T or with IEB primes PBMC to secrete IFN-y upon in vitro
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stimulation and suggests that a Thl type immune response is induced after
immunisation. The concentration of IFN-y in supernatants of PBMC obtained from
I/T were 2 times higher than those from IEB immunised goats. The reason for this is
unclear but it suggests that live organisms are more potent inducers of IFN-y
production than inactivated EBs. IFN-y is secreted by CD4+ Thl, CD8+, y8 and
natural killer cells in vivo (Kaufmann, 1993), and plays a pivotal role in cell-
mediated immune responses. The fact that supernatants from PBMC of goats
stimulated with EB contained IFN-y indicates that the induced response was of a Thl
type and not a Th2 type. IFN-y favours a CMI response by inhibition of IL-4
secreted by Th2 T cells, a cytokine whose effects lead to a Th2 type antibody
response (Tizard 1994).
Stimulation of PBMC obtained from an I/T goat (G74) with live antigens
lowered the proliferative responses whereas inactivated antigens did not. The
reduction of the lymphocyte proliferative responses by live C. ruminantium suggests
that one of the mechanisms used by this rickettsia to evade the immune response of
the host is by down regulation of lymphocyte activation. T cell activation is
dependent on antigen association with MHC class II or MHC class I molecules and
production of Interleukin I (IL-1) by antigen presenting cells in particular
macrophages (Grencis, 1990; Tizard, 1992). Therefore any process which alters
macrophage expression of MHC class II molecules or IL-1 production significantly
influences the immune response (Splitter and Everlith, 1989). Liposaccharides
(LPS) suppresses expression of class II molecules on the surfaces of macrophages
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(Koerner, Hamilton and Adams, 1987), inhibit induction of IFN-a and maintenance
of class II molecule expression on macrophages (Everlith, Brooksalder and Splitter,
1991). Evidence of reduced lymphocyte proliferative responses to specific antigens
caused by the down regulation of MHC class II has been observed with the
intracellular bacteria Brucella abortus (Splitter and Everlith, 1989) and C.
ruminantiurrr, (Totte et al., 1996). Other mechanisms used by intracellular bacteria
to evade the immune responses of lymphocytes and monocytes/macrophages
include:- Induction of hydrogen peroxide release, secretion of prostaglandins and
other mediators capable of inhibiting lymphocyte function (Shenker and Slots 1989,
Shenker, Vitale and Slots, 1991), selective killing of lymphocytes by toxic products
and impairment of lymphocyte activation by interfering with IL-2 receptor
expression and reduction of IL-2 production (Shenker, et al., 1987, Shenker, Vitale
and Slots, 1991). IL-2 is necessary for activation of B and T lymphocytes and
induces the release of other cytokines such as TNF-a and IFN-y which play a very
important role in anti-microbial immunity (Feng, Popov and Walker, 1994). The
mechanisms used by C. ruminantium to reduce lymphocyte responsiveness and
proliferation are unknown. Evidence from in vitro studies with bovine endothelial
cells infected with C. ruminantium indicate that infected endothelial cells do not
express MHC class II on their surface (Totte et al., 1996). This report suggests that
C. ruminantium inhibits expression of MHC class II which in turn will delay
development of an effective immune response to this organism.
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Immunisation of small ruminants with inactivated EBs of C. ruminantium
leads to development of protective immunity (Tafesse, 1992; Martinez et al., 1993;
Mahan et al., 1995). Tafesse (1992) observed that some immunised goats did not
survive challenge with a blood stabilate containing virulent homologous stock. The
two IEB goats used in this study were not protected against challenge with virulent
homologous stock. There are two possible reasons for this, the IEB inoculation did
not induce immunity or the challenge dose given (3.0 xlO5 EBs/dose) was too high.
The latter suggestion is supported by the sudden deaths of two goats and the fact that
the Welgevonden stock causes a more severe disease in small stock than the other
stocks (Du Plessis et al., 1989).
Lack of protection of immunised goats in this study may also be related to the
low INF-y responses of IEB goats compared to the I/T goat which recovered. IFN-y
is a strong inhibitor C. ruminantium in vitro and in vivo (Totte et al., 1994, Totte et
al., 1996). This cytokine has inhibitory properties against other rickettsial agents in
vitro for example Rickettsia prowazekii (Turco and Winkler, 1983a), R.
tsutsugamushi Gilliam strain (Hanson, 1991), Chlamydia psittaci (Byrne and
Krueger, 1983), Ehrlichia risticii (Park and Rikihisa, 1991). IFN-y also has
protective properties in vivo against R. conorii (Li et al., 1987), in recovery from
pnuemonia caused by Chlamydia trachomatis in mice (Byrne, et al., 1987) and is
required for resistance against Listeria monocytogenes during early stages of
infection (Nakane, et al., 1989) before T-cell mediated immunity develops. Since
CTL responses in heartwater appear late in infection of EB immunised animals after
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recovery has commenced (Section 6.3.6, Bensaid personal communication 1996)
IFN-y may be critical to early control.
Following challenge the infection/treatment goat (G74) did not develop any
clinical symptoms of disease as compared to the IEB inoculated goats. The T-cell
responses of this goat did not change significantly for the first 10 days after challenge
and the CD4:CD8 ratios was greater than 1. This suggested that other immune
effector mechanisms were in operation. The fact that the numbers of CD4+ cells
were the same or higher than those of CD8+ cells up to the 1 Oth day post challenge
suggests that the T cell response to the challenge was mediated by T helper cells
rather than CD8+ T cells. The scenario changed by the 17th day after challenge
whereby CD8+ T cells dominated for another month.
The possible mechanisms responsible for protective immunity before a
potentially protective CD8+ T cell response was in operation in the I/T goat could
have been by INF-y as in vitro stimulation of PBMC from this goat produced higher
amounts of INF-y than those from IEB inoculated goats. IFN-y has a direct lytic
effect on rickettsiae within infected cells (Hanson, 1991) and acts as an important
factor in controlling rickettsial infections in vivo (Hanson, 1991; Jerrels et al., 1986;
Li, et al., 1987; Turco and Winkler, 1983a, b, 1993). IFN-y has direct effect on the
in vitro infectivity of C. ruminantium, reducing the infectious yield of C.
ruminantium from bovine endothelial cells (Totte et al., 1994), and also inhibits the
growth of C. ruminantium in bovine endothelial cells in vitro (Mahan et al., 1996).
IFN-y stimulates the anti-microbial activity of macrophages by regulating oxygen
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metabolism, and the synthesis of reactive nitrogen intermediaries from arginine (Feng,
Popov and Feng, 1994). It also activates professional phagocytes, including
neutrophils and natural killer cells to kill invading organisms, it is important in the
activation of lymphocytes in response to infection and the up-regulation ofMHC class
II and class I, leading to effective response to infecting organism.
Neutrophils play a role in cell mediated-immunity by participating in two
mechanisms of cytotoxicity namely antibody dependent cell-mediated cytotoxicity
(ADCC) and antibody independent cell-mediated cytotoxicty (AIDCC). In ADCC
targets are opsonised by IgG2 and IgM. These two classes of antibody act as
important opsonins for bovine and ovine neutrophils (Roth, 1994). ADCC is
expected to participate in clearing C. ruminantium from the body via IgM or IgG2.
However IgG2 was not detectable in sera of one I/T goat (G74) after previous
challenge but was present in sera of both IEB immunised goats (Chapter 5). Both
ADCC and AIDCC are increased by pre-treatment of neutrophils with recombinant
IFN-y in vivo and in vitro (Lukacs, et al. , 1985; Chiang, et al. , 1991). It is most
likely that goat neutrophils were activated to kill Cowdria by AIDCC by IFN y
induced by challenge. Bovine neutrophils have been shown to be active in antibody
independent killing (Lukacs et al., 1985; Steinberg et al., 1989). Protective activity
of cytolytic CD4+ (Thl), CD8+ and possibly y8 T cells could also account for
immunity before the numbers ofCD8+ increases. The results suggests that at least 10
days are required for CD8+ T cells to reach levels greater than those ofCD4+ T cells.
Immunity to heartwater in the infection/treatment animal was probably mediated by
multiple effectors, IFN-y being the major activator before protective CD8+ T cell
response developed.
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Table 6.1. Monoclonal antibodies and FITC antibodies used for flow cytometric
analysis
Antibody Specicificity Isotype FITC
ST4 CD4 IgG, Mo-IgGrFITC
86D y5 IgG! Mo-IgGi-FITC
SBU CD8 IgG2a Mo-IgG2a-FITC
Key
FITC = fluorescein isothiocyanate conjugated immunoglobulins
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Table 6.2. Proportions of CD4+ and CD8+ T cells of I/T, IEB immunised and
control goats after in vitro stimulation with 15pg/ml of EB's anntigens of
the Welgevonden (homologous) stock of C. ruminantinm. The CD4:CD8
ratios are shown in the last column.
% ofT cells
Goat Nos/group stimulants CD4+ CD8+ CD4:CD8 ratios
G69 (I/T) 0 37.4 15.95 2:1
Con A 22.85 52.70 1:2
EB 38.00 21.32 2:1
G74 (I/T) 0 23.83 28.00 1:2
Con A 30.00 38.00 1:1
EB 27.0 21.00 1:1
G107 (IEB) 0 23.50 26.02 1:1
Con A 9.35 14.70 1:2
EB 26.30 16.67 2:1
G108 (IEB) 0 53.30 12.00 4:1
Con A 20.00 33.00 1:1
EB 56.10 12.5 5:1
G110 (control) 0 36.90 39.40 1:1
Con A 23.40 44.9 1:2
EB 38.3 24.00 2:1
Summary of percentage increase or decrease ofCD4+ and CD8+ after stimulation
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Table 6.3. Prduction of IFN-y by PBMC of immune goats after in vitro
stimulation with EBs of C. ruminantium or Concanavalin A.
Stimulators
I/T
Groups and IFN-y OD values (450 nm)
IEB Control
G69 G74 G107 G108 G109
EB (15|ig/ml) 0.650 0.334 0.274 0.102 0.082
35 kDa (5 tig) 0.063 0.088 0.069 0.056 0.010
ConA (5 |ag) 2.300 3.04 NA 0.250 2.880
Key.
The results given are the mean absorbance values (450nm) for 3 tests.
NA = not applicable samples were not available.
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Figure 6.1. Dose-dependent in vitro proliferative responses of PBMC from two l/T
goats G69 (Figure 6.1a) and G74 (Figure 6.1 b; stimulated with homologous EBs
(Welgevonden stock) of C. ruminantium.
Level proliferation measured by MTS assay (^) or by blastogenesis (# )




Figure 6.2. Dose-dependent in vitro proliferative responses of PBMC from two
IEB immunised goats (G107, G108) to EB antigens of homologous (Welgevonden) and
heterologous (Ball 3, Gardel) stocks of C. ruminantium.
Proliferative responses to Welgevonden ( 4.) Ball 3 ( #) and Gardel ( ■ ).
The results given are median of 4 tests.
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Figure 6.2c. Proliferative responses of PBMC from unimmunised control goat (G109)
to EB antigens of the Ball 3, Gardel Welgevonden stocks of C. ruminantium.
Proliferative responses to Ball 3 ), Gardel ( ■) and to Welgevonden (L ).
The median ODs of 4 tests are given.
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Figure 6.3. Proliferative responses of an l/T goat (G74), IEB goats (G107 & G108) and
a naive control after in vitro stimulation 15 pg/ml of EB antigen of the Welgevonden
stock and or with 5 pg/ml of Concanavalin A.
Proliferative responses to EBs ( [□ ), and to Concanavalin A ( ■)
Proliferative responses were determined by MTS assay and results given are the
correccted mean of three tests.
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Figure 6.4. Proliferatve responses of PBMC from I /T goats to Cowdria EBs,
recombinant antigen (35kDa GroEL fragment) and Concanavalin A.
Goats G 69 & G74 were immunisedby infection treatment and G109 was a naive control.
Responses to 5 pg/ml Concanavalin A ( |§§ ), 15 pg/ml of,homologous EBs ( Hg ),
recombinant (35kDa): 5 pg/ml ( U ), and 2.5 pg/ml (|||) and un-stimulated controls
( □)•
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Figure 6 .5. Comparison of the effect of live or inactivated homologous EBs
(Welgevonden) on the proliferative response of PBMC from one l/T goat (G74).
Responses measured by MTS assay (a) or by counting lymphoblasts using cytospin
smears (b).PBMC stimulated with live EBs (Jk) or inactivated EBs ( ■).
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Figure 6.6. Production of IFN-y in vitro by PBMC from goats immunised with
live EBs (G69 & G74),or with inactivated EBs (G107 & G108)
stimulated with 15 pg/ml of homologous EBs (■ ). or
or 5 pg/ml of recombinant (35kDa) antigen (^), control positive ( |||||) Concanavalin A
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Figure 6.7. Daily rectal temperatures (°C) of goats before and after challenge
with virulent of C. ruminantium (Welgevonden).
Temperature reactions of l/T goat G74 (A.), IEB goat G107 (■ ), IEB goat




Figure 6.8 a to c. Effects of challenge on peripheral blood T-cell populations of three
immunised goats. Counts of l/T goat G74 (Figure 6.9a), of IEBsgoatG107
(Figure 6.9b) and of IEB goat G108 (Figure 6.9c).
CD4+ counts ( £), CD8+ counts ( ■) and y8 counts ( A).
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Figure 6.8d and e. Effects of challenge on peripheral blood T cell populations of the
control goats. Counts of control goat G109 (Figure 6.9d), and control goat G110
(Figure 6.9e).




Figure 6.9a. Effect of challenge on the monocyte counts in peripheral blood of
immunised and control goats.
Counts of the l/T goat (Q ), mean counts of the IEB group ( ■ ) and mean counts







Figure 6.9b. The effect of challenge on the neutrophil counts in peripheral blood of
immunised and naivecontrol goats.
Counts of the l/T goat (#), mean neutrophil counts of the IEB group ( ■) and mean
neutrophil counts of the control group ( Jl. )
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CHAPTER SEVEN.
IMMUNISATION OF MICE AND SHEEP WITH
RECOMBINANT 58KDA PROTEINS (GroEL)) OF COWDRIA
RUMINANTIUM.
7.1 Introduction
Protective immunity against heartwater develops after animals recover from
natural and experimental infections (Stewart, 1987). It is also achieved by
intravenous immunisation of ruminants with predetermined doses of live C.
ruminantium, administered as blood stabilates or ground-up tick supernatants
(Oberem and Bezuidenhout, 1987a; Camus et al., 1996). Inoculated animals are
allowed to develop fever of above 40°C and treated on the second day of fever with
one or two doses of oxytetracycline at 20 mg/kilogram body weight (Jongejan et ah,
1993b). Recovered animals are solidly immune to homologous challenge for a
period ranging from 4 months to 3.5 years and are partially resistant to heterologous
challenge (Camus and Barre 1988; Jongejan et ah, 1993c; Uilenberg 1983). The live
vaccine is prepared from the Ball 3 stock (Haig 1952; Jongejan and Thielemans,
1989b). Live vaccines however, are limited by a number of factors: They are
expensive to produce and maintain, they require technical personnel to administer,
other tick-borne diseases such as East coast fever, babesiosis and anaplasmosis can
be transmitted and they can cause direct losses from cowdriosis (Oberem and
Bezuidenhout, 1987a; Camus et al., 1996). Another limitation on their usefulness is
the low level of cross-protection against several South African strains following
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vaccination with Ball 3 stock (Du Plessis et al., 1989b; Du Plessis et al., 1990a,
Jongejan and Thielemans, 1989b).
Two other vaccine preparations which have been used to immunise ruminants
against heartwater are, inactivated elementary bodies (Martinez et al., 1993, 1994;
Mahan et al., 1994a; 1995; Tafesse, 1992) and attenuated organisms (Jongejan,
1991a; Jongejan, et al., 1993b; Gueye et al., 1994). Animals receiving attenuated
organisms are solidly protected against virulent homologous challenge (Jongejan
1991, Jongejan et al. 1993b). On the other hand, not all animals receiving
inactivated organisms are protected against virulent homologous challenge (Mahan et
al., 1995b, Martinez et al., 1994; Tafesse, 1992). The latter immunogens are limited
by the high cost of production, and low level of cross-protection among Cowdria
isolates. Additionally, for the attenuated culture vaccines only the Gardel and
Senegal stocks have been attenuated(Jongejan 1991; Jongejan et al., 1993c; Gueye et
al., 1994). The Welgevonden stock which confers a broader level of cross-protection
by infection/treatment has not been attenuated (Du Plessis et al., 1989b, Camus et al.,
1996). However, attenuation may not necessarily preserve immunogenicity. In
recent studies in Kenya (Ngumi, 1997), low virulence Cowdria were not protective
against high virulence isolates but the converse was the case.
The most desirable approach to control heartwater is the development of a
'broad' spectrum vaccine composed of a number of protective antigens with
conserved epitopes present in all the strains of Cowdria ruminantium. Animals
which recover from natural or experimental heaartwater infection develop antibodies
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which detect several immunogenic proteins with relative molecular masses of 14kDa
to 118kDa (Barre and Camus, 1987; Semu et al., 1992, Section 4.3.1). A number of
these antigens, such as the 32kDa protein (MAPI), (Jongejan and Thielemans,
1989a), the 21kDa protein (MAP2) (Mahan et al., 1994b) and the 58kDa protein
(Lally et al., 1995) are immunodominant and conserved. The three antigens are
found on the surface of the EB as determined by biotin labelling (Section 4.3.1). The
58kDa protein is a heat shock protein (Hsp) which belongs to a family of heat shock
proteins, also considered as molecular chaperonins, designated Hsp 60 (Cpn 60)
which have homologues in all other bacteria with published sequences, for example
Rickettsia tsutsugamuchi and E. coli (Stover, Marana and Oaks, 1990). To date,
relatively little is known about the importance of some of the immunogenic proteins
of C. ruminantium with respect to protective immunity in susceptible ruminants.
Purified native, recombinant and synthetic peptide antigens are useful in determining
the role played by specific antigens of C. ruminantium in immune responses of
ruminants. Native antigens are obtained by growing large quantities of the organism
in tissue culture followed by separation with affinity, ion exchange or size exclusion
chromatography. Production of large amounts of C. ruminantium is very expensive
and time consuming. Genes for three immunodominant antigens of C. ruminantium
have been cloned and expressed, they are: the 32kDa protein (MAPI) van Vliet et al.
(1994), the 21kDa (MAP2) protein (Mahan et al., 1994b) and the 58kDa heat shock
protein (GroEL) (Lally et al., 1995). The GroEL antigen is recognised by antibodies
in sera of animals which have recovered from live infection and in from those
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immunised with inactivated elementary bodies. The gene encoding the 58kDa
antigen of C. ruminantium was cloned and expressed in E. coli (JM109) as a
recombinant protein encoded by plasmid pBluescript Cr9.4 (Lally et al., 1995). The
successful cloning and expression of the gene coding for the 58kDa Hsp permitted
investigation of the antibody and cellular responses of mice and sheep immunised
with this antigen. Studies of protection against heartwater by immunisation with
recombinant Cowdria antigens have not been published, this study represents an
investigation of the immunogenicity and protectve capacity of a recombinant heat
shock protein in mice and sheep against heartwater. The objectives of this studies
were
1. To determine if immunisation with recombinant 58kDa or antigen fragments of
this protein protected mice and ruminants against virulent challenge.
2. To determine if immunisation led to a reduction in level of rickettsial infection in
endothelial cells of infected sheep.
3. To determine the nature of cellular and humoral responses to GroEL induced by
immunisation.
7.2. Materials and Methods
7.2.1. Experiments with recombinant 58kDa Hsp antigen of C. ruminantium
7.2.1.2. Experiment 1. Immunisation of mice with bacterial lysates
containing recombinant 58kDa Hsp (JM109/pBSCr9.4) and plasmid
control (JM109/pBS).
The aim of this experiment was to immunise mice to achieve a detectable
antibody response to recombinant 58kDa Hsp and challenge them to test for
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protection. E. coli JM109 strain carrying the plasmid (pBSCr9.4) encoding the
58kDa antigen and control bacteria carrying the Bluescript plasmid
(JM109/Bluescript) were cultivated and the presence/absence of the recombinant
ascertained (Section 3.6). Then the bacterial antigens were prepared as described
earlier (Section 3.13) and used to immunise the mice. Six groups of mice were
inoculated as shown in Table 7.1.
Primary and booster inoculations were administered subcutaneously.
Boosters were given on days 14 and 21 post inoculation (PI).
7.2.1.3. Experiment 2. Immunisation of mice with bacteria hosting the
recombinant 58kDa Hsp antigen.
The aim of this experiment was to determine if the recombinant 58kDa Hsp
expressed by bacteria in the native form could confer greater protection than the
bacterial lysate which was prepared under denaturing conditions. In this experiment
mice were inoculated with E. coli cultures expressing the recombinant 58kDa Hsp
JM109/pBSCr9.4 or control bacterial cultures containing the plasmid (JM109/pBS).
Two groups (G and H) of 10 mice each were used. Mice in group G were inoculated
4 times with 0.1 ml LB broth culture of E.coli (JM109/pBSCr9.4) containing
5 5 5 5
5.2x10", 1.8x10 , 3x10 and 1.2x10" bacteria per dose administered subcutaneously
on days 0, 3, 7, and 14 PI respectively. Finally mice in this group were inoculated
with 1 .Ox 105 organisms intramuscularly (IM) in the quadriceps on day 21 PI. Mice
in the control group (group H) were inoculated 4 times with 7x103 of bacteria
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(JM109/pBluescript) containing the plasmid (pBScript) in 0.1 ml LB broth
subcutaneously.
Blood samples for serum preparation from all groups of mice were collected
on days 0, 14, 21, 28, and 34 PI as described in section 3.3. Sera were examined for
the presence of antibodies by Western blotting as described earlier (Section 5.2.1.4)
and ELISA (Sections 5.2.3) except that the conjugate used was a rat anti-mouse IgG
Fc specific HRP (Sigma).
7.2.1.4. Experiment 3. Immunisation ofmice with 35kDafusion protein.
The aim of this experiment was to investigate the level of protection induced
by immunisation with the 35kDa GroEL. Another reason was that large quantities of
this purified protein were available for immunisation whereas the 58kDa full length
protein could not to be expressed for purification.
Seven groups of 5 mice each (Groups A to G) were inoculated with the
35kDa subclone antigen or with adjuvants only as shown on Table 7.2. The antigens
were prepared as described in Section 3.14. Mice in group A were each inoculated 3
times with 50 pg protein of the purified 35kDa subclone protein. Antigen used for
primary immunisation of this group were prepared in FCA and boosters were
prepared in FIA while, those in group B were inoculated with the same amount of
purified 35kDa prepared in an oil adjuvant (Mantonide-ISA50) which had been
previously used successfully to immunise animals against heartwater (Martinez, et
al., 1993). All the inoculations were administered subcutaneously in 0.2 ml amounts
per mouse (Table 7.2).
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Mice in groups C and D were inoculated 3 times with 250 pg/ml of bacterial
lysates containing pTrcHis0.7 or the plasmid control respectively. The bacterial
lysates were prepared as described in Section 3.6 then they were prepared for mouse
inoculation in either FCA or Mantonide ISA50 as described for the purified
recombinant 35kDa (subclone) antigen.
Blood samples for serum preparation were collected on as described for
previous groups (Section 7.2.1.3) and tested for seroconversion by Western blotting
and indirect ELISA as described in Section 4.2.5 and Section 5.2.1.4 respectively
using goat anti-mouse conjugate IgG] horse radish peroxidase (whole molecule)
7.2.1.5. Challenge and monitoring ofmice after challenge.
Mice in these 3 experiments were each challenged with 1.2 x 10 live virulent
EBs in 0.1 ml culture of C. ruminantium (Wlgevonden stock) administered
intravenously in the tail vein 35 days after immunisation. Survivors of primary
challenge were challenged again with 4x10 live virulent EBs 30 days later.
After challenge mice were observed for clinical signs of heartwater. Post
mortem examination was carried out on mice which did not survive challenge,
presence of pulmonary oedema, pleural effusions, ascites and hepatic changes were
recorded. Impression smears prepared from lungs, brain and liver were fixed in
methanol for 5 minutes, stained with 5% Giemsa (Modified Wrights stain) and
examined for C. ruminantium by light microscopy ( Leitz LaborLux-K microscope)
at a magnification of 400x.
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7.2.2. Experiment 4. Inoculation of sheep with bacteriaI lysates containing
recombinant 58kDa Hsp (JM109/pBSCr9.4/GroEL) antigen of C.
ruminantium.
The aim of this experiment was to investigate the cellular and antibody
responses of sheep immunised with 58kDa Hsp recombinant protein (GroEL) of C.
ruminantium and to determine if they showed evidence of protection against virulent
homologous challenge.
7.2.2.1. Experimental animals.
Twelve Merino/Scottish Blackface cross rams (Section 3.1.3) were used in
this experiment. Six rams were selected randomly (3 from each age group) and
placed in two groups. Sheep in the first group were immunised with bacterial lysate
containing the recombinant 58kDa Hsp (JM109/pBSCr9.4). The immunised group
was made up of sheep numbers S66, S69, S71, S72, S74 and S76. Sheep in the
second group served as controls and were inoculated with bacterial lysate containing
the plasmid control (JM109/pBS). The controls were sheep numbers S67, S68, S70,
S73, S75 and S77.
7.2.2.2. Inoculation of antigens. Bacterial lysates containing the
plasmid (pBS) with or without the 58kDa Hsp were prepared as described earlier
(Section 3.6). Then they were mixed with equal volumes of FCA or FIA and
prepared as antigen/adjuvant suspensions as described in Section 3.14.
Sheep in the first group were immunised with 250 qg of recombinant 58kDa
Hsp (pBSCr9.4) prepared in FCA. Each sheep in the control group was inoculated
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with 250 \xg protein of bacterial lysate containing the plasmid control (pBS) prepared
in FCA. Primary inoculations on day 0 were administered intramuscularly in the
quadriceps. After primary inoculations, sheep in each respective group received 5
booster inoculations at days 14, 21, 34, 64 and day 121 PI administered
subcutaneously in the neck region.
7.2.2.3. Sample collection from immunised sheep.
Serum samples were collected from all sheep as described earlier (Section
3.3) at days 0, 14, 21, 28, 34, 64, 82 and day 143 PI. Seroconversion was monitored
by indirect ELISA and Western blotting. Blood samples for cell proliferation assays
and flow cytometric analysis were collected on days 21 and day 64 PI.
7.2.2.4. Test for specific antibody production to 58kDa Hsp in sera of
immunised sheep by ELISA and Western blotting.
Detection of specific antibody responses of immunised sheep by indirect
ELISA was carried out as described earlier (5.2.5) with the following modifications:
The antigen used was a purified 35kDa recombinant subclone protein of the
recombinant 58kDa Hsp (GroEL). It was purified as described earlier (Section 3.7).
Sera dilutions of 1:200 were used, a peroxide conjugated donkey anti-sheep
IgG whole molecule (Sigma) was used to detect antibody binding. Reagents, and
procedures were the as described eaerlier (Section 5.2.5). The mean OD values of 2
tests were calculated and the means were used to analyse the serological responses to
the recombinant antigen.
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Sera from immunised sheep were also examined for IgG] and IgG2 responses
using an indirect ELISA as described in Section 5.2.3.
Western blotting was used to verify that the specific antibodies in sera, of immunised
sheep detected by ELISA recognise EB antigens of C.ruminantium. The test was
carried as described earlier (Section 4.2.5) except that the conjugate used was donkey
anti-sheep IgG whole molecule horse radish peroxidase (Sigma).
7.2.2.5. Cellular immune responses to immunisation with 58kDa
recombinant antigen.
Proliferative responses.
Proliferative responses of PBMC obtained at days 21 and 64 PI from 5
randomly selected sheep from the immunised group and the two control sheep were
carried out in vitro. Briefly: Fresh PBMC were purified as described in Section 3.2.
Then stock cultures seeded with lx 106 cells/ml in complete RPMI 1640 medium
were stimulated with 1, 2.5, 5, 10, and 15 pg/ml of recombinant 58kDa Hsp or
bacterial lysates containing the plasmid only (Section 3.6). The cultures were
incubated in triplicate in aliquots of 200 pl/well in 96 microtitre well plates (Nunc,
Denmark) as described in Section 6.2.3. After 72 hours, 100 pi supernatants from
each culture were collected and assayed for interferon gamma (IFN-y) as described
earlier (Section 6.2.6). Additionally three more PBMC cultures from the sub-groups
used above were stimulated with 5 pg/ml of purified 35kDa subclone antigen
(Section 3.7), 15 pg/ml EB protein, or 5 pg/ml Concanavalin A supernatants colected
on day tested for IFN-y. After five days of incubation cultres were tested for
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proliferation by MTS assay as described in Section 6.2.4. The results were expressed
as the median OD values for three tests.
Flow cytometric analysis ofantigen stimulated T cells.
Following in vitro stimulation with 58kDa protein, the surface phenotype of PBMC
from a randomly selected subgroup of 4 immunised sheep and two controls were
analysed by indirect fluorescence staining using specific MAbs ST4, SBU, and 86D
(Table 6.1) which recognise ovine CD4+, CD8+ and y5 T cell receptors respectively.
Three stock cultures of PBMC from each sheep were stimulated with 15 pg/ml of
recombinant 58kDa Hsp protein or control plasmid (pBS/JM109) or Cowdria EBs
respectively. After 5 days of incubation PBMC were washed and subdivided into
three samples. Then one each was stained for CD4+, CD8+ and y/5 T cells and
analysed on a fluorescence-activated cell scanner (FACS) as described in Section
6.2.6.
Assays for cytotoxic activity after immunisation with 58kDa recombinant.
The aim of this experiment was to determine if Cytolytic activity (CTL) could
be detected in immunised animals before and after challenge providing that the
animals recovered, and to compare responses after challenge.
Non-radioactive cytotoxicity assays were performed with lymphocytes as
effectors against autologous endothelial cells as targets. They were obtained from
three sheep (S66, S69 and S72) in the immunised group. PBMC from these sheep
were collected 5 days after booster inoculations on day 69 and 87 PI, purified as
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described earlier (Section 3.2) and depleted of adherent cells to obtain effectors as
described in Section 3.2.1.
The effectors were divided into two equal fractions; one was used without antigen
stimulation and the other was stimulated with 15 pg/ml EB for 5 days before use.
The cytotoxic assays were carried out using a lactate dehydrogenase (LDH)
®
assay (The Cytotox 96 Non-radioactive Assay, Promega, Madison, WI). Lactate
dehyrogenase release was measured in an enzymatic assay following the
manufacturers instructions with some modifications. The target cells were prepared
as described in Section 3.16.
Optimisation of the targets was carried out according to the manufacturer's
instructions (Promega, Madison, WI, USA) with some modfications to suit the assay.
The endothelial cell cultures were maintained in GMEM supplemented with 20%
foetal calf serum (Sigma). The optimum number of targets (endothelial cells) used
were 1.5 x 104 cells/well. Infected targets were used to test for cytolytic activity
while un-infected targets served as controls. The tests were carried out using a range
of effector:target ratios of 20:1 to 0.312:1 aliqouts of 200 pi seeded in 96 well
microtitre plates. The mean OD of 4 tests taken at 492nm were used to determine if
lysis had occurred and specific lysis was calculated as in standard 3lCr release as
described by Brander et al., (1993) and was:-
100 X (experimental LDH release subract spontaneous LDH release)/(maximum
LDH release subract spontaneous LDH release). Results were expressed as percent
lysis of targets.
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7.2.2.6. Challenge ofsheep with live virulent Cowdria EB suspension.
Sheep were placed in isolation and challenged on day 143 PI (34 days after
the last booster). Then each sheep was inoculated intravenously in the jugular vein
with 2 ml of a virulent homologous culture of C. ruminantium (Welgevonden stock)
containing 3.0 x 105 EBs. Prior to challenge, blood samples were taken from each
sheep for haematology, and flow cytometric analysis. Samples were taken in EDTA
or heparinised vacutainer tubes. After challenge further sampling was carried out at
days 3, 7 and 12 PC and monitored for changes in white blood cell counts.
7.2.2.7. Peripheral blood cell counts after challenge.
Total WBC and differential counts were carried out at the Haematology
Laboratory, Department of Veterinary Clinical studies, Royal (Dick) School of
Veterinary Studies, University Edinburgh as described in Section 6.2.7.
Mononuclear cell counts for all the sheep were determined after challenge
following the same procedures described earlier (Section 6.2.8.1). Additionally the
surface phenotypes of T cells in peripheral blood obtained from the immunised and
control sheep at days 0, 3, 7 and 12 PC were determined (Section 6.2.7). The
+ ■+■
percentage of CD4 , CD8 and y5 T cells were transformed into absolute numbers
using the total and differential counts of lymphocytes in peripheral blood (section
6.2.8.1).
After challenge, lymphocytes (effectors) were obtained from two immunised sheep




The medians of the daily counts of the T cells, monocytes, and neutrophils
were used to analyse day to day, sheep to sheep and inter-group differences using
Fischer's exact test, student t-test or Anova two way analysis of the variance.
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7.3. Results
7.3.1. Evidence that bacterial lysates contained the 58kDa Hsp recombinant
antigen
Western blot analysis of bacterial lysates containing the 58kDa recombinant
protein revealed that the bacterial lysates contained an antigen of 58kDa that reacted
with immune sera obtained from an I/T goat. No reaction was observed with
bacterial lysates of the control pBS plasmid (Figure 7.1).
7.3.2. Development of antibodies to 58kDa lisp after immunisation of mice with
58kDa Hsp recombinant antigen.
Sera collected at days 0, 14, and 21 PI from mice immunised with bacterial
lysates containing recombinant 58kDa Hsp did not show evidence of antibodies to
the 58kDa antigen. Sera collected from day 28 PI onwards reacted with the
homologous 58kDa Hsp protein of the Cowdria EB (Figure 7.2 lanes 6 and 7). Sera
collected from mice in the control group did not react with this antigen (Figure 7.2
lanes 10 to 14)
7.3.3. Effects of challenging mice immunised with bacterial lysates containing
58kDa Hsp and controls inoculated with plasmid (pBS).
A total of 4 out of 29 mice immunised with recombinant 58kDa Hsp as lysate
(Group A, B) or bacteria (Group G) survived virulent homologous challenge (Table
7.3). Two of the surviving mice had been immunised with bacterial lysates of the
recombinant 58kDa prepared in FCA or FIA and the others had been immunised with
bacteria (JM109/pBCr9.4) expressing this recombinant antigen. None of the controls
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(Group C, D, E, F and F) survived challenge with virulent homologous stock (Table
7.3).
The incubation period of heartwater in the immunised and control groups
ranged between 8 and 12 days. All mice showed classical clinical signs of Cowdria
infection before death. Death occurred 24 hours after the appearance of the clinical
signs. The survivors were depressed and had raised hair for 3 days before recovery.
No respiratory signs were noticed in mice which survived whereas all non survivors
had respiratory signs.
Western blotting with sera from 4 mice which survived primary challenge gave very
strong reaction with the native 58kDa Hsp of the EB of C. ruminantium in contrast to
sera after recombinant immunisation and other antigens of the EB (Figure 7.3, lanes:
6 and 7) indicating an active response to Cowdria. The presence of reactions to at
least five EB antigens not recognised by pre-challenge sera indicate that the animals
made an active immune response to challenge. The four mice which survived the
first challenge also survived a second challenge using 4x10 EBs.
Analysis for differences between groups in the survival time/day of death
showed that immunised and the control groups to survive showed that immunised
mice died earlier than the controls (P =0.015) (Table 7.4).
7.5.4. Evidence of purification of the recombinant 35kDa protein (subclone of
GroEL) of C. ruminantium.
SDS-PAGE analysis and Coomassie blue staining of gels containing eluates
obtained after purification of the recombinant 35kDa protein revealed that the second
and third eluates were free from bacterial protein contamination (Figure 7.4a lanes: 5
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and 6). Western blots containing purified 35kDa antigen, plasmid controls or EBs
screened with sera from an immune goat showed that lanes with purified antigen and
the EB antigens reacted with specific antibodies from recovered animals to respective
antigens (Figure 7:4b lanes: 2 and 3).
7.3.5. Effect of challenge with virulent culture of C. ruminantium (Welgevonden
stock) on survival of immunised mice.
A total of 7 of 20 mice inoculated with the 35kDa subclone (Histag) protein
survived the first challenge with a virulent culture of homologous stock (Table 7.5).
Three of the survivors had previously been primed with the purified recombinant
antigen, and 4 had received bacterial lysate incorporated in FCA. Four of five FCA
controls also survived this challenge (Table 7.5). To ensure survival was not the
result of mal-administration of the challenge, a second challenge was given and one
of the FCA inoculated survivors and none of those immunised with 35 kDa antigen
survived. The incubation period for all the groups was 9.8±1.2 days.
The post mortem findings of mice after challenge were similar to those seen
in classical heartwater. Examination of lung, liver and brain impression smears
collected at necropsy and stained with Giemsa showed the presence of a low number
of C. ruminantium colonies in lung macrophages and rarely in the brain and liver.
A summary of the results of the mouse immunisation experiments is given in
Table 7.6. A total of 4 out of 49 mice inoculated with full length or subclone GroEL
antigen survived challenge with virulent homologous stock of C. ruminantium. This
gives a protection rate of 27.5% against primary and secondary challenge.
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7.3.6. Results ofsheep immunisation experiment
7.3.6.1. Serological responses of sheep inoculated with the recombinant
58kDa Hsp.
(a) Antibodies which developed following immunisation of sheep with
recombinant 58kDa Hsp protein recognise epitopes on the 35kDa subclone.
The mean ELISA OD values of sera from sheep immunised with recombinant
58kDa Hsp increased progressively from day 0 to the highest values on day 34 PI
(Figure 7.5). Individual variations were however observed between individual
animals with OD values ranging from 0.1 to 0.4 within this group (Appendix C:
Figure 1 ). The ELISA OD values of sera from the controls were lower than 0.1
except for two sheep (S68 and S70) which had OD values higher than 0.15 (Figure
7.5).
(b) Development of antibodies to 58kDa Hsp after immunisation ofsheep with
bacterial lysates containing recombinant 58kDa Hsp protein.
Inoculation of sheep with bacterial lysates containing the 58kDa Hsp
recombinant antigen led to the development of specific antibodies which reacted
strongly with the homologue in the EB of C. ruminantium (Figure 7.6a) by Western
blotting. Antibodies to this antigen were detectable in sera collected from day 14
post inoculation onwards. Western blots probed with sera from sheep inoculated
with control plasmid did not show evidence of anti-Cowdria 58kDa antibodies
(Figure 7.6b, lanes: 2 to 7).
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7.3.6.2. Proliferative responses ofPBMCfrom immunised and control sheep PI.
to bacterial lysates containing recombinant 58kDa Hsp protein ofC. ruminantium
PBMC from both immunised and control sheep responded in a dose
dependent manner to bacterial lysates containing the recombinant 58kDa Hsp
(pBSCr9.4) but not with that carrying the plasmid control antigen alone (Figures
7.7a, b, c). The highest OD values were obtained with 15 pg/ml of pBSCr9.4 as
antigen.
7.3.6.3. Evidence ofcytotoxic activity after immunisation.
There was no evidence of lysis of targets (Ec) by un-stimulated or stimulated
effectors. The percent lysis of Ec by different effector:target ratios were lower 0%.




Classical signs of heartwater were observed in all cases of immunised and
control sheep after challenge. Three sheep in the immunised group developed
clinical signs on the fifth day post challenge (PC). Fever was recorded first in 2 of 6
sheep in the immunised group on day 6 PC and by day 7 PC all sheep in this group
had developed fever of 40.7°C and higher (Table 7.7). In the control group, 1 of 6
sheep developed fever on day 6 PC, 4 of 6 on day 7 and 1 of 6 on day 9 PC
respectively. Ten sheep in both groups developed fever by day 7 PC (temperatures
ranging from 40.8°C to 41.7°C). The highest temperature (42.5°C) reaction recorded
in both groups was in a control sheep. The maximum rectal temperature for the
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control group was 42.2 ± 0.6°C (mean ± SD) and that of the immunised group was
42.3 ± 0.8°C. The duration of fever in the immunised group was 6 ± 3 (mean ± SD)
days and 6 ± 1 days for the control.
The mean temperature for the immunised group remained higher than that of
the control group from day 5 PC except on days 0, 3 and 11 PC (Figure 7.8).
The mean incubation period for the immunised group was 7 ± 1 SD days and
that of the control was 7.5 ± 1.5SD days. The immunised group developed fever
earlier than the control group and this fever remained until death.
Two sheep in the immunised group (S66 and S69) developed nervous signs
including aggression, knocking of head on objects, turning in circles, grinding of
teeth, nystagmus and mild convulsive seizures and were euthanised by administration
of Pentobarbitone intravenously. One control sheep (S77) developed a foul smelling
diarrhoea two days before it died. None of the immunised animals survived the
challenge (Table 7.7a and b).
Sheep in the immunised and control groups died on different days after
development of fever (Table 7.7a and b). In general fever lasted 3 days longer in the
immunised group than controls.
7.3.6.5. Effect ofchallenge on peripheral blood leukocytes counts.
CD4—populations after challenge.
The mean CD4+ counts of the immunised group increased above pre-
challenge counts (day 0 counts) to the highest counts at day after challenge 3 (Figure
7.9) followed by a highly significant (F=9.11, P<0.05, Table 7.8) reduction at day 7
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PC. The counts dropped further on day 12 PC (Figure 7.9). Highly significant
differences between sheep in the immunised group (F=9.11, P<0.05) were also
observed in this group. The mean CD4+ counts of the control group increased on day
3 PC above day 0 counts, followed by a highly significant (F=16.79, p<0.05)
reduction on day 7PC (Table 7.8) then, the counts restored to the high level noted on
day 3 at day 12 PC. In contrast to the immunised group there were no significant
differences between counts of sheep in the control group (F=2.66, P>0.005). The
CD4+ counts of individual animals in the immunised and control groups were
characterised by individual variations (Appendix B Table 8a, b)
Analysis for group to group differences between the median CD4+ counts of the
immunised verses the control groups revealed no significant differences (t =0.99,
p>0.05).
CDS counts after challenge.
The mean CD8+ T cell counts of the immunised group increased from day 0 counts to
about twice on day 3 PC, followed by a reduction in numbers to counts lower than
that of day 0 at day 7 PC (Figure 7.10). Unlike the reduction noted in median counts
of CD4+ in this group the reduction in CD8+ counts was not significant (F=2.81,
p>0.05). There was another increase to about 2.5 times day 3 counts at day 12 PC
(Figure 7.10). It was also noted that differences between median counts of sheep in
the immunised group were not significant (F=3.09, p>0.005). The mean CD8+ T cell
counts for the control group behaved in a similar manner (Figure 7.10). In this group
no significant differences between median counts of day 3 vs day 7 (F=2.38, p>0.05)
189
or median counts sheep to sheep(F=1.95, p=>0.05), (Table 7.9). Individual variation
were noted in CD8+ counts of animals in the immunised and control groups
(Appendix B Table 10a, b ).
Analysis for group to group differences between the median CD8+ T-cell counts of
the two groups revealed no significant differences (t =-0.9, p>0. .05).
Determination of the CD4+:CD8+ ratios of the immunised group PC showed
that on day 3 PC the median ratio was 4:1, on day 3PC, 6:1 on day 7 PC and 3:1 on
day 12 PC (Appendix B Table 12). In the control group the ratios were 3:1 on days 3
and 7 PC and 2:1 on day 12 PC (Appendix B. Table.12).
y5 T cell counts after challenge.
The mean y8 T cell counts in peripheral blood of sheep in the immunised and
control groups decreased from day 3 counts to he lowest on day 10 PC. Pre-
challenge counts in all the groups were not available. Analysis for differences
between median counts of the two groups revealed no significant differences.
(F=1.869,p>0.05).
Monocyte and neutrophil counts after challenge.
The mean monocyte counts in peripheral blood of the immunised group
decreased from day 0 to their lowest on day 3 PC(Figure 7.11) and then increased
gradually to the highest on day 12 PC. Analysis for day to day and sheep to sheep
differences between the medians monocyte counts in the immunised group revealed
significant differences between days (day 3 vs 7) (F=8.80, P<0.05) and a highly
significant difference between sheep to sheep (F=31.51, P<0.05) (Table 7.10). The
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mean monocyte counts in peripheral blood of the control behaved in a similar manner
as those of the immunised group (Figure7.11). Despite the differences between day
to day and sheep to sheep ofmonocyte counts, there were no differences between the
median counts of the immunised and control groups (t=2.093, P>0.05).
The mean neutrophil counts of the immunised group increased from day 0 to
the highest on day 3 PC (Figure 7.12) and decreased significantly on day 7 PC
(p<0.05, Table 7.11) followed by another increase on day 10 PC which restored the
counts back to those of day 3 PC. There were however no differences between sheep
(P=0.05). The mean neutrophil counts of the control group behaved in a similar
manner like those of the immunised group (Figure 7.12). In the control group there
were no significant differences between days 3 and 7 PC (F=2.69, p>0.05) and also
between sheep (F=5.18, p>0.05).
Analysis for differences group to group differences showed that there were no
differences between them (t=2.093, p=0.286).
7.3.6.6. Cytotoxicity assays after challenge..
Cytotoxic activity was not demonstrated with effectors obtained at day 3 and day 7
PC. The LDH OD values of the controls were higher than those of the tests. As a
consequence to the high LDH OD values of the controls computation of the percent
lysis resulted in negative values.
7.3.6.7. Post mortem findings.
The PM changes observed in fatal cases of the immunised and control groups were
similar to those observed in classical cases of heartwater except for the intense gall
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staining observed in tissues adjacent to the liver. A summary of each pathological
change is given in Table 7.12.
7.3.6.8. Examination of Brain Smears
Examination of Giemsa stained smears prepared from the brains of
immunised and control sheep revealed the presence of a high number of C.
ruminantium in the cytoplasm of the capillary endothelial cells (Figure 7.13). Counts
of the number of infected endothelial cells (Ecs) are summarised in Table 7.13.
The mean infection rate of Ecs of the immunised sheep was 30 % (SD±23.3)
with a range of 20 to 45.5% while the mean rate of infection in the controls was
62.95% with a range of 43.75 to 77.5%.
Analysis for differences in the degree of infection using the means of infected brain
endothelial cells (Ecs) of immunised and control groups showed that the degree of




The work reported above constitutes the first trial of a recombinant antigen for
immunisation against Cowdria ruminantium. Partial protection in mice, but not in
sheep was achieved but in the latter there was significant reduction in the capillary
endothelial cell infection rate. The use of capillary infection rate to determine the
level of infection is novel and easier than the more technically demanding DNA
hybridisation method reported for the same purpose (Mahan, et al., 1992).
Immunisation of mice and sheep with full length recombinant 58kDa Hsp
(GroEl) or the 35kDa recombinant protein (subclone of GroEL) led to development
of specific antibodies which reacted to the native homologue (58kDa) the EB of C.
ruminantium. Antibodies to the full length recombinant protein were detected by day
14 post inoculation in sheep, in mice antibodies to the 58kDa and subclone 35kDa
antigen were detected on day 21 and 34 post inoculation respectively. Except for
four mice immunised with the full length recombinant GroEL the rest did not survive
challenge with a dose of 1.0 x 10 EBs of the Welgevonden stock. Two of 10 mice
immunised with bacterial lysate or with E. coli carrying the plasmid pBSCr9.4
survived challenge. Sera from these survivors showed strong reactions to the 58kDa
antigen in contrast to sera from infection/treatment mice which reacted weakly to the
same antigens. There was a significant difference between the survval time of
immunised and control mice: the controls lived longer than the immunised ones.
This suggests that immunisation with the recombinant antigen induced development
of a rapid course of fatal heartwater in the mice. This may be explained by the
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activity of pro-inflammatory cytokines such as IL-1 or TNF-a (Delanoy, Lekeux and
Miossec, 1993) or IL-6 (Bensaid et ah, 1993) which are known to exacerbate certain
diseases if high levels are produced for long periods of time during infection.
All the 6 sheep immunised with the recombinant 58kDa Hsp were not
protected against challenge with a dose of 3.0 x 103 EBs of the Welgevonden stock.
There was no significant difference in the period of survival or in the lesions
observed on post mortem between immunised and control sheep. Different methods
of computing the challenge dose have been described, but the determinantion of LD50
in small ruminants is required since repeated use of large number of animals cannot
be considered humane. The choice of challenge was emperical but the use of EB
quantitation allows accuracy to formulate. It is important to determine the incubation
period associated with reduced EB challenge, with the aim of getting an incubation
period similar to that which occurs with tick infection (about 13-14 day) in the
natural disease compared to 6-8 days in this trial. However significant differences
between the rates infection of brain capillary endothelial cells of the immunised and
control groups were observed. It is possible that the reduction was mediated by
antibodies since antibodies from immune sheep inhibit infectivity of C. ruminantium
to mice in the presence of complement (Du Plessis, 1993). The other possibility is
that undetected cellular responses such as the release of IFN-y by natural killer cells,
or by CD8+ and y5 T cells (Kaufmann, 1993) could have been responsible. Low
levels of IFN-y which did not influence the course of the disease but which were able
to reduce the infection rates of brain endothelial cells of the immunised sheep may
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also be responsible. In vitro studies have shown that IFN-y inhibits infection of
endothelial cells and reduces the yield of EBs from infected cultures (Totte et al.,
1994; Mahan et al., 1996).
Following immunisation the serological responses of mice and sheep were
characterised by higher IgG, than IgG2 ELISA OD values (Chapter 5.3.8) This
suggests that a Th2 response driven by IL-4 was induced by immunisation with
recombinant antigens. These findings are in agreement with those of other workers
who have demonstrated that immunisation with dead organisms or soluble proteins
preferentially stimulates CD4+ Th2 cells and antibody production but usually fails to
induce a Thl/CD8+ CTL response (Schirmbeck et al., 1994). However low IgG2 was
detectable which suggests that a Thl type response is also induced but at a lower
level.
Determination of the T cell phenotypes in PBMC obtained from immunised
sheep then stimulated in vitro with recombinant 58kDa revealed the presence of a
higher proportion of CD4+ T cells than CD8+ T cells. CD4:CD8 ratios of 3:1 and
higher were observed in these cultures. In addition determination of the phenotype
of T cells in PBMC obtained from immunised sheep at day 3, 7 and day 10 of
challenge revealed high CD4:CD8 ratios. No evidence of a CD8+ response was
observed in one I/T and one of the IEB animals (chapter 6) was noted in this
experiment. There was an absence of IFN-y in supernatants from PBMC cultures
stimulated with either the 58kDa Hsp or 35kDa subclone in vitro which indicates that
these antigens may not stimulate release of IFN-y from PBMC of immunised
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animals. In contrast to the proliferative responses to 58kDa antigen of PBMC from
goats immunised with IEB or I/T, EBs stimulated PBMC from the same goats
immunised to produce IFN-y in vitro (Section 6.3.3).
There was a highly significant decrease in monocyte counts on days 3 compared to
day 7 PC (P <0.006) in the immunised group. This suggested that monocytes were
actively involved in the immune response against challenge in this group and the
decrease may also reflect activation and reduction in migration from circulation from
the because of intravascular infection.
Monocytes play a very important role in immune response to intracellular bacteria.
They form part of the innate immune system which responds to infection before T
cell mediated protection occurs. In addition they process and present antigens to T
cells to initiate T cell responses. IFN-y activates macrophages making them potent
effectors of microbicidal CMI following T cell-mediated (Tizard, 1992). IFN-y was
not detected in PBMC culture supernatants in this study. Flowever challenge with
virulent Cowdria may have induced its production. Macrophages are crucial in
inducing Thl type responses in that they secrete IL-12 after stimulation by certain
microbial factors secreted by live bacteria. IL-12 plays a key role in the development
of Thl responses to intracellular bacteria (Cheers and Zhan, 1996). IL-12 stimulates
naive CD4+ T cells to secrete IFN-y which which in turn stimulates B cells to
produce IgG2 in the bovine (Estes el al., 1994) mouse and rat (Mossman and
Coffman, 1989) and in addition activates both macrophages and neutrophils into
powerful effectors to destroy intracellular bacteria (Lukacs et al., 1985, Chiang
196
Murata and Roth 1991). Evidence from experiments with the intracellular bacterium
Listeria monocytogenes indicate that killed bacteria do not induce a Thl response but
the addition of IL-12 to killed bacteria stimulates a protective immunity against
challenge (Miller et al., 1995/ Stress proteins fail to induce CMI unless injected
with special adjuvants such as ISCOMS (Cheers and Zhan, 1996). In the
experiments described in this chapter complete Freund's adjuvant and Mantonide
were used to deliver bacterial lysates or purified antigens and judging from the
results, these adjuvants potentiated an antibody mediated response but not a cell
mediated one.
Lack of proliferation of PBMC from I/T goats stimulated with 35kDa
recombinant protein (Section 6.3.3) suggested that this part of GroEL lacks T cell
epitopes or absence of detectable cellular responses to the 58kDa may underline the
failure to protect the animals. Also since it was purified and soluble it may not have
been processed correctly.
Failure of this recombinant to protect sheep and the partial protection ofmice
mice and against virulent challenge with C. ruminantium indicates that the
recombinant 58kDa Hsp alone does not induce a strong protective immunity and may
therefore require to be administered with other antigens to enhance the partial
protection demonstrated in mice. Immunisation with two or more recombinant
antigens have been shown to give better protection due to potentiation of the immune
response (Shankarapa et al., 1991). It is also possible that this antigen does not play
any role in protective immunity to C. ruminantium but this would be surprising given
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the role ofHsp 60 in other infections (Young et al., 1988). Another possibility is that
the challenge dose used was too high, particularly as the virulent Welgevonden stock
which causes fatal heartwater was used (Du Plessis and Van Gas, 1989). The most
important reason for the failure of protection could be due the inability of this antigen
to stimulate PBMC from goats which had been immunised by I/T or with IEBs to
produce IFN-y whereas, EBs stimulated them to produce this cytokine (Section
6.3.3). In vitro studies have demonstrated that IFN-y inhibits infection of endothelial
cells by C. ruminantium (Totte et al., 1994, Mahan et al., 1996) indicating that this
cytokine could be involved in protective immune responses to C. ruminantium.
The findings of this study lead to a number of recommendations which
include:
1. The relationship between challenge dose of EBs and incubation period and
mortality of the Welgevonden stock in small stock needs to be determined for
future protection experiments.
2. Other adjuvants and other methods of antigen delivery should be tested to
find out if they will improve the immunogenicity of this recombinant antigen.
3. Experiments with full length purified GroEL should be carried out in mice to
investigate the value of this antigen in immune responses to C. ruminantium.
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Table 7.1. Organisation of groups of mice for immunisation with recombinant
(Cr9.4) containing 58kDa Hsp (GroEL), bacterial control (pBScript) and
adjuvant controls (FCA, IFA).
No
Group .Mice Antigen Adjuvant dose Booster
Day
Challenged
A 10 Cr9.4 FCA 200 pg 100 pg+IFA 35 PI
B 10 Cr9.4 FIA 200 pg 100 pg/ml 35 PI
C 10 pBScript FCA 200 pg 100 pg/ml 35 PI
D 10 pBScript FIA 200 pg 100 pg/ml 35 PI
E 5 none CFA 0.1 ml 0.1 ml 35 PI
F 5 none FIA 0.1 ml 35 PI
Key
Cr9.4 = lysate of pBSCr9.4/JM109 containing the 58kDa recombinant antigen.
pBScript = lysate ofE. coli containing plasmid pBluesript (pBS/JM109);
FCA = Freund's complete adjuvant; IFA = Freund's incomplete adjuvant
PI = days post inoculation
Booster was given day 14 and 21 PI.
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Table 7 2. Immunisation of mice with 35kDa subclone protein of
C. ruminantium. Groups received purified 35kDa (A, B), bacterial lysate
containing 35kDa antigen (C, D), with presence (E, F) and absence of
adjuvant (G).
Day of Day
Group Antigen Dose Adjuvant Boosters challenged
A 35kDa pure 50 pg FCA 14,21 PI. 35 PI.
B 35kDa pure 50 pg Mantonide 14,21 PI. 35 PI
C 35kDa lysate 200 pg FCA 14,21 PI. 35 PI
D 35kDa lysate 200 pg Mantonide. 14,21 PI. 35 PI
E FCA 200 pi None 21 PI. 35 PI
F Mantonide 200 pi None 21 PI 35 PI
G None None







Table 7.3. Results of Cowdria challenging Groups of mice which had been
immunised with 58kDa Hsp recombinant protein as bacterial lysate (A, B),
or whole bacteria (G). Groups C and D are controls for Groups A and B,
Groups E and F are controls for adjuvants Group H, is control for Group G.
Challenge Days to death
Group Antigen+Adjuvant dose No.challenged No dead survivors ±SD
A Cr9.4+FCA l.OxlO3 EBs 9 8 1 8 ± 1.2
B Cr9.4+FIA 10 9 1 9 ±0.4
C pBS+FCA 10 10 0 11 ±2.5
D pBS+FIA 10 10 0 11 ±1.2
E FCA 5 5 0 11 ±0.5
F FIA 5 5 0 10.5 ± 1
G(t) E.coli
JM109/pBScr9.4
10 8 2 8.5 ± 1
H(I) E.coli JM109/pBS
< 9 10 10 0 7 ±0.5
Key
(J) mice in group G and H received 5 doses ofwhole bacteria (Section 7.2.3.2).
Cr9.4 = bacterial lysate containing recombinant 58kDa hsp
pBS = plasmid bluescript
FCA = Freund complete adjuvant
FIA = Freund incomplete adjuvant
Table 7.4. Summary data of analysis for differences between medians of days of
survival of groups of mice immunised with 58kDa Hsp recombinant antigen
(GpsA, B, C and G) and controls (G and H).
groups t value P value significance
GpsA vs GpB 2.365 0.503 NS
GpA vs GpC 2.362 0.0148 S
GPA vs GpD 2.365 0.026 S
Gp G vs Gp H 2.364 1.0 NS
Key
S = Significant, NS= Not significant
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Table 7.5. Challenge of mice immunised with 35kDa antigen in purified form
(A, B), as lysate (C, D) and controls: Survival data.
No.immunised No. survivors
Group Treatment or inoculated Days to death XSO
o 2° ch Overall survival
A 35 kDa+ FCA 5 11.7 ± 2.5 3/5 0/3 0/5
B 35kDa+ Mantonide 5 11.3 ± 1.2 4/5 0/4 0/5
C Lysate + FCA 5 10± 1 0/5 NA 0/5
D Lysate +Mantonide. 5 11.5 ±2.4 0/5 NA 0/5
E plasmid +FCA 5 10± 1 4/5 3/4 1/5
F FCA 4 11 ± 1 0/5 NA 0/5
G uninoculated 5 10.7 ±2.4 0/5 NA 0/5
Key
10 & 2° eh = first and second challenge respectively.
FCA = Freund complete adjuvant
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Table 7.6. Summary of immunisation and challenge of mice immunised with
58kDa Hsp (Cr9.4), with 35kDa subclone (pure/lysate) and control mice





Cr9.4 + FCA 9* 8 1 1/1
Cr9.4 + FIA 10 9 1 1/1
Cr9.4 (whole) 10 8 2 2/2
35 kDa + FCA 5 2 3 0/3
35kDa + Mantonide 5 5 0 NA
35 kDa Lysate + FCA 5 1 4 0/4
35kDa lysate+ Mantonide 5 5 0 NA
plasmids+ FCA 15 15 0 NA
+ FIA 10 10 0 NA
FCA none 10 6 4| 1/4
FIA 5 5 0 NA
Uninoculated " 5 5 0 NA
Key
* one of the mice in 10 died during inoculation
% 3 out of 4 died on second challenge
d* mice survived two more challenges with 2x10 EB's of Welgevonden stock.
Summarv
No. Dead survived
Received 58kDa & 35kDa 49 45 4
controls 45 44
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Table 7.7a. Clinical data from challenge of immunised and control sheep
indicating incubation period, febrile response, duration of febrile response
and length of time to death.
(a) immunised group n =161
sheep/No Treatment I.P Highest Temp. Days of fever Days to death PC
S66 GroEL 7 42.2 6 12
S69 C 9 7 42.2 9 14
S71 6 9 7 42.3 7 12
S72 6 9 7 42.0 5 11
S74 6 9 7 41.7 4 10
S76 6 9 6 42.2 6 11
Medians 6 42.2 6 11.5
MeansiSD 6.83±0. 4210.2 6.211.7 11.711.2
control group n = (6)
sheep/No Treatment I.P Highest Temp. Days of fever Days to death PC
S67 pBS 9 42.5 5 13
S68 t 9 8 42.2 5 12
S70 6 9 7 42.1 6 12
S73 6 9 7 41.7 5 11
S75 6 9 7 41.9 5 11
S77 6 9 7 41.7 6 11
Medians 7
42.0 °C 5 11.5
Mean ±






lysate containing recombinant 58 kDa Hsp.
lysate containing plasmid control pBluescript
Incubation period; D fever = days of fever, p.c. = post challenge
Maximum temperature reaction of sheep.
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Table 7.8. Analysis for differences between median counts of CD4+ T cell of
days (day 3 vs day 7 PC), sheep to sheep in the immunised and control
groups and groups (immunised vs control).
F value P value Significance
immunised group = t6t
Differences between days PC (day 3 vs 7) 9.11 0.006 HS
Differences between sheep 9.11 0.006 HS
control group n = t6t
Differences between days PC (day 3 vs 7) 16.79 0.0006 HS
Differences between sheep 2.66 0.09 NS
Differences between groups t = 0.99, p = 0.37 NS
Key
HS = highly significant
NS = not significant
205
Table 7.9. Analysis for differences between median counts of CD8+ T cell of days
(day 3 vs day 7 PC), sheep to sheep in the immunised and control groups
and groups (immunised vs control).
F value P value Significance
immunised group n= (6)
Differences between days PC (day 3 vs 7) 2.81 0.11 NS
Differences between sheep 3.09 0.06 NS
control group n= 161
Differences between days PC (day 3 vs 7) 2.38 0.14 NS
Differences between sheep 1.95 0.17 NS
Differences between groups t = -0.91 0.41 NS
Key
NS = not significant.
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Table 7.10. Analysis for differences between median counts of monocytes of days
(day 3 vs day 7 PC), sheep to sheep in the immunised and control groups
and groups (immunised vs control).
F value P value Significance
immunised group n= (6).
Differences between days PC (day 3 vs 7) 80 0.006 HS
Differences between sheep 31.51 0.0001 HS
control group n= (6).
Differences between days PC (day 3 vs 7) 88 0.03 NS
Differences between sheep 3.48 0.04 NS
Differences between groups t= 2.093 p>0.29 NS
Key
HS = highly significant
NS = not significant
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Table 7.11. Analysis for differences between neutrophils counts of days (day 3 vs
day 7 PC), sheep to sheep in the immunised and control groups and groups
(immunised vs control).
F value P value Significance





Differences between groups t = 2.093 p>0.05).
Key
S = significant
NS = not significant
Differences between days PC (day 3 vs 7) 1.59 0.025
Differences between sheep 3.33 0.05
control group= f61
Differences between days PC (day 3 vs 7) 2.69 0.012
Differences between sheep 5.18 0.01
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Table 7.12. Number of cases of immunised or control sheep showing specific
pathological changes at necropsy.
Pathological change immunised group n==6 Control group n=6
Lung oedema and congestion 6 5
pleural fluid 4 3
hydropericardium 4* 4
liver enlargement, icterus 4 5
gastro-intestinal haemorrhage 1 4
Kidney haemorrhages 3 3
Key
* one of the 4 had endocardial/myocardial haemorrhages
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Table 7.13. Infection rates of capillary endothelial cells from immunised and
control sheep following challenge with virulent C. ruminantium
































Fig ure 7.1. Western blots of bacterial lysates containing recombinant 58 kDa Hsp
demonstrating the presence of recombinant 58kDa Hsp in lysate. Western blots were
reacted with sera from an immune goat.
Lane 1, SDS low molecular weight protein standards; lane 2, lysate of
JM109/pBSCr9.4 indicating presence of recombinant antigen (58kDa Hsp), thick
black band indicated by arrow; lane 3, control plasmid (pBluecript) in E.coli.
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Figure 7.2. Western blots demonstrating recognition of C. ruminantium EB antigens
by antibodies in pooled sera obtained from mice immunised with 58 kDa FIsp
recombinant antigen and absence of such response in the plasmid control group.
Lanes 1, SDS Molecular weight standards; lanes 2 to 7, sequential sera from
immunised group which received 58kDa Hsp. Lanes 10 to 14 sequential sera from
plasmid control group; lanes 15 to 16, FCA control group (day 21 PI); lanes 17 and
18 negative control sera; lanes 8 and 9 positive control sera(day 34 PI) from I/T
mouse
lanes 2 and 3, 10 and 11 sera collected pre-immunisation. Lanes 4 and 5, 12 and 13,
sera collected day 21 Pilanes 6 and 7,14 and 15 serum collected day 28 PI.
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Figure 7.3. Western blots demonstrating presence of specific antibodies to at least 5
antigens of the Cowdria EB following challenge ofmice immunised with bacterial
lysates containing 58kDa Hsp recombinant antigen.
Lanes were tested as follows: lane 1, negative control serum; lanes 2 and 3, day
positive control serum from an I/T mouse; lanes 4 and 5, day 34 PI sera from plasmid
control mouse; lanes 6 and 7, day 14 PC sera from mice immunised with 58kDa Hsp
and lane 8 was tested with day 34 PC sera from a mouse immunised with 58kDa
recombinant rotein (95A4). Arrow indicates the position of 58 kDa antigen.
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Figure 7.4a. Coomassie blue stained SDS-PAGE gel to demonstrate purity of 35kDa
subclone protein antigen after affinity chromatography.
Lanes 1 and 2, un-purified bacterial lysate; Lanes 3, SDS molecular weight markers;
Lane 4 wash; Lanes 5 and 6 first and second eluates of purified 35kDa subclone
protein antigen.
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Figure 7.4b. Western blots of C. ruminantium EBs and the purified
recombinant 35kDa subclone indicating strong reactions between the 35kDa
by immune sera obtained at day 28 PI serum from an immune goat.
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Figure 7.5. Serological responses to 35kDa recombinant antigen of immunised and
control sheep.
Antibody responses of sheep immunised with recombinant 58kDa ( 0 ) and
control sheep inoculated with plasmid only ( ■ ). Results are mean OD of two tests.
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Figure 7.6a. Western blots demonstrating recognition of the 58 kDa EB antigen of
C. ruminantium by sequential sera from sheep immunised with recombinant 58 kDa
Hsp.
Lanes were tested with sera as follows: lane 1, day 0 sera; lane 2, day 14 sera; lane 3,
day 21 sera; lane 4. day 28 sera; lane 5 day 34 sera; lane 6 day 64 sera; lane 7, day 82
sera and lane 8 day 143 sera. Lane 9 SDS low molecular weight markers.
Arrow indicates the position of the 58kDa antigen.
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Figure 7.6b. Western blots demonstrating absence of reactions between the 58kDa
antigen of the EB with sequential sera from sheep inoculated with plasmid (pBS)
control.
Lane 1, day 34 sera from immunised group; lane 2, day 0 serum from control group;
lane 3, day 14 serum; lane 4, day 21 serum; lane 5, day 28 serum; lane 6, day 64












0 1 2.5 5 10 15
Antigen concentration (fag/ml)
Figure 7.7.Dose dependent proliferative responses of PBMC from two sheep immunised
with recombinant 58kDa Hsp : S71 (Figure 7.7a), S72 (Figure 7.7b) and control sheep
inoculated with plasmid pBS: S67 (Figure 7.7c). PBMC were stimulated in vitro with
bacterial lysates of the recombinant 58kDa (Cr9.4) or plasmid (pBS).
Proliferative responses to Cr9.4 ( g), and proliferative responses to plasmid /pBS ( #)
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Figure 7.8. Temperature reactions of immunised and control sheep in °C before and
after challenge. Mean daily temperatures of immunised group ( Q) and mean
daily of the control group ( ■ ).
The dotted line indicates the maximum upper limit of 'normal' temperature.
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Figure 7.9. Mean counts of CD4+T cells in peripheral blood of sheep immunised
with recombinant 58kDa Hsp and controls before and post challenge.






Figure 7.10. Mean counts of CD8+ T cells in peripheral blood of sheep immunised
with recombinant 58kDa Hsp and controls before and post challenge.






Figure 7.11. Mean monocyte counts in peripheral blood of sheep immunised
with recombinant 58 KDa Hsp and control sheep before and post- challenge.
Mean counts for group immunised with recombinant 58kDa hsp ( #). and counts of










Figure 7.12 . Mean neutrophil counts in peripheral blood of sheep immunised
with recombinant 58kDa Hsp and control before and post-challenge.
Mean counts of sheep immunised with recombinant 58kDa hsp (#), and
mean counts of the control group ( ■)
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Figure 7.13. Giemsa stained brain smear from challenged sheep showing brain




GENERAL DISCUSSION AND CONCLUSIONS
Experiments carried out in the early part of this century by scientists in South
Africa produced valuable knowledge about immunity to C. ruminantium. The first
attempts to protect ruminants against heartwater were carried out by Dixon (1898)
followed by Hutcheon (1902), Spreull (1904) and Theiler (1905, 1906). Three
discoveries by Alexander (1931), Neitz (1941) and Neitz and Alexander (1941)
culminated in the development of a successful infection and treatment (I/T) method
for vaccination ruminants which is still in use in South Africa.
Immunisation of ruminants by I/T confers solid immunity to homologous
challenge however, this method has some significant limitations including:- the risk
of spreading other tick-borne diseases, the requirement of qualified personnel to
administer it by the intravenous route, the possibility of direct loss through virulence
of infection and the limited scale on which it can be used. These factors have led to
the search for safer vaccines. Two types of vaccines have since been developed and
tested with promising results in the 1990's. They are an attenuated culture vaccine
(Jongejan, 1991; Gueye et al., 1994) and an inactivated elementary body vaccine
(Tafesse, 1992; Martinez et al., 1993, 1994; Mahan et al., 1995). However, the
mechanisms involved in protective immunity against heartwater in the ruminant have
remained poorly understood. In the mouse, protective immunity against heartwater
is cell mediated and is mainly by cytotoxic T lymphocytes (Lyt-2+/CD8+ T cells) as
demonstrated by experiments in adoptive transfer of CD8+ T cells from immune mice
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to naive mice (Du Plessis, 1991, 1992). It was speculated that protective immunity
in ruminants was cell-mediated since passive transfer of hyper-immune serum
(Alexander, 1931) or injection of gamma globulins from immune sheep into
susceptible sheep did not increase protection (Du Plessis, 1970a; Du Plessis and
Bezuidenhout, 1979). Additionally elementary bodies were not neutralised in vitro
by sera from immune animals (Martinez et al., 1993, 1994) however, antibodies
neutralised C. ruminantium (Byrom et al., 1993; Du Plessis, 1993) in vitro which
explains the disparity or provide reasons for differences observed and provide
evidence for the possible role of antibodies in protective immunity.
In order to understand the mechanisms involved in protective immune
responses against heartwater, antigenic components of C. ruminantium have to be
identified and characterised. Identification of antigens of C. ruminantium was
carried out first by Jongejan and Thielemans (1989a) who used a combination of
SDS-PAGE and immunoblotting to identify an immunodominant 32kDa protein
antigen which has cross reactive epitopes with the genus Ehrlichia. Further
identification of antigenic components was carried out by other workers (Rossouw et
al., 1990; Van Kleef et al., 1993; Mahan et al., 1993). These studies have generated
valuable knowledge of the antigenic components recognised by sera from immunised
animals. However, they have concentrated on antigens in general and not those
which are on the surface of the EB. In this study surface components of the EB of C.
ruminantium (Welgevonden stock) were identified by biotin labelling and were
found to be antigenic by immunoblotting. Six major surface antigenic proteins of
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21kDa, 28kDa, 31kDa, 62kDa, 74kDa and 115kDa were identified. Three of the
antigens identified (21kDa, 32kDa and 58kDa) belong to a group of C. ruminantium
antigens termed major antigenic peptides (Mahan et al., 1994; Mahan, 1995). SDS-
PAGE of individual EB antigens led to the purification of 2 antigens of 24kDa and
32kDa which were used cell proliferation assays using PBMC from immune goats.
Although these antigens did not stimulate PBMC to proliferate, their purification
paved a way for further investigation into their value in immunisation experiments in
the future.
Immunisation of goats with IEBs stimulated development of antibodies to 5
antigens of the EB of molecular masses 24kDa, 27kDa, 28kDa, 32kDa, and 58kDa.
After challenge of IEB-immunised goats, those which survived developed antibodies
reacting with additional antigens, of 14kDa, 21kDa, 45kDa, 66kDa, and 80kDa.
Antibodies to the same EB antigens given above were detected in sera collected from
two of the survivors 18 to 24 months after recovery from challenge. Since these
animals were protected against virulent challenge, the antigens recognised by sera
after challenge with live EBs may be significant in the development of protective
immune responses. The appearance of extra bands after challenge may also indicate
that these antigens are less abundant and responses to them are made only on
replication of C ruminantium in vivo. Immunisation of ruminants with the 32kDa
(MAPI) antigen did not lead to protection (van Vliet et al., 1994) but it is possible
that the method of presentation (oil adjuvant) of the antigen may not have been
optimal for iinducing cellular responses because T helper epitopes on MAPI have
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been identified (Totte 1996 personal communication). Other antigens of C.
ruminantium need to be evaluated to identify those which induce protective
immunity against this rickettsia. However, the nature of the protective immune
response must be defined in order that suitable markers of immunity can be
determined to assist the screening for adjuvants and antigens.
Immunisation with IEB appears to prime the immune system to respond with
a Thl type response. The evidence for this was production of IgG2 and protection of
goats against challenge, as shown by the responses of 4 IEB-immuised goats which
survived challenge. Upon challenge, of the IEB immunised goats they developed a
temperature reaction, temporary loss of appetite and mild depression for some days
followed by recovery in others. This indicated that the type of immunity which
develops after immunisation with IEBs seems to be insufficient to prevent severe
cowdriosis if the level of challenge is high, in contrast to challenge of I/T immunised
animals which show few or no clinical signs.
The immune response to challenge by IEB-immunised goats seems to be
determined by the dose of the challenge inoculum since IEB-immunised sheep
exposed to natural field conditions survived (Mahan et al., 1995). Experimental
challenge of goats led to development of temperature reaction and other clinical
siigns of heartwater with some of them not surviving (Martinez et al., 1993; Tafesse,
1992). In this study IEB-immunised goats and sheep immunised with a 58kDa
recombinant Hsp antigen developed severe heartwater and did not survive challenge.
In contrast immunisation of ruminants by I/T confers solid immunity against
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challenge and no development of clinical signs (Uilenberg et al., 1983). The I/T
method of immunisation leads to a predominant IgG, response, an indication that live
C. ruminantium does not induce a classical Thl response but rather surprisingly
induces a Th2 antibody profile. This could be due to the induction of IL-4 or IL-10,
cytokines which promote IgGb IgM and IgE production by B cells (Tizard, 1995).
Bovine IL-4 upreglates productionof IgGb IgM and IgGE but not IgG2 (Estes et al.,
1995) and Ehrlichia chaffeensis induces expression of IL-10 by human macrophages
a cytokine which has similar effects to IL-4 (Lee and Rikihisa, 1996). Despite the
fact that a Th2 type antibody response is induced, goats which recover from infection
after treatment are protected against subsequent challenge. Development of high
CD8+ counts very late after challenge suggests that the antibody profile is perhaps
misleading and may not reflect the cellular bias. The I/T method is used extensively
in South Africa where up to 250,000 doses are used every year (Bezuidenhout et al.,
1994). The mechanisms by which C. ruminantium circumvents the immune system
resulting in long-term carrier status are not known.
In this study results of a preliminary experiment carried out to determine the
effects of live and inactivated EBs on the proliferative responses of PBMC from an
I/T goat showed that live EBs reduced the proliferative responses. This result
suggests that C. ruminantium down regulates lymphocyte responses or the antigen
presenting capacity of macrophages possibly by inhibiting phagolysosome fusion as
observed in Chlamydia psittaci (Wyrick and Brownridge, 1978). However, Du
Plessis et al., (1992) argues that in mice phagolysosomal fusion occurs in
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macrophages which leads to CD8+ responses because antigens are processed by the
cytoplasmic (MHC class I) route. It could also be due to down regulation of MHC
class II expression (Totte et al., 1997) or co-stimulatory molecule expression.
The IgG concentration of sera from cattle exposed to natural challenge of
heartwater were similar to those of I/T cattle and goats, indicating that ruminants
respond to natural and experimental C. ruminantium infection by producing mainly
IgG, (Th2 type response). In contrast, I/T recovered mice develop a dominant IgG2
response, an indication of a classical Thl response which is consistent with the
development of antigen specific CTL important in the control of infection (Du
Plessis et al 1992). The differences between the immune responses of ruminants and
mice questions the validity of using mice for protection experiments against C.
ruminantium.
It is now known that immune responses to infections of intracellular
organisms are determined at the beginning of infection by the type of cytokine
induced by the invading organism (Kaufmann, 1995). Organisms which are potent
inducers of IL-12 such as Listeria monocytogenes induce secretion of IL-12 from
macrophages early in the infection leading to IFN-y production by NK cells which
favours development of a Thl type response. In contrast, organisms which are potent
inducers of IL-4 such as Leishmania major, will induce a Th2 type response. In this
study the IgG isotype responses of sera from naturally and experimentally infected
cattle and those of I/T goats were characterised by dominant IgG, antibody
responses. An explanation for this could be that C. ruminantium induces IL-4 or IL-
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10 production at the outset of infection, to reduce the anti-rickettsial effects of IL-12
and IFN-y, and stimulation of B cell responses (by IL-10) towards IgG, (Th2) type
response. Evidence from studies with a closely related organism, the human
pathogen Ehrlichia chaffeensis indicates that killed and live ehrlichiae induce
expression ofmRNA for IL-1(3, IL-8 and IL10 by human macrophages and that this
could be used by ehrlichiae as a way of delaying development of protective immune
responses (Lee and Rikihisa, 1996). It is likely that C. ruminantium behaves in a
similar manner.
Stimulation of PBMC from goats immunised either by I/T or with IEBs with
homologous EBs led to IFN-y production in vitro. This indicates that the
immunisation had primed the PBMC to release this cytokine since PBMC from a
naive control did not produce IFN-y after stimulation with EBs. Flow cytometric
analysis of PBMC following EB stimulation showed that the proportion of CD4+
increased in contrast to CD8+ T cells indicating that a T helper responses were
induced. Challenge of an I/T led to development of a late CTL response (day 17 PC)
evidenced by a 5 fold increase in CD8+ counts.
The role played by antibodies in protective immunity against heartwater is
controversial. However, natural infection, I/T and IEB immunisation lead to strong
IgG, responses. Adoptive transfer of serum or purified antibodies did not protect
mice against challenge (Byrom et al., 1993). In contrast, Du Plessis (1993) found
that transfer of serum with complement inhibited infectivity of C. ruminantium
(Kumm stock) in outbred mice. In this study, sheep immunised with recombinant
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58kDa Hsp antigen of C. ruminantium developed a dominant IgG, response and
upon challenge they had significantly lower rates of infection in brain capillary
endothelial cells than the control group. This suggests that either antibodies had a
role perhaps by opsonisation or undetected cellular responses were responsible
through IFN-y released at a low level, to an extent which reduced Cowdria infection
in brain EC. In view of the unclear role played by antibodies in protective immunity
against heartwater, further investigation is necessary to determine the significance of
IgG, and IgG2 in ruminants, as a marker for underlying responses and in terms of
their possible roles in protection.
Protective immunity in ruminants is induced by I/T immunisation (Neitz and
Alexander, 1941), immunisation with attenuated organisms (Jongejan, 1991; Gueye
et al., 1994) and immunisation with inactivated EBs (Martinez et al., 1993, 1994;
Mahan et al., 1995). The fact that the IEB vaccine induces a protective immunity is
important because it is safe (non-virulent) to use and can be used safely outside the
area of geographical origin of the isolate. Inactivated EB vaccines are the best
options for protecting ruminants against heartwater in the near future until subunit,
recombinant or nucleic acid vaccines are available. In this study immunisation of
mice and sheep with a recombinant 58kDa Hsp and a 35kDa subclone was attempted
with limited protection against challenge in mice but none in sheep. The fact that
only three adjuvants (FCA, FIA and Mantonide ISA50) were used to deliver the
recombinant antigens requires that other adjuvants and delivery systems need to be
used in protection experiments with this antigen in order to identify a suitable one for
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use in future. In addition other recombinant antigens such as MAPI (van Vliet et al.,
1994) and MAP2 (Mahan et al., 1994) and some of the other surface antigens
identified in this study (Chapter 4) should be used in protection experiments to
identify those which are protective.
Heartwater remains an economically important disease of ruminants in sub-
Saharan Africa and the search for a safe and economically feasible vaccine and
investigations of the biology of the rickettsia, mechanisms of immunity and
pathogenesis should continue.
Finally this study has demonstrated that:
1. Six antigenic proteins of 21, 28, 31, 62 and 72kDa are located on the surface
of EBs and are recognised by immune sera from goats immunised with live
and inactivated EBs additionally sera obtained from IEB goats before
challenge recognised fewer antigens than sera obtained after challenge.
2. Natural and experimental infection of ruminants with C. ruminantium results
in a Th2 type antibody profile whereas, immunisation of goats and cattle with
killed EBs induces a mixed a Th2 profile in goats but Thl/Th2 profile in
cattle. Upon challenge of the IEB immunised animals both antibody isotypes
are raised, with greater increase in Thl type antibodies being evident.
3. Mice IgG antibody profiles after infection/treatment are dominated by IgG2a,
evidence of a Thl type response. In contrast, inactivated EBs or recombinant
antigen immunisation induces a strong IgGj antibody responses consistent
with a mainly Th2 typeresponse.
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4. PBMC from immunised goats are primed to produce IFN-y upon subsequent
stimulation by homologous EBs in vitro. The CD4+ and CD8+ T cell
responses of immunised goats are dominated by CD4+ for the first 10 day of
challenge and after that CD8+ T cells increase to about 5 times that of CD4+
by day 17 PC. CD8+ remained 2 times higher than CD4+ for at least one
month.
5. Immunisation of mice with recombinant 58kDa (GroEL) and 35kDa subclone
partially protected mice against virulent homologous challenge.
6. Evidence was found that Cowdria affects the nature of immune responses in a
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Growth Medium for Heartwater Cultures


















Reagents and Buffers For Indirect ELISA for the Detection of IgGj and IgG2 Isotype
Antibody Responses.
ELISA coating buffer
Carbonate/bicarbonate buffer pH 9.0 (Sigma)











Blocking buffer (4% Normal rabbit serum/PBS/0.05% Tween)
PBS-Tween-20 100 ml
Normal rabbit serum 4.0 ml
Appendix A.5




Buffer B (pH 8.0) 8 M urea, 0.1 M NaHP04, 0.01 M Tris-HCl, pH 8.0.
Wash buffer
buffer C (pH 6.3) 8 M urea, 0.1 M NaHP04, 0.01 M Tris-HCl pH 6.3
32 mM Imidazole, 0.005% Triton 100-X.
Elution buffers 8 M urea, 0.1 M NaHP04, 0.01 M Tris-HCl pH 4.5.
Appendix A.6
Reagents and gel preparation for SDS-PAGE slab gels (Laemmli buffer system)
Stock solutions
A. Acrylamide/bis (40%)
B. 1.5 M Tris -HC1, pH 8.8
27.23 g Tris base (18.15 g/100 ml)
-80 ml distilled water
Adjust pH to 8.8 with 1 N HC1. to make 150 ml with distilled water and store at 4°C
C. 0.5 M Tris-HCl, pH 6.8
6 g Tris base
-60 ml distilled water.
Adjust to pH 6.8 with 1 N HC1. Make to 100 ml with distilled water store at 4 C.
D. 10 % SDS
Dissolve 10 g SDS in water with gentle stirring and bring to 100 ml with
h2o.
Preparation of separating gels
10% 12%
Distilled water 4.05 ml 3.35 ml
1.5M Tris-HCl pH 8.8 2.50 ml 2.50 ml
10% SDS 100 pi 100 pi
40% Acrylamide 3.0 ml 2.50 ml
TEMED 5 pi (0.5 pl/ml) 5 pi
10% Ammonium persulphate 50 pi (5 pi / ml) 50 pi
Stacking gel
Distilled water 6.10 ml
0.5M Tris-HCl pH 6.8 2.50 ml
10% SDS (w/v) 1.0 ml
40% Acrylamide 1.0 ml
TEMED 10 ml
10% Ammonium persulphate 50 pi (5 pl/ml)
Sample buffer (SDS reducing buffer) stored at room temperature
Volume
Distilled water 2.0 ml
0.5M Tris-HCl pH 6.8 1.0 ml
Glycerol 0.8 ml
10% (w/v) SDS 1.6 ml
2-b-mercaptoethanol 0.4 ml
0.05 % (w/v) bromophenol blue 0.2 ml
Sample diluted at 1:1 with buffer and heated at 95°C for 5 minutes.
5X Electrode buffer (running) Buffer, pH 8.3
Tris base 15 g/1
Glycine 72 g/1
SDS 5 g/1
make up to 1000ml with distilled water
Store at 4°C. warm to 37°C before use if precipitation occurs
Bjerrum and Schaefer-Nielsen transfer buffer
48 mM Tris 5.82 g/1
39 mM Glycine 2.93 g
1.3 mM SDS (0.0375) 3.75 ml (10%)
20% methanol 200 ml
Dissolve in ddH20 adjust volume to a litre
Tris-buffered saline (TBS)
20 mM Tris 24.22 g
150 mM NaCl 87.66 g
Dissolve in de-ionised distilled water adjust the pH to 7.5 with 1 N HC1
and make it up to 1 litre
Appendix A.7
Reagents for Coommassie Blue Staining and Destaining
10 % Acetic acid
40 % Methanol
50 % distilled water.
800 ml Methanol + 200 ml Acetic acid +1000 ml distilled water
Appendix A.8
Protein elution buffer
25 mM Tris base 3.0 g
192 mM Glycine 14.4 g
0.1 % SDS 1.0 g
to 1 litre with dH20










Appendx B Table 1. Proliferative responses ofPBMC from two IEB immunised
goats (G107, G108) and control goat (G109) stimulated in vitro with EBs of the Ball
3 Gardel (heterologous) and Welgevonden (homologous) stocks of C. ruminantium.
The responses were determined by MTS assay.
Antigen
concentration C.ruminantium stocks & OD values
Goat No. pg/ml Ball 3 Gardel Welgevonde
n
G107 IEB 1 0.0435 0.0405 0.1033
5 0.0485 0.043 0.089
10 0.124 0.096 0.0615
15 0.115 0.083 -0.006























1 -0.024 -0.011 -0.020
5 -0.020 0.007 0.018
10 -0.015 0.019 0.012
15 0.002 0.043 -0.032
20 0.018 0.059 -0.029
Key:
OD values are the medians of 3 tests taken at 570nm using a plate reader
Appendix B Table 2. T-cell counts (109) of immunised goats before and after
challenge with virulent homologous culture of Welgevonden stock of C.
ruminantium.
group/goats No days post challenge
I/T T cells 0 3 7 10 17 21 32













0.6 1.01 3.68 2.66 2.8
yd 0.15 0.10 0.04 0.11 0.13 0.15 0.16
1 4 7 2 3
IEB gp
G107 CD4+ 1.00 1.67 0.59 0.40
CD8+ 0.77 1.49 0.3 0.59
yd 0.17 0.24 0.06 0.13
G108 CD4+ 5.17 4.00 3.46 1.29
CD8+ 2.31 1.80 0.74 0.87
yd 1.25 1.00 0.32 0.37
controls
G109 CD8+ 2.97 0.94 0.89 0.79
CD4+ 1.72 1.17 0.73 0.91
yd 1.21 0.67 0.42 0.45
G110 CD8+ 2.95 2.29 2.10 0.84
CD4+ 2.63 1.12 2.28 4.48
yd 1.23 1.14 0.68 0.45
Appendix B Table 3 Changes in CD4+:CD8+ ratios of goats after challenge with
virulent culture of C. ruminantium (Welgevonden).
days post challenge & CD4+:CD8+ ratios
Goat No. 3 7 10 17 21 32
G74 I/T 2:1 1.3:1 1:1 1:5 1:2 1:2
G107 1:1 2:1 1:1
IEB
G108 2:1 5:1 2:1
IEB
G109C 1:1 1:1 1:1
G110C 2:1 1:1 1:5
Key:
I/T = infection /treatment, IEB = inactivated elementary bodies C = control.
Appendix B. Table 4. Counts (109) of PBMC of immunised and control goats
before and after challenge with virulent stock of C. ruminantium (Welgevonden).
Goat No/, group cell type days post challenge & counts
0 3 7 10
I/T G74. WBC 6.30 10.80 7.40 10.80
Monocytes 0.19 0.12 0.37 0.32
Neutrophils 2.46 7.78 4.44 7.02
IEB G107. WBC 11.50 14.70 16.20 13.20
Monocytes 0.12 1.03 0.16 1.45
Nuetrophils 6.56 6.76 12.78 8.10
IEB G108. WBC 19.40 19.20 19.10 20.40
Monocytes 0.190 0.19 0.57 2.24
Neutrophils 4.66 6.53 6.11 9.20
Control G109. WBC 19.30 12.60 12.10 15.50
Monocytes 0.77 0.38 1.21 1.86
Neutrophils 7.91 7.81 6.41 10.39
Control G110. WBC 19.40 17.80 13.00 21.50
Monocytes 0.58 0.53 0.91 2.58
Neutrophils 6.79 9.43 3.12 10.32
Key:
I/T = infection /treatment, IEB = inactivated elementary bodies C = control.
Appendix B Table 5. Summary statistics for T cell counts (109/l)in peripheral
blood of goats inoculated with live EB's (I/T), immunised with inactivated EB's
(IEB) and controls following challenge with C. ruminantium. (Welgevonden).
a) CD4+ counts.
Goat No. mean median stdev SE mean
G74 I/T 0.969 0.957 0.204 0.102
G107 IEB 0.914 0.793 0.563 0.281
G108 IEB 3.473 3.73 1.623 0.812
G109 Control 1.379 0.918 1.048 0.524
G110 Control 2.046 2.194 0.883 0.524
Analysis for group to group differences between the CD4+ counts by student t test
showed no differences between IEB and the controls t = 0.67, p= 0.52
b) CD8+ counts Summary statistics.
Goat No. mean median stdev SE mean
G74 I/T 0.779 0.754 0.197 0.010
G107 IEB 0.789 0.683 0.506 0.253
G108 IEB 1.43 1.34 0.753 0.377
G109 Control 1.383 1.043 0.901 0.454
G110 control 2.628 2.457 1.392 0.692
Analysis for group to group differences between the CD8+ counts by student t test
showed that there were no significant differences t = -1.53, p= 0.16.
Appendix B Table 5c. y5 counts Summary statistics
Goat No. mean median stdev SE mean
G74 I/T 0.0103 0.111 0.046 0.023
G107 IEB 0.149 0.151 0.074 0.036
G108 IEB 0.734 0.683 0.463 0.232
G109 Control 0.686 0.559 0.364 0.182
G110 Control 0.875 0.909 0.370 0.185
Analysis for group to group differences between the y/5 counts of IEB and controls
indicated that there were no significant differences t = -1.70, p= 0.11.
Analysis for group to group differences the monocyte counts of the IEB and control
groups showed no significant differences t = 0.49, p= 0.37.
There also no significant differences between the neutrophil counts of the two groups
t = 0.15, p= 0.88.
Appendix B Table 6. Effect of challenge with a virulent homologous culture of C.
ruminantium on the mean monocyte counts 109/l) in peripheral blood of immunised
and control goats.
counts & days post challenge
group 0 3 7 10
I/T n=l 039 032 037 032
IEB n=2 0.155 0.61 0.400 1.85
Control n=2 0.68 0.46 1.06 2.22
Appendix B Table 7. Effect of challenge with a virulent homologous culture of C.
ruminantium on the mean neutrophil counts (109/1) in peripheral blood of immunised
and control goats.
counts & days post challenge
group 0 3 7 10
I/T n=l 236 7/78 434 7.02
IEB n=2 5.61 6.64 9.41 8.65
Control n=2 7.35 8.62 4.68 10.36
Appendix B Table 8a. Changes in the absolute number (109/1) of CD4+ T-cells in
peripheral blood of the sheep inoculated with 58kDa recombinant Hsp following
immunisation and after challenge.
days post-challenge & CD4+ counts
group sheep 0 3 7 12
immunised S66 0.235 1.082 0.524
S69 0.838 1.807 0.647 1.143
S71 1.385 1.177 1.034 0.747
S72 1.315 2.097 0.868
S74 0.871 1.120 0.992
S76 2.045 2.708 1.561
Appendix B Table 8b. Summary data for CD4+ counts (days) of immunised group
post challenge.
day mean stdev sem median
0 1.115 0.615 0.251 1.093
3 1.665 0.659 0.269 1.492
7 0.938 0.364 0.1485 0.930
Appendix B Table 8c. Summary data for CD4+ counts of immunised group after challenge.
sheep mean stdev sem median
S66 0.6137 0.4306 0.2486 0.5240
S69 1.097 0.622 0.3591 0.8380
S71 1.199 0.177 0.102 1.177
S72 1.427 0.622 0.359 1.315
S74 0.994 0.124 0.072 0.992
S76 2.105 0.576 0.333 2.045
Appendix B Table 9a. Changes in the absolute number (109/1) of CD4+ T cells in the
peripheral blood of control group before and afterr challenge.
days post challenge & counts
group Sheep 0 3 7 12
control S67 1.487 1.614 0.813 1.597
S68 1.233 1.684 0.939 1.364
S70 0.743 0.803 0.503 0.239
S73 0.827 0.997 0.213
S75 1.210 1.050 0.494
S77 0.464 0.614 0.426
Appendix B Table 9b. Summary data CD4+ counts (109) of the control group before and
after challenge.
day mean stdev sem median
0 0.994 0.379 0.155 1.020
3 1.127 0.433 0.177 1.023
7 0.565 0.266 0.109 0.498
Appendix B Table 9c. Summary data of CD4+ counts (109) of the control group before and
after challenge.
Sheep mean stdev sem median
S67 1.378 0.381 0.519 1.542
S68 1.305 0.309 0.154 1.299
S70 0.575 0.257 0.129 0.623
S73 0.679 0.412 0.238 0.827
S75 0.918 0.376 0.217 1.050
S77 0.501 0.099 0.057 0.464
Appendix B Table 10a. Changes in the absolute numbers (109/1) of CD8+ T cells
in peripheral blood of sheep before and after challenge.
group days post challenge & counts
immunised sheep 0 3 7 12
S66 0.032 0.165 0.080
S69 0.267 0.534 0.121 0.411
S71 0.238 0.318 0.318 0.44
S72 0.395 0.262 0.287
S74 0.165 0.225 0.171
S76 0.308 0.453 0.242
Control S67 0.316 0.764 0.219
S68 0.382 0.31 0.293
S70 0.335 0.427 0.199
S73 0.144 0.199 0.121
S75 0.199 0.564 0.216
S77 0.099 0.144 0.101
Appendix B Table 10b. Summary data of CD8+counts (109/1) days before and afterchallenge
in the immunised group.
days mean stdev. sem median
day 0 0.234 0.125 0.051 0.252
day3 0.326 0.141 0.058 0.290
day7 0.203 0.094 0.039 0.206
Appendix B Table 10c. Summary ofCD8+counts (109/1) of individual animals in immunised
group.
sheep mean stdev sem median
S66 0.092 0.067 0.039 0.080
S69 0.307 0.210 0.121 0.267
S71 0.291 0.046 0.027 0.318
S72 0.315 0.071 0.048 0.287
S74 0.187 0.033 0.019 0.171




Appendix B Table 11a. Summary data of CD8+counts (109/1) of days before and
afterchallenge in the control group.
group Means stdev SE median
day 0 0.246 0.114 0.047 0.258
day 3 0.372 0.258 0.105 0.313
day 7 0.192 0.071 0.029 0.208
Appendix B Table lib. Summary data of CD8+ counts (109/1) of individual animals in
control group.
SD
group mean deviation SE ofmean median
S67 0.433 0.290 0.168 0.316
S68 0.270 0.128 0.073 0.293
S70 0.320 0.115 0.066 0.335
S73 0.155 0.040 0.0234 0.144
S75 0.326 0.206 0.120 0.216
S77 0.115 0.025 0.015 0.010
Appendix B Table 12. Ratios of CD4+:CD8+ T cells in peripheral blood of
immunised and control sheep with virulent culture of C. ruminantium
(Welgevonden).
Group/Sheep ratios/days post challenge
immunised day 3 day 7 day 12
S66 7:1 6:1 5:1
S69 4:1 6:1 3:1





S67 2:1 4:1 1.3:1
S68 5:1 3:1 2:1




The ratios ofCD4:CD8 show that CD4+ remained higher than CD8+
throughout challenge period.
Appendix B Table 13a. Changes in the absolute number (109/1) of y/S T-cells in
peripheral blood of sheep before and after challenge with virulent homologous
culture C. ruminantium (Welgevonden).
days after challenge & counts
group Sheep day 0 day 3 day 7 day 12
immunised S66 0.0012 1.169 0.412
S69 0.0011 0.964 0.264 0.160
S71 0.0 2.613 0.291 0.283
S72 0.006 1.360 0.5.3
S74 0.003 0.842 0.614
S76 0.035 1.287 0.166
control S67 0.005 1.02 0.499 0.365
S68 0.005 1.237 0.270 0.363
S70 0.002 0.429 0.108 0.081
S73 0.013 1.280 0.378
S75 0.004 1.586 0.486
S77 0.005 0.498 0.171
Appendix B Table 13b. Anova two way analysis of T cell counts of sheep
immunised with recombinant 58 kDa Hsp and controls.
Source of variation SS DF V F20 Tabular signific.
Between sets 3.088 3 F05 F01
Between days p.c. 3.047 1 3.047 40.0 4.35 8.09 VS
Between treatments 0.038 1 0.030 0.050 6 9 6 9 NS
Interactions 0.003 1 0.003 0.04 C 9 (. 9 NS
Within sets 1.520 20 0.076 NS
Key
VS = very significant, NS = not significant
Appendix B Table 14a. Changes in the absolute number (109/1) of monocytes in
peripheral blood of sheep before and after challenge in immunised group with
virulent homologous culture of C. ruminantium (Welgevonden).
group Sheep Days post challenge & counts
0 3 7 12
immunised S66 4.80 5.30 3.00
S69 5.20 8.70 4.70 5.70
S71 11.80 12.40 8.00 6.70
S72 15.10 13.60 13.80
S74 6.30 8.70 5.60
S76 9.50 11.30 8.90
control S67 8.70 12.70 6.30 7.30
S68 6.80 10.50 6.70 7.90
S70 6.30 6.50 6.00 3.60
S73 7.30 8.90 6.70
S75 8.10 8.90 7.10
S77 5.70 4.70 5.20
Appendix B Table 14b. Summary data ofmonocyte counts (109/1) days before and after
challenge in the immunised group.
days mean stdev. sem median
0 8.783 4.108 1.677 7.900
3 10.000 3.029 1.237 10.000
7 7.330 3.832 1.565 6.800
Appendix B Table 14c. Summary of monocyte counts (109/1) of individual animals in
immunised group.
sheep mean stdev sem median
S66 4.367 1.210 0.698 4.800
S69 6.200 2.179 1.258 5.200
S71 10.733 2.386 1.378 11.800
S72 14.167 0.815 0.470 13.800
S74 6.867 1.626 0.939 6.300
S76 9.900 1.249 0.721 9.500
Appendix B Table 14d. Summary data monocyte counts (109/1) of days in the
control group.
days Means stdev sem median
0 7.150 1.120 0.457 7.050
3 8.700 2.834 1.157 8.900
7 6.333 0.671 0.274 6.500
Appendix B Table 14e. Summary data monocyte counts of sheep in the control
group
sheep mean std. deviation sem median
S67 9.233 3.233 1.867 8.700
S68 8.000 2.166 1.250 6.800
S70 6.267 0.217 0.145 6.300
S73 7.633 1.137 0.657 7.300
S75 8.033 0.902 0.521 8.100
S77 5.200 0.500 0.289 5.300
Appendix B Table 15a. Changes in the absoltue number (109/1) of neutrophil in
peripheral blood of immunised and control sheep before and after challenge with
virulent homologous culture of C. ruminantium (Welgevonden).
group Sheep days post challenge & counts
0 3 7 12
immunised S66 3.396 1.060 1.521
S69 2.704 3.393 2.726
S71 3.422 4.464 0.080
S72 4.832 6.120 6.072
S74 2.646 4.490 1.736
S76 2.660 3.204 3.204
control S67 3.741 5.715 2.52 2.92
S68 1.904 2.205 2.412 3.239
S70 3.402 3.51 3.6 2.52
S73 2.482 4.005 2.546
S75 1.458 2.581 1.207
S77 1.596 1.504 2.08
Appendix B Table 15b. Summary data for neutrophil counts (109/1) of days in the
immunised group before and after challenge.
days mean stdev. sem median
0 3.277 0.844 0.345 0.305
3 3.789 1.693 0.691 3.928
7 2.557 2.034 0.830 2.231
Appendix B Table 15c. Summary of neutrophill counts (109/1) in peripheral blood of
individual animals in immunised group after challenge
sheep mean stdev sem median
S66 1.992 1.237 0.714 1.521
S69 2.941 0.392 0.226 2.726
S71 2.655 2.290 1.322 3.422
S72 5.675 0.730 0.423 6.072
S74 2.957 1.403 0.801 2.646
S76 3.023 0.314 0.181 3.204
Appendix B Table 15d. Summary data neutrophil counts (109/1) of days in the
control group before and after challenge.
days means stdev std error ofmean median
0 2.431 0.957 0.391 2.193
3 3.253 1.503 0.614 3.045
7 2.394 0.775 0.316 2.466
Appendix B Table 15e. Summary data neutrophil counts (109/1) in peripheral blood
of sheep in the control group before and after challenge.
sheep mean std. deviation sem median
S67 3.992 1.612 0.931 3.741
S68 2.1740 0.255 0.148 2.205
S70 3.504 0.099 0.057 3.510
S73 3.011 0.861 0.497 2.546
S75 1.749 0.732 0.422 1.458
S77 1.727 0.309 0.179 1579
Appendix B Table 16a. Serological responses of sheep immunised with 58kDa Hsp
recombinant antigen of C. ruminantium. Median ELISA absorbance values at 450
nm.
days post challenge and absorbance values
group 0 7 14 21 28 34 64 82
S66 0.011 0.03 0.028 0.048 0.042 0.115 0.03 0.084
S69 0.011 0.092 0.221 0.071 0.31 0.398 0.272 0.322
S71 0.053 0.069 0.083 0.183 0.207 0.383 0.192 0.154
S72 0.033 0.082 0.116 0.137 0.197 0.294 0.117 0.313
S74 0.015 0.055 0.053 0.105 0.119 0.175 0.05 0.198
S76 0.004 0.02 0.035 0.032 0.102 0.088 0.07 0.163
Appendix B Table 16b. Serological responses of control sheep to 35 kDa antigen of C.
ruminantium Mean ELISA absorbance values (450 nm)
group days post challenge & absorbance values (450 nm)
Controls 0 7 14 21 28 64 82
S67 0.022 0.063 0.132 0.216 0.218 0.178
S68 0.01 0.035 0.070 0.076 0.072 0.060
S70 0.026 0.069 0.100 0.167 0.184 0.143 0.13
S73 0.007 0.017 0.026 0.046 0.076 0.080 0.06
S75 0.017 0.046 0.065 0.094 0.072 0.020 0.08
Appendix B Table 17. IgGl and IgG2 responses of sheep immunised with a
recombinant 58kDa antigen to 35kDa subclone.
ahsorbance values t450 nm) of isotvpes at different days
Day34 PI day 64 PI day 143 PI
IgGl IgG2 IgGl IgG2 IgGl IgG2
Sheep
S66 0.106 0.00 0.047 0.00 0.068 0.00
S69 0.427 0.292 0.532 0.237 0.527 0.146
S71 0.775 0.149 0.188 0.00 0.267 0.00
S72 0.248 0.143 0.089 0.017 0.221 0.00
S74 0.094 0.00 0.047 0.00 0.067 0.00
S76 0.087 0.00 0.062 0.00 0.158 0.00
Appendix B Table 18. Proliferative responses in vitro of PBMC of sheep stimulated
with 15 pg/ml bacterial lysates containing recombinant 58 kDa Hsp (Cr9.4) of C.
rnminantium or plasmid control (pBluescript).
Sheep antigens/absorbance values at 570 nm






























Cr9.4 = recombinant 58 kDa Hsp (GroEL), pBS = plasmid pBluescript.
OD values are means of two tests
Appendix B Table 19a. IgG, and IgG2 responses of sheep after live infection with
C. ruminantium (Nonile and Mara stocks).
ELISA mean absorbance values of isotypes and days serum
was collected
Dav 14 PI Dav 28 PI
Sheep IgG, IgG2 IgG, IgG2
S2416 0.00 0.00 0.013 0.00
S2455 0.14 0.001 0.605 0.000
S2347 0.006 0.00 0.045 0.000
Appendix B Table 19b. IgG, and IgG2 responses of goats following immunisation
with inactivated EB's (day 34 PI) after challenge (day 28 PC) of the goats with a
virulent homologous stock of C.ruminantium (Welgevonden).
IgG! day 34 PI lgG2 day 34 PI
Goat Nos. Mean OD ±Sem Stdev Mean OD ±Sem Stdev
G476 0.280 0.005 0.006 0.061 0.003 0.004
G601 0.207 0.008 0.012 0.142 0.009 0.013
G614 0.232 0.001 0.001 0.100 0.004 0.006
G668 0.111 0.009 0.013 0.088 0.019 0.027
day 28 PC igG, day 28 PC lgG2 & ODs
Goat Nos. Mean OD ±Sem Stdev Mean OD ±Sem Stdev
G476 0.970 0.051 0.072 0.418 0.051 0.071
G601 0.849 0.052 0.074 1.067 0.008 0.011
G614 0.625 0.141 0.199 1.031 0.022 0.030
G668 0.013 0.029 0.040 0.42 0.006 0.008
Appendix B Table 19c. IgGl and IgG2 responses of South African cattle after live
infection (infection/treatment) with 3 stocks of C. ruminantium.
fgCh
No. OD1 OD2 mean OD ±Sem SD
B7 0.087 0.112 0.100 0.012 0.018
B9 0.605 0.576 0.591 0.014 0.021
B10 0.729 0.831 0.780 0.051 0.072
B25 0.328 0.332 0.330 0.002 0.003
B60 0.044 0.041 0.043 0.002 0.002
B61 0.308 0.32 0.314 0.006 0.008
B155 0.24 0.233 0.237 0.004 0.005
B196 0.94 1.003 0.972 0.032 0.045
B199 1.714 1.778 1.746 0.032 0.045
B200 0.062 0.036 0.049 0.013 0.018
B201 1.641 1.612 1.627 0.014 0.021
B202 0.83 0.828 0.829 0.001 0.001
B203 0.696 0.833 0.765 0.069 0.097
B204 0.443 0.454 0.449 0.006 0.008
B205 0.932 0.957 0.945 0.012 0.018
B206 0.192 0.194 0.193 0.001 0.001
B211 0.335 0.318 0.327 0.008 0.012
positive 0.493 0.418 0.456 0.037 0.053
negative 0.014 0.017 0.016 0.002 0.002
lgG2
No. OD1 OD2 mean OD ±Sem SD
B7 0.102 0.101 0.10 0.00 0.00
B9 0.068 0.09 0.08 0.01 0.02
B10 0.155 0.146 0.15 0.00 0.01
B25 0.024 0.018 0.02 0.00 0.00
B60 0.032 0.035 0.03 0.00 0.00
B61 0.131 0.124 0.13 0.00 0.00
B155 0.197 0.203 0.20 0.00 0.00
B196 0.331 0.345 0.34 0.01 0.01
B199 0.49 0.567 0.53 0.04 0.05
B200 0.012 0.144 0.08 0.07 0.09
B201 0.402 0.449 0.43 0.02 0.03
B202 0.054 0.059 0.06 0.00 0.00
B203 0.112 0.139 0.13 0.01 0.02
B204 0.008 0.007 0.01 0.00 0.00
B205 0.084 0.067 0.08 0.01 0.01
B206 0.064 0.059 0.06 0.00 0.00
B211 0.031 0.031 0.03 0.00 0.00
positive 0.041 0.048 0.04 0.00 0.00
negative 0.007 0.013 0.01 0.00 0.00
Appendix B: Table. 20. Mortality of mice immunised with recombinant 58 kDa
Hsp and controls after challenge with C. ruminantium (Welgevonden).
Antig.+.Adj type
Group
A Cr9.4+FCA Lysate days 7 8 9 11
No. mice 1 4 2 1
B Cr9.4+FIA 66 days 8 9
No. mice 2 7
C pBS+FCA
66
days 7 8 10 11
No. mice 1 2 2 2
D pBS+FIA
66
days 8 9 11
No. mice 1 3 6
E FCA days 10 11
No. mice 2 3
F FIA days 9 10 11
No. mice 2 1 2
G Cr9.4 Live days 7 8 9 10
No. mice 2 2 3 1
H pBS Live days 7 8 10
No. mice 5 4 1
Key
Adj = adjuvant
Cr9.4 = recombinant 58 kDa Hsp (GroEL), pBS = plasmid pBluescript
FCA= Freunds complete adjuvant, FIA = Incomplete Freund adjuvant.
Appendix B Table 21a. Rectal temperature reactions (°C) of sheep before and after
challenge with virulent culture of C. ruminantium (Welgevonden).
sheep & temperatures of the immunised group ( C)
Days S66 S69 S71 S72 S74 S76
-2 40.1 40.0 40.3 40 40.2 40
-1 40.0 39.9 40 40.1 40.1 40
0 39.8 40.1 40.1 40.2 40 40.2
1 39.7 39.8 40.1 40.2 39.9 39.9
2 39.8 39.9 39.14 40.4 40.5 39.9
3 39.3 39.0 39.6 40.3 39.8 39.8
4 39.7 39.4 39.9 40.6 40.1 40.3
5 39.7 39.7 39.8 40.0 40.1 40.1
6 40.1 39.4 40.9 39.8 39.9 41.8
7 40.9 40.7 41.1 41.1 40.8 40.8
8 41.4 41.2 42.0 41.6 40.8 41.6
9 42.2 41.4 42.0 41.7 41.7 41.6
10 41.6 41.3 42.3 42.0 41.5 41.7
11 42.0 41.9 41.9 42.0 42.2




Appendix B Table 21b. Mean daily rectal temperatures (°C) of immunised sheep
after and after challenge with virulent culture of C. ruminantium (Welgevonden).
Day Mean Temp. ±Sem Medians SD
-2 40.1 0.052 40.1 0.194
-1 40.0 0.031 40.0 0.261
0 40.1 0.061 40.1 0.197
1 39.9 0.076 39.9 0.138
2 39.9 0.119 39.9 0.276
3 40.0 0.184 39.7 0.376
4 39.9 0.175 40.0 0.223
5 40.3 0.077 39.9 0.207
6 40.9 0.359 40.0 0.819
7 41.4 0.068 40.9 0.794
8 41.8 0.167 41.5 0.554
9 41.7 0.117 41.7 0.274
10 42.0 0.148 41.7 0.358
11 42.0 0.055 42.0 0.223




Appendix B Table 21c. Rectal temperature (°C) of the controls before and after
challenge with virulent culture of C. ruminantium (Welgevonden).
sheep & temperatures of the control group in C
Days S67 S68 S70 S73 S75 S77
-2 39.9 40.2 40.2 39.8 40.1 40.3
-1 39.6 39.7 39.9 39.8 40.1 40.3
0 39.7 39.9 39.9 39.9 40 40.3
1 39.9 40.2 39.9 39.8 39.9 40
2 39.9 39.9 39.9 40.2 40.1 40.6
3 39.2 39.3 39.8 40.2 39.7 39.9
4 39.6 39.7 40 40.2 40 40
5 39.7 39.7 39.9 40.2 40 40.1
6 39.8 39.5 40 40.2 39.3 41.6
7 39.7 39.8 41.3 41.1 40.8 41.6
40.1 41.2 41.8 41.1 40.9 41.2
9 41.2 41.3 41.9 41.6 41.5 41.2
10 41.6 41 42 41.5 41.2 41.7
11 42.2 42.1 41.7 41.7 41.9 41.7
12 42.5 41.3 42
13 41.1
Appendix B Table 21d. Mean daily rectal temperatures (°C) of control sheep before




-2 40.1 0.079 40.2 0.194
-1 39.9 0.106 39.9 0.261
0 40.0 0.081 39.9 0.197
1 40.0 0.056 39.9 0.138
2 40.1 0.113 40.0 0.276
3 39.7 0.154 39.8 0.376
4 39.9 0.091 40.0 0.223
5 39.9 0.084 40.0 0.207
6 40.1 0.084 39.9 0.819
7 40.7 0.334 41.0 0.794
8 41.1 0.324 41.2 0.554
9 41.5 0.226 41.4 0.274
10 41.5 0.112 41.6 0.358
11 41.9 0.146 41.8 0.223
12 41.9 0.091 42.0 0.603
13 41.1 0.348 41.0
Appendix B. Table 22. Rectal temperatures (°C)goats before and after challenge
with a virulent culture of C. rumnantium (Welgevonden).
I/T. IEB Goats control goats
days post
challenge G74 (I/T) G107 (IEB) G108 G109 G110
-2 40.1 39.2 40.1 40.2 39.9
-1 39.8 39.5 39.6 39.6 39.4
0 39.7 39.3 40.0 39.4 39.8
1 39.7 39.4 40.1 39.6 39.8
2 39.5 39.6 40.0 39.3 39.6
3 39.5 39.0 40.4 40.5 39.6
4 39.6 39.1 39.8 40. 39.6
5 38.8 39.4 40.0 39.8 39.6
6 38.6 40 39.9 40.0 40.1
7 38.6 40.6 40.3 39.9 39.7
8 40.3 40.7 40.3 40.3 40.9
9 39.4 41.6 41.9 41.3 41.2
10 39.2 41.6 41.8 40.8 40.4
11 39.0 41.4
